GWAS
Diversity Monitor
Additional Information
Metric
By
Participants
Stage
Discovery
GWAS
Diversity Monitor
Additional Information
Privacy Policy
NHGRI-EBI Catalog
GitHub
How to cite this
Global Initiative
Q&As
Loader
Total GWAS participants diversity
Version 1.0.0. Last check for data: 2021-12-05 06:06:22 .
94.68%
European
3.88%
Asian
0.11%
African
0.22%
African American or Afro-Caribbean
0.3%
Hispanic or Latin American
0.81%
Other/Mixed
Ancestry over time by parent term
Discovery
Stage
All parent terms
Other disease
Cancer
Other measurement
Other trait
Immune system disorder
Biological process
Lipid or lipoprotein measurement
Digestive system disorder
Response to drug
Metabolic disorder
Neurological disorder
Cardiovascular measurement
Body measurement
Cardiovascular disease
Hematological measurement
Inflammatory measurement
Liver enzyme measurement
OR
Fuchs's corneal dystrophy
Nasopharyngeal carcinoma
Diastolic blood pressure
Systolic blood pressure
Colorectal cancer
Colorectal adenoma (advanced)
Colonoscopy-negative controls vs population controls
"Allergic disease (asthma, hay fever or eczema)"
Fear of severe pain
Fear of minor pain
Fear of medical pain (dental)
Fear of pain
Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms
Lipoprotein (a) levels
Severe malaria (adjusted for sickle cell variant rs334)
Severe malaria
Paclitaxel disposition in epithelial ovarian cancer
Carboplatin disposition in epthelial ovarian cancer
Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel
Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin
Nodular sclerosis Hodgkin lymphoma
Mixed cellularity Hodgkin lymphoma
Hodgkin's lymphoma
Facial emotion recognition
Facial emotion recognition (happy faces)
Facial emotion recognition (sad faces)
Facial emotion recognition (angry faces)
Facial emotion recognition (fearful faces)
Type 2 diabetes
White matter microstructure in first episode schizophrenia (right posterior cingulate cortex)
Total mean fractional anisotropy measurement in first episode schizophrenia
White matter microstructure in first episode schizophrenia (left posterior cingulate cortex)
White matter microstructure in first episode schizophrenia (left inferior parietal cortex)
Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis)
White matter microstructure in first episode schizophrenia (left anterior cingulate cortex)
White matter microstructure in first episode schizophrenia (right anterior cingulate cortex)
Glomerular filtration rate (cystatin C)
Glomerular filtration rate (creatinine)
Primary biliary cirrhosis
Alzheimer's disease
Alzheimer's disease (APOE e4 interaction)
Alzheimer's disease in APOE e4+ carriers
Alzheimer's disease in APOE e4- carriers
Coronary atherosclerosis (increased number of diseased vessels) (traffic exposure interaction)
Nicotine dependence
Breast cancer (estrogen-receptor negative)
Breast cancer
Breast Cancer in BRCA1 mutation carriers
Major depression and alcohol dependence
Diastolic blood pressure x sodium interaction (1df test)
Systolic blood pressure x sodium interaction (2df test)
Diastolic blood pressure x sodium interaction (2df test)
Mean arterial pressure x sodium interaction (2df test)
Systolic blood pressure x sodium interaction (1df test)
Mean arterial pressure x sodium interaction (1df test)
Pulse pressure x sodium interaction (1df test)
Pulse pressure x sodium interaction (2df test)
White coat effect (clinic systolic blood pressure minus home systolic blood pressure)
White coat effect (clinic diastolic blood pressure minus home diastolic blood pressure)
Alcohol consumption over the past year
Insulin levels in response to oral glucose tolerance test (fasting)
Glucagon levels in response to oral glucose tolerance test (fasting)
GIP levels in response to oral glucose tolerance test (fasting)
GLP-1 levels in response to oral glucose tolerance test (fasting)
Insulin levels in response to oral glucose tolerance test (30 minutes)
Insulin levels in response to oral glucose tolerance test (120 minutes)
GLP-1 levels in response to oral glucose tolerance test (120 minutes)
GIP levels in response to oral glucose tolerance test (120 minutes)
Glucagon levels in response to oral glucose tolerance test (120 minutes)
Pursuit maintenance gain in psychotic disorders
Initial pursuit acceleration
Pursuit maintenance gain
Anti-saccade response
Initial pursuit acceleration in psychotic disorders
Anti-saccade error rate in psychotic disorders
Femoral neck bone mineral density
Lumbar spine bone mineral density
Lung function (maximal voluntary ventilation)
Lung function (forced expiratory volume in 1 second)
Lung function (forced expiratory flow during mid-portion (25% and 75%) of forced vital capacity)
Lung function (forced vital capacity)
Lung function (FEV1/FVC)
Orofacial clefts (cleft lip vs. cleft lip and palate)
Problematic alcohol use in trauma-exposed individuals
Whole body bone mineral density and alcohol drinking
Hip bone mineral density and alcohol drinking
Spine bone mineral density and alcohol drinking
Gallbladder cancer
Prostate-specific antigen levels
Prostate-specific antigen levels (conditioned on lead SNPs)
Gut microbiota (functional units)
Gut microbiota (bacterial taxa)
Parkinson's disease
Breast size
Migraine
Asthma
Hypothyroidism
Chin dimples
Allergy
Childhood ear infection
Photic sneeze reflex
Menarche (age at onset)
Age at voice drop
Tonsillectomy
Monobrow
Myopia
Joint mobility (Beighton score)
Nose size
Male-pattern baldness
Peak velocity of the mitral E-wave
Isovolumetric relaxation time
Peak velocity of excursion of lateral mitral annulus in early diastolic phase
Peak velocity of the mitral A-wave
Ratio of the peak velocity of the mitral E-Wave divided by the peak velocity of the mitral A-wave.
Deceleration time of the mitral E-wave
Ratio of the peak velocity of the excursion of the lateral mitral annulus in the early diastolic phase and the peak velocity of the mitral E-wave
Diastolic dysfunction with preserved ejection pressure
Heart failure with preserved ejection fraction
Aortic root size
Left atrial antero-posterior diameter
Left ventricle diastolic internal dimension
Left ventricle wall thickness
Left ventricular mass
Left ventricular fractional shortening
Left ventricle systolic dysfunction
Hepcidin/transferrin saturation ratio
Hepcidin/ferritin ratio
Hepcidin levels
Nonsyndromic cleft lip with or without cleft palate
Agoraphobic traits
Clopidogrel active metabolite levels
Response to clopidogrel therapy
Sepsis in extremely premature infants
Melanoma
Lung function (FEV1/FVC) in asthma (dust mite allergen exposure interaction)
Lung function (FEV1) in asthma (dust mite allergen exposure interaction)
Diabetes in response to antihypertensive drug treatment (treatment strategy interaction)
Pre-treatment pain in head and neck squamous cell carcinoma
Body mass index
Resting heart rate
Liver injury in anti-tuberculosis drug treatment
Brain activation in response to working memory task
Kidney disease (end stage renal disease vs non-end stage renal disease) in type 1 diabetes
Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes
Chronic kidney disease (severe chronic kidney disease vs normal kidney function) in type 1 diabetes
Kidney disease (early and late stages) in type 1 diabetes
Kidney disease (early stage) in type 1 diabetes
Kidney disease (late stage) in type 1 diabetes
Chronic kidney disease (chronic kidney disease vs normal or mildly reduced eGFR) in type 1 diabetes
Central corneal thickness
Pulse pressure
Hippocampal volume
Thyroid cancer
Rectal cancer
Colon cancer
Palmitoleic acid (16:1n-7) levels
Vaccenic acid (18:1n-7) levels
Oleic acid (18:1n-9) levels
Gondoic acid (20:1n-9) levels
Erucic acid (22:1n-9) levels
Nervonic acid (24:1n-9) levels
Lean body mass
QRS duration
QRS complex (12-leadsum)
QRS complex (Cornell)
QRS complex (Sokolow-Lyon)
Hepatitis B (viral clearance)
Rheumatoid arthritis
Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)
Rheumatoid arthritis (rheumatoid factor and anti-cyclic citrullinated peptide seronegative)
Carotenoid levels (cryptoxanthin)
Carotenoid levels (alpha-carotene)
Vitamin E levels (alpha-tocopherol)
Carotenoid levels (beta-carotene)
Carotenoid levels (lutein)
Carotenoid levels (zeaxanthin)
Vitamin E levels (gamma-tocopherol)
Retinol levels
Otitis media
Otitis media (chronic)
Otitis media (recurrent)
"Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy)"
Mean corpuscular hemoglobin concentration
Red blood cell count
Mean corpuscular hemoglobin
Hematocrit
Mean corpuscular volume
Hemoglobin levels
Carotid plaque burden
Hypertension
Adiponectin levels in pregnancy
Systolic blood pressure (long-term average)
Diastolic blood pressure (long-term average)
Pulse pressure (long-term average)
Mean arterial pressure (long-term average)
Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder
Chronic obstructive pulmonary disease
Cognitive function
Fasting plasma glucose
HDL cholesterol
"Cholesterol, total"
Body fat percentage
Urate levels
Height
Creatinine levels
Urea levels
Waist-to-hip ratio adjusted for body mass index
Age-related diseases and mortality
"Age-related diseases, mortality and associated endophenotypes"
Age-related disease endophenotypes
Nicotine metabolite ratio
Total cholesterol levels
LDL cholesterol levels
HDL cholesterol levels
Triglyceride levels
Survival in breast cancer (TP53 expression interaction)
Survival in TP53 positive breast cancer
Vasculitis associated with antineutrophil cytoplasmic antibody reactive to myeloperoxidase
Vasculitis associated with antineutrophil cytoplasmic antibody reactive to proteinase-3
Antineutrophil cytoplasmic antibody-associated vasculitis
Depressive symptoms
Depressive symptoms (stressful life events interaction)
QT interval (tricyclic/tetracyclic antidepressant use interaction)
RR interval (tricyclic/tetracyclic antidepressant use interaction)
Immune response to measles vaccine (measles-specific neutralising antibody titre)
Immune response to measles vaccine (measles-induced IFN gamma)
Cleft palate
Orofacial clefts
Cleft lip with or without cleft palate
Liver injury in anti-retroviral drug treated HIV
Liver injury in combined anti-retroviral and anti-tuberculosis drug-treated HIV with tuberculosis
Atrial fibrillation
Paneth cell defects in Crohn's disease
Progression free survival in EGFR-mutation-positive never-smoking lung adenocarcinoma treated with gefitinib or erlotinib
Emphysema distribution in smoking
Lung function (FEV1)
Lung function (FVC)
Chronic lymphocytic leukemia
Optic cup area
Vertical cup-disc ratio
Optic disc area
Intraocular pressure
Resistance to antihypertensive treatment in hypertension
Body fat mass
Skin pigmentation
Daytime sleep phenotypes
Night sleep phenotypes
Methadone dose in opioid dependence
Craniofacial microsomia
Telomere length
Estrone conjugates/estrone ratio in resected early stage estrogen-receptor positive breast cancer
Estrone/androstenedione ratio in resected early stage-receptor positive breast cancer
Plasma estrone levels in resected estrogen-receptor positive breast cancer
Plasma androstenedione levels in resected early stage-receptor positive breast cancer
Plasma estrone conjugates levels in resected early stage estrogen-receptor positive breast cancer
Aggressive periodontitis
Prevalent type 2 diabetes
Hemoglobin
Red cell distribution width
Preterm birth (maternal effect) (maternal pre-pregnancy BMI interaction)
Preterm birth (maternal effect)
Spontaneous preterm birth (maternal effect)
Gestational age at birth (maternal effect)
Knee osteoarthritis
Insomnia complaints
Sleep duration
Insomnia complaints (sex interaction)
Insomnia complaints (continuous)
Insomnia complaints (dichotomous)
Chronotype
Ease of getting up in the morning
Daytime nap
Snoring
Daytime sleepiness
Heart rate
Heart rate variability traits (RMSSD)
Heart rate variability traits (SDNN)
Anorexia nervosa (excluding migration to or from binge-eating disorder or bulimia nervosa)
Cerebral blood flow
Testicular germ cell tumor
Depressive symptoms (MTAG)
Subjective well-being (MTAG)
Neuroticism (MTAG)
Neuroticism
Subjective well-being
Neurocognitive impairment in HIV-1 infection (continuous)
HIV-associated neurocognitive disorder (mild neurocognitive disorder or asymptomatic neurocognitive impairment)
HIV-associated neurocognitive disorder (mild neurocognitive disorder)
HIV-associated neurocognitive disorder
Neurocognitive impairment in HIV-1 infection (dichotomous)
HIV-associated neurocognitive disorder (asymptomatic neurocogntive impairment)
Obstetric antiphospholipid syndrome
Primary biliary cholangitis
Residual cognition
Peripheral arterial disease (traffic-related air pollution interaction)
Juvenile idiopathic arthritis (oligoarticular or rheumatoid factor-negative polyarticular)
Pediatric non-alcoholic fatty liver disease activity score
Liver fibrosis in pediatric non-alcoholic fatty acid liver disease
Pediatric nonalcoholic steatohepatitis
Nicotine metabolite ratio in current smokers
Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia
Atopy
Alcohol consumption
Alcohol consumption in current drinkers
Renal cell carcinoma
Heart rate variability traits (pvRSA/HF)
Nonalcoholic steatohepatitis-derived hepatocellular carcinoma
Brunt stage in nonalcoholic fatty liver disease
Brunt grade in nonalcoholic fatty liver disease
Hepatocyte fat droplet content in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease
Neuroblastoma (11q deletion)
Neuroblastoma (11q deletion vs 11q undeleted and MYCN amplification)
Neuroblastoma (1p deletion)
Neuroblastoma (MYCN amplification)
Hepatocellular carcinoma in hepatitis C infection
Blood protein levels
Amyotrophic lateral sclerosis (sporadic)
BMI x dairy intake interaction (1df interaction test)
Menopause (age at onset)
Borderline personality disorder
"B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)"
Blood osmolality (transformed sodium)
Breast cancer in childhood cancer survivors treated with less than 10 gray radiotherapy
Breast cancer in childhood cancer survivors treated with more than 10 gray radiotherapy
Breast cancer in childhood cancer survivors
Cow's milk allergy
Food allergy
Peanut allergy
Hen's egg allergy
Idiopathic pulmonary fibrosis
Extrinsic epigenetic age acceleration
Intrinsic epigenetic age acceleration
Pulmonary arterial hypertension
Small vessel stroke
NHDL cholesterol to HDL cholesterol ratio
LDL cholesterol to HDL cholesterol ratio
Triglyceride to HDL cholesterol ratio
Obstructive sleep apnea trait (apnea hypopnea index)
Obstructive sleep apnea during non-REM sleep (apnea hypopnea index)
Obstructive sleep apnea during REM sleep (apnea hypopnea index)
Alzheimer's disease (age of onset)
Uncontrolled blood pressure in combination therapy (beta blocker and thiazide diuretic)
Systolic blood pressure in combination therapy (beta blocker and thiazide diuretic)
Diastolic blood pressure in combination therapy (beta blocker and thiazide diuretic)
PR interval
Systolic blood pressure x smoking status (current vs non-current) interaction (1df test)
Systolic blood pressure x smoking status (current vs non-current) interaction (2df test)
Diastolic blood pressure x smoking status (current vs non-current) interaction (1df test)
Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test)
Systolic blood pressure x smoking status (ever vs never) interaction (2df test)
Diastolic blood pressure x smoking status (ever vs never) interaction (1df test)
Diastolic blood pressure x smoking status (ever vs never) interaction (2df test)
Systolic blood pressure x smoking status (ever vs never) interaction (1df test)
Systolic blood pressure (cigarette smoking interaction)
Diastolic blood pressure (cigarette smoking interaction)
Body mass index x sex interaction
Body mass index x sex x age interaction (4df test)
Body mass index (age>50)
Body mass index (age <50)
Body mass index x age interaction
Body mass index x sex x age interaction
Waist-to-hip ratio adjusted for BMI
Waist-to-hip ratio adjusted for BMI (age <50)
Waist-to-hip ratio adjusted for BMI (age >50)
Waist-to-hip ratio adjusted for BMI x sex interaction
Waist-to-hip ratio adjusted for BMI x sex x age interaction
Waist-to-hip ratio adjusted for BMI x age interaction
Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test)
White blood cell count
White blood cell count (basophil)
White blood cell count (eosinophil)
White blood cell count (lymphocyte)
White blood cell count (monocyte)
White blood cell count (neutrophil)
Alcohol consumption (drinks per week)
Alcohol consumption (drinkers vs non-drinkers)
Elevated serum prostate-specific antigen levels in healthy men
Autism spectrum disorder or schizophrenia
Autism spectrum disorder
BMI (smoking interaction)
Waist circumference adjusted for BMI (adjusted for smoking behaviour)
Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour)
Waist-to-hip ratio adjusted for BMI (smoking interaction)
Waist circumference adjusted for BMI (smoking interaction)
Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction)
Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction)
BMI (adjusted for smoking behaviour)
Body mass index (joint analysis main effects and smoking interaction)
Waist circumference adjusted for BMI in non-smokers
Waist-to-hip ratio adjusted for BMI in smokers
BMI in non-smokers
Waist circumference adjusted for BMI in smokers
BMI in smokers
Waist-to-hip ratio adjusted for BMI in non-smokers
Systemic sclerosis
Blood pressure traits (multi-trait analysis)
Endometriosis
Intelligence
Tissue factor pathway inhibitor levels
Body mass index (adult)
Sarcoidosis
Tacrolimus trough concentration in kidney transplant patients
Psoriasis
Energy expenditure (24h)
Resting metabolic rate
Rheumatic heart disease
Anorexia nervosa
Peak insulin response
Acute insulin response
Insulin secretion rate
Insulin disposition index
Insulin disposition index (BMI adjusted)
Peak insulin response (BMI and insulin secretion adjusted)
Peak insulin response (insulin secretion adjusted)
Acute insulin response (insulin secretion and BMI adjusted)
Acute insulin response (insulin secretion adjusted)
insulin secretion rate (BMI adjusted)
Bone ultrasound measurement (velocity of sound)
Bone ultrasound measurement (broadband ultrasound attenuation)
Primary sclerosing cholangitis
"Primary sclerosing cholangitis associated immune-mediated diseases (Crohn's disease, celiac disease, psoriasis, rheumatoid arthritis, sarcoidosis, type 1 diabetes or ulcerative colitis) (pleiotropy)"
Dehydroepiandrosterone sulphate levels
Glycated hemoglobin levels
Alanine transaminase levels
Serum albumin levels
Serum alkaline phosphatase levels
Fibrinogen levels
Aspartate aminotransferase levels
Gamma glutamyl transferase levels
C-reactive protein levels
Insulin-like growth factor 1 levels
Ferritin levels
Testosterone levels
LDL cholesterol
Glomerular filtration rate
Neuropathy in taxane-treated breast cancer
Psychosis proneness (hypomanic personality scale)
Psychosis proneness (perceptual aberration scale)
Psychosis proneness (revised physical anhedonia scale)
Psychosis proneness (revised social anhedonia scale)
Psychosis proneness (hypomanic personality scale and perceptual aberration scale)
Psychosis proneness (schizoidia scale)
Psychosis proneness (hypomanic personality scale and revised physical anhedonia scale)
Psychosis proneness (hypomanic personality scale and revised social anhedonia scale)
Psychosis proneness (perceptual aberration scale and revised physical anhedonia scale)
Psychosis proneness (perceptual aberration scale and revised social anhedonia scale)
Psychosis proneness (revised physical anhedonia scale and revised social anhedonia scale)
Bone erosion in rheumatoid arthritis
Lung cancer
Lung adenocarcinoma
Squamous cell lung carcinoma
Small cell lung carcinoma
Lung cancer in ever smokers
Lung cancer in never smokers
Ankylosing spondylitis
Ankylosing spondylitis (SNP x SNP interaction)
Breast cancer (estrogen-receptor positive)
Acute graft versus host disease in bone marrow transplantation (recipient effect)
Acute graft versus host disease in bone marrow transplantation (donor effect)
Barrett's esophagus
Esophageal adenocarcinoma
Barrett's esophagus or Esophageal adenocarcinoma
Waist-to-hip ratio adjusted for BMI (joint analysis for main effect and physical activity interaction)
Waist circumference adjusted for body mass index
Body mass index (physical activity interaction)
Waist circumference adjusted for BMI (physical activity interaction)
Waist-to-hip ratio adjusted for BMI (physical activity interaction)
Body mass index (joint analysis main effects and physical activity interaction)
Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction)
Body mass index in physically active individuals
Body mass index in physically inactive individuals
Waist circumference adjusted for BMI in active individuals
Waist circumference adjusted for BMI in inactive individuals
Waist-to-hip ratio adjusted for BMI in active individuals
Waist-to-hip ratio adjusted for BMI in inactive individuals
Hepatocellular carcinoma in post hepatitis C eradication by interferon therapy
Tooth agenesis
Tooth agenesis (mandibular second premolars)
Tooth agenesis (maxillary lateral incisors)
Tooth agenesis (maxillary second premolars)
Smoking status (daily vs non-daily)
Smoking status (heavy vs light)
Smoking status (current vs former)
Smoking status (ever vs never smokers)
Incident atrial fibrillation
Prevalent atrial fibrillation
Severe gingival inflammation
Left ventricular obstructive tract defect (inherited effect)
Conotruncal heart defects (maternal effects)
Left ventricular obstructive tract defect (maternal effect)
Congenital heart disease (inherited effect)
Congenital heart disease (maternal effect)
Conotruncal heart defects (inherited effects)
Early onset atrial fibrillation
Itch intensity from mosquito bite
Itch intensity from mosquito bite adjusted by bite size
Mosquito bite size
Perceived unattractiveness to mosquitoes
Plasma trimethylamine N-oxide levels
Myeloid white cell count
Lymphocyte counts
Immature fraction of reticulocytes
Neutrophil count
Basophil percentage of white cells
Lymphocyte percentage of white cells
Neutrophil percentage of white cells
Basophil percentage of granulocytes
Mean platelet volume
Survival in pancreatic cancer
Achilles tendinopathy
Anterior cruciate ligament rupture
Systemic lupus erythematosus
HIV-1 viral setpoint
HIV-1 susceptibility
Age-related macular degeneration
Glioma
Acute lymphoblastic leukemia (childhood)
Body mass index (SNP x SNP interaction)
Cannabis dependence
Drug-induced liver injury
Plasminogen activator inhibitor type 1 levels (PAI-1)
Vitiligo
Sex hormone-binding globulin levels
Systolic blood pressure in sickle cell anemia
Lipoprotein diameter
Fat body mass
Autism
Response to antidepressants
Pancreatic cancer
Atopic dermatitis
Response to haloperidol in psychosis
Esophageal squamous cell carcinoma
Post-traumatic stress disorder
Conduct disorder (symptom count)
Conduct disorder
Bladder cancer
Chronic hepatitis B infection
Digestive system disease (Barrett's esophagus and esophageal adenocarcinoma combined)
Smoking cessation
Response to radiotherapy in cancer (late toxicity)
Toenail selenium levels
Blood and toenail selenium levels
Vitamin B levels in ischemic stroke
Electroencephalogram traits
Laryngeal squamous cell carcinoma
Hearing function
Nicotine use
Alcohol dependence
Illicit drug use
Non-substance related behavioral disinhibition
Behavioural disinhibition (generation interaction)
Fibrinogen
Resting oxygen saturation in chronic osbtructive pulmonary disease (pulse oxymetry)
Acne (severe)
Smoking quantity
Smoking initiation
Age of smoking initiation
Anger
Birth length
Infant length
Pulmonary function
Plasma homocysteine levels (post-methionine load test)
Mitochondrial DNA levels
Serum thyroid-stimulating hormone levels
Maternal genotype effects in autism spectrum disorder families
Type 2 diabetes (young onset) and obesity
Chronic obstructive pulmonary disease (moderate to severe)
Chronic obstructive pulmonary disease (severe)
Preschool internalizing problems
Local histogram emphysema pattern
Blood pressure measurement (cold pressor test)
Blood pressure measurement (high sodium and potassium intervention)
Blood pressure measurement (low sodium intervention)
Blood pressure measurement (high sodium intervention)
Corneal curvature
Response to platinum-based chemotherapy (carboplatin)
Response to platinum-based chemotherapy (cisplatin)
Attention deficit hyperactivity disorder
Colorectal cancer (SNP x SNP interaction)
Factor VIII levels
Factor VII levels
vWF levels
IgG levels
Schizophrenia
Narcolepsy
Hypertriglyceridemia
Waist-to-hip circumference ratio (ever vs never smoking interaction)
Body mass index (alcohol intake interaction)
Body mass index (dietary energy interaction)
Body mass index (recreational physical activity interaction)
Body mass index (ever vs never smoking interaction)
Body mass index (smoking years interaction)
Waist-to-hip circumference ratio (dietary energy interaction)
Waist-to-hip circumference ratio (smoking years interaction)
Waist-to-hip circumference ratio (recreational physical activity interaction)
Waist-to-hip circumference ratio (alcohol intake interaction)
Self-reported allergy
Arthritis (juvenile idiopathic)
Depression and alcohol dependence
Coronary heart disease
Bone mineral density
Bipolar disorder
Temporomandibular joint disorder
Ulcerative colitis
Eosinophilic esophagitis (pediatric)
Breast cancer (early onset)
Type 1 diabetes and autoimmune thyroid diseases
Polychlorinated biphenyl levels
Behavioral disinhibition
Verbal declarative memory
Myasthenia gravis
Carotid artery intima media thickness (sex interaction)
Diisocyanate-induced asthma
Prostate cancer
Prostate cancer aggressiveness
Serum total protein level
Dental caries
Neuropathic pain in type 2 diabetes
Vincristine-induced peripheral neuropathy in acute lymphoblastic leukemia
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe mucosal involvement
Response to Homoharringtonine (cytotoxicity)
Ticagrelor levels in individuals with acute coronary syndromes treated with ticagrelor
AR-C124910XX levels in individuals with acute coronary syndromes treated with ticagrelor
Suicide in bipolar disorder
Serum tamsulosin hydrochloride concentration
Iron status biomarkers (ferritin levels)
Iron status biomarkers (transferrin saturation)
Iron status biomarkers (iron levels)
Iron status biomarkers (transferrin levels)
Diffuse large B cell lymphoma
Hip circumference (psychosocial stress interaction)
Thiazide-induced adverse metabolic effects in hypertensive patients
Clozapine-induced cytotoxicity
Sitting height ratio
Magnesium levels
Calcium levels
Response to serotonin reuptake inhibitors in major depressive disorder
Creutzfeldt-Jakob disease (sporadic)
Chronic obstructive pulmonary disease-related biomarkers
Response to chemotherapy in breast cancer (hypertension) (bevacizumab)
Response to chemotherapy in breast cancer hypertensive cases (cumulative dose) (bevacizumab)
Circulating phylloquinone levels
Mammographic density
Acoustic startle blink response
Metabolic syndrome
Gene methylation in lung tissue
Milk allergy
Egg allergy
Parkinson disease and lewy body pathology
Exudative age-related macular degeneration
Nickel levels
Chromium levels
Cobalt levels
Aluminium levels
Manganese levels
Molybdenum levels
Lead levels
Zinc levels
Mercury levels
Cadmium levels
Copper levels
Vascular endothelial growth factor levels
Low high density lipoprotein cholesterol levels
Entorhinal cortical thickness
Entorhinal cortical volume
Whole-brain volume
Entorhinal cortical thickness (Alzheimer's disease interaction)
Total ventricular volume
Entorhinal cortical volume (Alzheimer's disease interaction)
Total ventricular volume (Alzheimer's disease interaction)
Whole-brain volume (Alzheimer's disease interaction)
Hippocampal volume (Alzheimer's disease interaction)
Scalp hair shape
Beard thickness
Eyebrow thickness
Monobrow thickness
Hair greying
Hair color
Balding
Vitamin D levels
Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia
Squamous cell carcinoma
Ischemic stroke (large artery atherosclerosis)
Ischemic stroke (small artery occlusion)
Ischemic stroke (undetermined subtype)
Ischemic stroke
Ischemic stroke (cardioembolic)
Thoracic-to-hip circumference ratio
White matter hyperintensities in ischemic stroke
Periodontal disease-related phenotype (Socransky)
Periodontal disease related phenotype (PCT2)
Periodontal disease related phenotype (PCT3)
Periodontal disease related phenotype (PCT4)
Periodontal disease related phenotype (PCT5)
Periodontal disease related phenotype (PCT6)
Incident coronary heart disease
Incident myocardial infarction
Serum lycopene concentrations
Percentage gas trapping
Airway imaging phenotypes
Emphysema imaging phenotypes
Urinary albumin-to-creatinine ratio in diabetes
Urinary albumin-to-creatinine ratio in non-diabetics
Microalbuminuria
Urinary albumin-to-creatinine ratio
Colorectal or endometrial cancer
Bone mineral accretion in asthma (oral corticosteroid dose interaction)
Adolescent idiopathic scoliosis
Serum alpha1-antitrypsin levels
Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder
Attention function in attention deficit hyperactive disorder
Asperger syndrome
Ultraviolet-induced skin pigmentation (minimal erythema dose)
Post-bronchodilator lung function in asthma (FEV1)
Post-bronchodilator lung function in asthma (FEV1/FVC)
Platelet thrombus formation
Pediatric autoimmune diseases
Bone mineral density (spine) and age at menarche
Bone mineral density (hip) and age at menarche
Alzheimer's disease (late onset)
Extraversion
Adiponectin levels
Adiponectin levels (BMI-adjusted)
Plasma lactate levels
Postburn hypertrophic scarring severity
Carotid intima media thickness
Coronary artery disease
Myocardial infarction
Eating disorder in bipolar disorder
Bipolar disorder and eating disorder
Coronary artery aneurysm in Kawasaki disease
White matter lesion progression
White matter lesion progression (adjusted for white matter lesion burden at baseline)
Cingulate cortical amyloid beta load
Lung disease severity in cystic fibrosis
Staphylococcus aureus infection
Skin and soft tissue Staphylococcus aureus infection
Mucinous ovarian carcinoma
Joint damage progression in ACPA-negative rheumatoid arthritis
Stroke
Platinum-induced hepatotoxicity in non-small cell lung cancer
Response to montelukast in asthma (change in FEV1)
Gastric cancer
Gastric adenocarcinoma (histologically verified)
Suicide behavior
Suicide ideation score in major depressive disorder
Suicide
Suicide attempts in major depressive disorder
Advanced glycation end-product levels
Cardiovascular disease in hypertension (ACE inhibitor interaction)
Cardiovascular disease in hypertension (calcium channel blocker interaction)
Myocardial infarction in hypertension (calcium channel blocker interaction)
Cardiovascular disease in hypertension (diuretic interaction)
Cardiovascular disease in hypertension (beta blocker interaction)
Myocardial infarction in hypertension (ACE inhibitor interaction)
Myocardial infarction in hypertension (beta blocker interaction)
Myocardial infarction in hypertension (diuretic interaction)
Late-onset myasthenia gravis
Response to Pazopanib in cancer (hepatotoxicity)
LDL peak particle diameter (total fat intake interaction)
Dysphagia
Triptolide cytotoxicity
Frontotemporal dementia
Prostate cancer (survival)
Response to lithium treatment in bipolar disorder (dichotomous phenotype)
Response to lithium treatment in bipolar disorder (continuous phenotype)
Platelet count
Sense of smell
Rheumatoid factor seropositivity in rheumatoid arthritis
Parental longevity (father's age at death)
Parental longevity (mother's age at death)
Parental longevity (combined parental age at death)
Parental extreme longevity (95 years and older)
Triglycerides
Multiple system atrophy
Cannabis use
Brain arteriovenous malformations (sporadic)
Response to anti-TNF therapy in rheumatoid arthritis
Glomerular filtration rate in non diabetics (creatinine)
Glomerular filtration rate in diabetics (creatinine)
Chronic kidney disease
Waist circumference
Waist-hip ratio
World class endurance athleticism
Endurance athleticism
Morning vs. evening chronotype
Oligoclonal band status in multiple sclerosis
Immunoglobulin G index levels in multiple sclerosis
Motion sickness
Periodontitis
Leprosy
Adenocarcinoma
Platinum-induced myelosuppression in non-small cell lung cancer
Alzheimer disease and age of onset
Bone mineral density (spine)
Bone mineral density (hip)
Blood metabolite levels
Trans fatty acid levels
Subcortical brain region volumes
Cutaneous psoriasis
Psoriasis vulgaris
Psoriatic arthritis
Psoriatic arthritis vs Cutaneous psoriasis
circulating leptin levels adjusted for BMI
circulating leptin levels
Gut microbiome composition (summer)
Gut microbiome composition (summer and winter)
Gut microbiome composition (winter)
Proteinuria in chronic kidney disease
Proteinuria and chronic kidney disease
Glomerular filtration rate in chronic kidney disease
Narcolepsy with cataplexy
Response to stavudine in HIV (lipoatrophy)
Perioperative myocardial infarction in coronary artery bypass surgery
Sex hormone levels
Yu-Zhi constitution type in type 2 diabetes
Multiple myeloma (survival)
Trichloroethylene-induced hypersensitivity syndrome
Amyotrophic lateral sclerosis
Warfarin maintenance dose
Anthracycline-induced cardiotoxicity in childhood cancer
Fentanyl consumption in laparoscopic-assisted colectomy (first 24 hours)
Cutaneous malignant melanoma
Postprandial triglyceride response to high fat diet meal
Mean arterial pressure
Obstructive sleep apnea (average oxygen saturation during sleep)
Obstructive sleep apnea trait (average respiratory event duration)
Response to cyclophosphamide in systemic lupus erythematosus with lupus nephritis
Glucocorticoid-induced osteonecrosis (time dependent analysis)
Glucocorticoid-induced osteonecrosis (time independent analysis)
Glucocorticoid-induced osteonecrosis
Endophenotypes for schizophrenia in healthy individuals
Multiple myeloma
Multiple myeloma and monoclonal gammopathy
Paclitaxel-induced neuropathy
Paclitaxel-induced cytotoxicity
3-hydroxypropylmercapturic acid levels in smokers
3-hydroxy-1-methylpropylmercapturic acid levels in smokers
Blond vs non-blond hair color
Brown vs. non-brown hair color
Light vs. dark hair color
Red vs non-red hair color
Black vs. non-black hair color
Rotator cuff tears
Influenza A (H1N1) severity
Influenza A (H1N1) infection
Mild influenza (H1N1) infection
Severe influenza A (H1N1) infection
Antipsychotic drug-induced weight gain
Antipsychotic drug-induced weight gain (time interaction)
Myositis
Childhood body mass index
Cannabis dependence symptom count
Liver fibrosis severity in HIV/hepatitis C co-infection
Spherical equivalent (joint analysis main effects and education interaction)
"Parkinson's disease (non-familial, age at onset)"
Parkinson's disease (age of onset)
"Parkinson's disease (familial, age at onset)"
Membranous nephropathy
Ischemic stroke (non-cardioembolic)
Sleep duration (oversleepers vs undersleepers)
Sleep duration (oversleepers)
Sleep duration (undersleepers)
Endometrial endometrioid carcinoma
Endometrial cancer
Anti-thyroid drug induced agranulocytosis
Non-chemotherapy drug induced agranulocytosis
S-phenylmercapturic acid levels in smokers
Estrogen receptor status in HER2 positive breast cancer
Estrogen receptor status in HER2 negative breast cancer
Estrogen receptor status in breast cancer
Diastolic blood pressure response to hydrochlorothiazide in hypertension
Systolic blood pressure response to hydrochlorothiazide in hypertension
Memory performance
Verbal-numerical reasoning
Educational attainment
Reaction time
Thyroid-associated orbitopathy in graves' disease
Ideal cardiovascular health (clinical and behavioural)
Ideal cardiovascular health (clinical)
Celiac disease and Rheumatoid arthritis
middle facial morphology traits (ordinal measurement)
lower facial morphology traits (ordinal measurement)
middle facial morphology traits (quantitative measurement)
lower facial morphology traits (quantitative measurement)
facial morphology traits (multivariate analysis)
upper facial morphology traits (ordinal measurement)
Collagenous colitis
Migraine without aura
Migraine with aura
Pneumococcal bacteremia
Bacteremia
Metabolite levels (lipid measures)
Metabolite levels (small molecules and protein measures)
Metabolite levels (lipoprotein measures)
Asparaginase-induced acute pancreatitis in acute lymphoblastic leukemia (onset time)
Subcutaneous adipose tissue
Visceral adipose tissue
Pericardial adipose tissue adjusted for height and weight
Visceral adipose tissue adjusted for BMI
Pericardial fat
Subcutaneous adipose tissue attenuation (Hounsfield unit scale)
Visceral adipose tissue attenuation (Hounslow unit scale)
Visceral adipose tissue/subcutaneous adipose tissue ratio
Visceral adipose tissue/subcutaneous adipose tissue ratio adjusted for BMI
Serum parathyroid hormone levels
Clinical laboratory measurements
Urinary electrolytes (magnesium/calcium ratio)
Depressive symptoms measurement (somatic complaints domain)
Depressive symptoms measurement (lack of negative affect domain)
Depressive symptoms measurement (lack of positive affect domain)
Gestational age at birth in labor-initiated deliveries (child effect)
Gestational age at birth in premature rupture of membrane-initiated deliveries (child effect)
Gestational age at birth in labor-initiated deliveries (maternal effect)
Gestational age at birth in premature rupture of membrane-initiated deliveries (maternal effect)
Gestational age at birth (child effect)
Alcohol consumption (heavy vs. light/non-drinkers)
Agreeableness
Conscientiousness
Openness
Multiple sclerosis
Bone mineral density (Ward's triangle area)
Adverse response to dabrafenib or dabrafenib-trametinib treatment in melanoma (pyrexia)
Cluster headache
Abdominal aortic aneurysm
Number of children ever born
Age at first birth
Excessive daytime sleepiness
Sleep traits (multi-trait analysis)
Insomnia
Sciatica caused by lumbar disc herniation (treated with microdiscectomy)
Response to selective serotonin reuptake inhibitors in depression
Response to citalopram or escitalopram in depression
Response to antidepressants in depression
Non-response to bupropion and depression
Response to bupropion and depression
Response to selective serotonin reuptake inhibitors and depression
Non-response to citalopram or escitalopram and depression
Response to citalopram or escitalopram and depression
Non-response to antidepressants and depression
Non-response to selective serotonin reuptake inhibitors and depression
Response to antidepressants and depression
Response to bupropion in depression
Nonsyndromic cleft lip with cleft palate
Monocyte-lymphocyte ratio
Monocyte count
Loneliness (multivariate analysis)
Loneliness
Loneliness (linear analysis)
Presence of antiphospholipid antibodies
Gout
Renal underexcretion gout
Renal overload gout
Midgestational circulating levels of organochlorine pesticides
Midgestational circulating levels of PCBs (fetal genetic effect)
Midgestational circulating levels of PBDEs
Midgestational circulating levels of PBDEs (fetal genetic effect)
Midgestational circulating levels of organochlorine pesticides (fetal genetic effect)
Midgestational circulating levels of PCBs
"Caffeine metabolism (plasma 1,3,7-trimethyluric acid level)"
"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) level)"
"Caffeine metabolism (plasma 3,7-dimethylxanthine (theobromine) level)"
"Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level)"
"Caffeine metabolism (plasma 1,3-dimethylxanthine (theophylline) level)"
"Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio)"
Large artery stroke
Glomerular load of uric acid
Uric acid clearance
Fractional excretion of uric acid
Creatinine clearance
Urinary uric acid to urinary creatinine ratio
Lumbar spondylosis (disc space narrowing)
Lumbar spondylosis (presence and severity of osteophytes)
Lumbar spondylosis (Kellgren-Lawrence grade)
Thrombin-activatable fibrinolysis inhibitor levels
Thrombin-activatable fibrinolysis inhibitor activation peptide
Response to metformin in type 2 diabetes (HbA1c reduction)
Circulating chemerin levels
Family history of upper gastrointestinal cancer in esophageal squamous cell carcinoma
Obsessive-compulsive disorder or autism spectrum disorder
Serum uric acid levels in response to allopurinol in gout
Alzheimer's disease or type 2 diabetes (pleiotropy)
Matrix metalloproteinase-8 levels
Restless legs syndrome
Adult asthma
Asthma (childhood onset)
QT interval
Response to cognitive-behavioural therapy in anxiety disorder
Core binding factor acute myeloid leukemia
Selective IgA deficiency
Mosaic loss of chromosome Y
Luteinizing hormone levels in polycystic ovary syndrome
Follicle stimulating hormone levels in polycystic ovary syndrome
Sex hormone-binding globulin levels in polycystic ovary syndrome
Testosterone levels in polycystic ovary syndrome
Polycystic ovary syndrome
DHEAS levels in polycystic ovary syndrome
Taxane-induced peripheral neuropathy in breast cancer
Hand grip strength
Lower body strength
HER2 status in breast cancer
Differentiated thyroid cancer
Papillary thyroid cancer
Follicular thyroid cancer
Immunoglobulin A vasculitis
General cognitive ability
Forced expiratory volume in 1 second (environmental tobacco smoke interaction)
Opioid requirements during laparoscopic-assisted colectomy
Response to metformin (IC50)
Coenzyme Q10 levels
Apolipoprotein B levels
Ratio of apolipoprotein A1 to apolipoprotein B
Esterified cholesterol levels
Free cholesterol levels
Total cholesterol levels in HDL
Total cholesterol levels in LDL
Serum total cholesterol levels
Total triglycerides levels
Mean diameter of HDL particles
Mean diameter of LDL particles
Mean diameter of VLDL particles
Very large VLDL particle concentration
Phospholipid levels in very large VLDL
Triglyceride levels in very large VLDL
Phospholipid levels in large VLDL
Total cholesterol levels in large VLDL
Free cholesterol levels in large VLDL
Triglyceride levels in large VLDL
Cholesterol ester levels in large VLDL
Medium VLDL particle concentration
Phospholipid levels in medium VLDL
Total cholesterol levels in medium VLDL
Cholesterol ester levels in medium VLDL
Free cholesterol levels in medium VLDL
Triglyceride levels in medium VLDL
Small VLDL particle concentration
Phospholipid levels in small VLDL
Total cholesterol levels in small VLDL
Free cholesterol levels in small VLDL
Triglyceride levels in small VLDL
Very small VLDL particle concentration
Phospholipid levels in very small VLDL
Triglyceride levels in very small VLDL
IDL particle concentration
Phospholipid levels in IDL
Free cholesterol levels in IDL
Triglyceride levels in IDL
Large LDL particle concentration
Phospholipid levels in large LDL
Total cholesterol levels in large LDL
Cholesterol ester levels in large LDL
Free cholesterol levels in large LDL
Medium LDL particle concentration
Phospholipid levels in medium LDL
Total cholesterol levels in medium LDL
Cholesterol ester levels in medium LDL
Small LDL particle concentration
Total cholesterol levels in small LDL
Survival in head and neck cancer
Dysmenorrheic pain
Job-related exhaustion in shift workers
Intelligence (MTAG)
Bipolar disorder (early onset)
Drug abuse
Breast cancer-free interval (treatment with aromatase inhibitor)
Post-term birth
Risky sexual behaviors (alcohol dependence interaction)
Risky sexual behaviors in alcohol dependence
Hair shape
Food addiction
Bipolar disorder lithium response (continuous) or schizophrenia
Bipolar disorder lithium response (categorical) or schizophrenia
Male sexual orientation
Dementia with Lewy bodies
Delayed reward discounting
Chronic rhinosinusitis with nasal polyps
Low density lipoprotein cholesterol levels
High density lipoprotein cholesterol levels
Inhibitory control
Parental lifespan
Response to mepolizumab in severe asthma
Moyamoya disease
Thiazide-induced hyponatremia
Laterality in neovascular age-related macular degeneration
Eosinophil percentage of white cells
Eosinophil counts
Plateletcrit
Granulocyte percentage of myeloid white cells
Monocyte percentage of white cells
High light scatter reticulocyte count
Sum neutrophil eosinophil counts
Granulocyte count
High light scatter reticulocyte percentage of red cells
Hemoglobin concentration
Platelet distribution width
Eosinophil percentage of granulocytes
Reticulocyte fraction of red cells
Sum basophil neutrophil counts
Reticulocyte count
Neutrophil percentage of granulocytes
Sum eosinophil basophil counts
Bone fracture in osteoporosis
B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio
Midregional pro atrial natriuretic peptide levels
N-terminal pro B-type natriuretic peptide levels
B-type natriuretic peptide levels
HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes
Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes
Dupuytren's disease
Post bronchodilator FEV1 in COPD
Post bronchodilator FEV1/FVC ratio
Post bronchodilator FEV1
Post bronchodilator FEV1/FVC ratio in COPD
Pre bronchodilator FEV1
Pre bronchodilator FEV1/FVC ratio
Major depressive disorder
Recurrent major depressive disorder
Plasma kynurenine levels in major depressive disorder
Plasma kynurenine to tryptophan ratio in major depressive disorder
Fatty acid desaturase activity (serum)
Fatty acid desaturase activity (adipose tissue)
Familial lung cancer
Familial lung adenocarcinoma
Familial squamous cell lung carcinoma
Type 2 diabetes or obesity or coronary artery disease (pleiotropy)
Treatment resistant depression
Depressive symptom improvement
Schizophrenia vs type 2 diabetes
Type 2 diabetes vs schizophrenia and type 2 diabetes
Schizophrenia and type 2 diabetes
Schizophrenia vs schizophrenia and type 2 diabetes
Obsessive-compulsive disorder
Obsessive-compulsive disorder x sex interaction
Insulin resistance/response
Cerebrospinal AB1-42 levels in Alzheimer's disease dementia
Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia
Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia
Hippocampal volume in Alzheimer's disease dementia
Logical memory (immediate recall) in Alzheimer's disease dementia
Logical memory (delayed recall) in Alzheimer's disease dementia
Cerebrospinal AB1-42 levels in mild cognitive impairment
Cerebrospinal fluid t-tau levels in mild cognitive impairment
Cerebrospinal fluid p-tau levels in mild cognitive impairment
Hippocampal volume in mild cognitive impairment
Logical memory (immediate recall) in mild cognitive impairment
Logical memory (delayed recall) in mild cognitive impairment
Cerebrospinal AB1-42 levels in normal cognition
Cerebrospinal fluid t-tau levels in normal cognition
Cerebrospinal fluid p-tau levels in normal cognition
Hippocampal volume in normal cognition
Logical memory (immediate recall) in normal cognition
Logical memory (delayed recall) in normal cognition
Cerebrospinal fluid AB1-42 levels
Cerebrospinal fluid t-tau levels
Cerebrospinal fluid p-tau levels
Logical memory (immediate recall)
Logical memory (delayed recall)
Estimated glomerular filtration rate in diabetes
Estimated glomerular filtration rate in non-diabetics
Estimated glomerular filtration rate
PEG-asparaginase hypersensitivity without enzyme activity in childhood acute lymphoblastic leukaemia
Silent asparaginase inactivation in childhood acute lymphoblastic leukaemia
PEG-asparaginase hypersensitivity in childhood acute lymphoblastic leukaemia (allergic reaction grade 2 or more)
Platelet count and reactivity phenotypes
Subscapular skin fold thickness
Estradiol levels
Cortisol levels (plasma)
DHEAS levels
Progesterone levels
17-hydroxyprogesterone (17-OHP) levels
Androstenedione levels
Aldosterone levels
Pneumococcal meningitis
Nonsyndromic cleft lip
Nonsyndromic cleft palate
Subjective response to placebo treatment in childhood asthma (change in cough/wheeze)
Response to placebo treatment in childhood asthma (FVC change)
Facial morphology
Forehead morphology
Eye morphology
Nose morphology
Lip morphology
Upper eyelid morphology
Verbal intelligence quotient (cesarean section interaction)
Performance intelligence quotient (cesarean section interaction)
Full scale intelligence quotient (cesarean section interaction)
Uveitis (juvenile idiopathic arthritis-associated)
Uveitis in juvenile idiopathic arthritis
Dentate gyrus volume x schizophrenia interaction
Dentate gyrus volume
Left ventricular end-diastolic volume
Left ventricular end-systolic volume
Left ventricular stroke volume
Left ventricular ejection fraction
Left ventricular mass to end-diastolic volume ratio
Perceived sweetness of sucrose
Sucrose liking
Intake of sweets
Perceived intensity of fructose
Perceived intensity of neohesperidin dihydrochalcone
Perceived intensity of aspartame
Perceived intensity of sweet substances
Perceived intensity of sucrose
Intake of total sugars
Perceived intensity of glucose
Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia
Suicide attempts in bipolar disorder
Suicide attempts in schizophrenia
Suicide attempts in major depressive disorder or bipolar disorder
Suicide attempts in bipolar disorder or schizophrenia
Alzheimer's disease in hypertension-negative individuals
Alzheimer's disease in hypertension
Infliximab-induced mucosal healing in Crohn's disease
Bicuspid aortic valve without aortic dilation
Bicuspid aortic valve
Adverse response to drug
Handedness (non-right-handed vs right-handed)
Handedness (Left-handed vs. non-left-handed)
Handedness (left-handed vs. right-handed)
Colorectal cancer or advanced adenoma
Childhood steroid-sensitive nephrotic syndrome
Childhood dental caries in primary teeth
Childhood dental caries in permanent teeth
Autistic traits score (Social and Communication Disorders Checklist)
Systemising
Bone mineral density (lumbar spine) in inflammatory bowel disease
Bone mineral density (femoral neck) in inflammatory bowel disease
Alopecia areata
Visceral adipose tissue (sex interaction)
Subcutaneous adipose tissue (sex interaction)
Visceral adipose tissue/subcutaneous adipose tissue ratio (sex interaction)
Visceral adipose tissue adjusted for BMI (sex interaction)
Duloxetine response in major depressive disorder (remitter/non-remitter status)
Duloxetine response in major depressive disorder (responder/non-responder status)
Placebo response in major depressive disorder (remitter/non-remitter status)
Placebo response in major depressive disorder (responder/non-responder status)
Duloxetine response in major depressive disorder (% change in symptom score)
Placebo response in major depressive disorder (% change in symptom score)
Weight
Trunk fat mass
Hip circumference adjusted for BMI
Hip circumference
Subjective response to lithium treatment
Subjective response to lithium treatment in bipolar disorder
Objective response to lithium treatment
Objective response to lithium treatment in bipolar disorder
Low vWF levels
Response to exercise (triglyceride level interaction)
"Breast cancer, ovarian cancer or prostate cancer (pleiotropy)"
Modified Stumvoll Insulin Sensitivity Index (BMI interaction)
Modified Stumvoll Insulin Sensitivity Index
Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)
Familial hepatitis B virus-related hepatocellular carcinoma
Progranulin levels
High altitude adaptation
Tanning
Response to bronchodilator in chronic obstructive pulmonary disease (change in FEV1)
Peripheral artery disease
Serum 25-Hydroxyvitamin D levels
Alcoholic chronic pancreatitis
Bronchial hyperresponsiveness in asthma
Lobe attachment (rater-scored or self-reported)
Lobe attachment (rater scored)
Cognitive ability
Cognitive ability (MTAG)
Caudate volume in trauma-exposed individuals
Nucleus accumbens volume in trauma-exposed individuals
Pallidum volume in trauma-exposed individuals
Amygdala volume in trauma-exposed individuals
Hippocampal volume in trauma-exposed individuals
Putamen volume in trauma-exposed individuals
Lateral ventricle volume in trauma-exposed individuals
Thalamus volume in trauma-exposed individuals
P wave terminal force
P wave duration
Thyroid stimulating hormone levels
Free thyroxine concentration
Spontaneous preterm birth (preterm birth)
Chickenpox
Shingles
Cold sores
Mumps
Plantar warts
Tuberculosis
Bacterial meningitis
Yeast infection
Myringotomy
Measles
Hepatitis A
Rheumatic fever
Number of common colds
Chronic sinus infection
Urinary tract infection frequency
Rubella
Mononucleosis
Hepatitis B
Strep throat
Scarlet fever
Pneumonia
Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes
Coronary artery calcified atherosclerotic plaque score in type 2 diabetes
Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes
Interleukin-10 levels
Interleukin-6 levels
Interleukin-1-receptor antagonist levels
Vitamin D levels (dietary vitamin D intake interaction)
Atazanavir levels
"Intracranial, abdominal aortic or thoracic aortic aneurysm (pleiotropy)"
Apolipoprotein A-IV levels
Early gestational weight gain (fetal effect)
Gestational weight gain (fetal effect)
Late gestational weight gain (fetal effect)
Early gestation weight gain (maternal effect)
Late gestational weight gain (maternal effect)
Gestational weight gain (maternal effect)
Iris color (b* coordinate)
Iris heterochromicity
Iris color (L* coordinate)
Iris color (a* coordinate)
Alloimmunization response to pregnancy (HLA class I and II)
Alloimmunization response to pregnancy (HLA class I)
Alloimmunization response to pregnancy (HLA class II)
Alloimmunization response to pregnancy
Foot ulcer in diabetes and neuropathy
Foot ulcer and neuropathy in diabetes
Mood instability
Estrone levels
"Response to radiotherapy in prostate cancer (toxicity, urinary frequency)"
Toxicity response to radiotherapy in prostate cancer (decreased urine stream) (time to event)
Response to radiotherapy in prostate cancer (overall toxicity)
"Response to radiotherapy in prostate cancer (toxicity, rectal bleeding)"
Response to ranibizumab in age-related macular degeneration (visual acuity)
Response to ranibizumab in age-related macular degeneration (additional treatment requirement)
Response to ranibizumab in age-related macular degeneration (dry maculae)
Idiopathic inflammatory myopathy
Polymyositis
Dermatomyositis
Clinically amyopathic dermatomyositis
Insulin sensitivity index
Insulin levels
Insulin levels adjusted for BMI
Ratio of the area under the curve for insulin and the area under the curve for glucose
Area under the curve of insulin levels
Incremental insulin
Corrected insulin response
Corrected insulin response adjusted for insulin sensitivity index
Crohn's disease
Cervical cancer
Decreased fine motor function in Charcot-Marie-Tooth disease 1A (eating with utensils)
Hearing loss in Charcot-Marie-Tooth disease 1A
Decreased sensory function in Charcot-Marie-Tooth disease type 1A
Neuropathy in Charcot-Marie-Tooth disease type 1A
Balance difficulty in Charcot-Marie-Tooth disease type 1A
"Decreased fine motor function in Charcot-Marie-Tooth disease 1A (buttons, zippers, fasteners, bottles)"
Walking difficulty in Charcot-Marie-Tooth disease 1A
Reduced foot dorsiflexion strength in Charcot-Marie-Tooth disease type 1A
First dorsal interosseous strength in Charcot-Marie-Tooth disease 1A
Foot deformity in Charcot-Marie-Tooth disease 1A
Foot plantar flexion strength in Charcot-Marie-Tooth disease 1A
Scoliosis in Charcot-Marie-Tooth disease 1A
Arthritic-like pain in Charcot-Marie-Tooth type 1A
Burning or tingling in extremities in Charcot-Marie-Tooth disease type 1A
Blood urea nitrogen levels
Diabetic maculopathy with decreased visual acuity in type 2 diabetes
Diabetic maculopathy in type 2 diabetes
Diastolic blood pressure x physical activity (least active quartile vs others) interaction (2df)
Diastolic blood pressure x physical activity (less vs more active half) interaction (2df)
Diastolic blood pressure x physical activity (least vs most active quartile) interaction (2df)
Systolic blood pressure x physical activity (least active quartile vs others) interaction (2df)
Systolic blood pressure x physical activity (less vs more active half) interaction (2df)
Systolic blood pressure x physical activity (least vs most active quartile) interaction (2df)
Systolic blood pressure x physical activity interaction (2df)
Diastolic blood pressure x physical activity (least active quartile vs others) interaction (1df)
Diastolic blood pressure x physical activity (less vs more active half) interaction (1df)
Diastolic blood pressure x physical activity (least vs most active quartile) interaction (1df)
Systolic blood pressure x physical activity (least active quartile vs others) interaction (1df)
Systolic blood pressure x physical activity (less vs more active half) interaction (1df)
Systolic blood pressure x physical activity (least vs most active quartile) interaction (1df)
Systolic blood pressure x physical activity interaction (1df)
Diastolic blood pressure x physical activity interaction (1df)
DIastolic blood pressure x physical activity interaction (2df)
Longevity (age >90th survival percentile)
Longevity (age >99th survival percentile)
Takayasu arteritis
Chronic central serous retinopathy
Alcohol and nicotine co-dependence
Benign prostatic hyperplasia and lower urinary tract symptoms
Benign prostatic hyperplasia and lower urinary tract symptoms (prostate cancer excluded)
Appendicitis
"Cough x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction"
"Dyspnea x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction"
"Phlegm x occupational exposure (biological dust, mineral dust, gases and fumes, pesticides, aromatic solvents, chlorinated solvents, other solvents or metals) interaction"
Alcohol withdrawal symptoms
Pemphigus foliaceus
Pemphigus
Pemphigus vulgaris
Non-muscle-invasive bladder cancer age at diagnosis
Non-muscle-invasive bladder cancer age at diagnosis (< 70 years vs ≥ 70 years)
Non-muscle-invasive bladder cancer tumour size
Non-muscle-invasive bladder cancer tumour size (< 3 cm vs ≥ 3 cm)
Non-muscle-invasive bladder cancer tumour stage (Tis/T1 vs Ta)
Non-muscle-invasive bladder cancer tumour grade (G3 vs G2/G1)
Non-muscle-invasive bladder cancer EORTC risk category
Plasma factor V levels in venous thrombosis
Plasma factor V levels in venous thrombosis (conditioned on rs6027)
Chronic lymphocytic leukemia or multiple sclerosis
Diffuse large B-cell lymphoma or multiple sclerosis
Follicular lymphoma or multiple sclerosis
Marginal zone lymphoma or multiple sclerosis
Chronic lymphocytic leukemia or rheumatoid arthritis
Diffuse large B-cell lymphoma or rheumatoid arthritis
Follicular lymphoma or rheumatoid arthritis
Marginal zone lymphoma or rheumatoid arthritis
Chronic lymphocytic leukemia or systemic lupus erythematosus
Diffuse large B-cell lymphoma or systemic lupus erythematosus
Follicular lymphoma or systemic lupus erythematosus
Marginal zone lymphoma or systemic lupus erythematosus
Stress sensitivity (neuroticism score x major depressive disorder status interaction)
Social isolation
Ability to confide in someone
Regular attendance at a gym or sports club
Regular attendance at a pub or social club
Regular attendance at a religious group
Loneliness (MTAG)
Fasting glucose change
Fasting glucose change (long-term)
Fasting glucose change (short-term)
Response to interferon treatment in hepatitis C virus genotype 3
Response to direct-acting antiviral treatment in hepatitis C virus genotype 3
Pre-treatment viral load in hepatitis C virus genotype 3
Diabetes (gestational)
Platelet reactivity measurement (collagen-ADP)
Platelet reactivity measurement (collagen-epinephrine)
End-stage kidney disease
Mild to moderate chronic kidney disease
Chronic mountain sickness
Urinary sodium excretion
Urinary potassium excretion
Attention function
Working memory
Verbal memory
Visual memory
Reasoning
Information processing speed
Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)
Systolic blood pressure x alcohol consumption interaction (2df test)
Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test)
Pulse pressure x alcohol consumption interaction (2df test)
Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test)
Mean arterial pressure x alcohol consumption interaction (2df test)
Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test)
Diastolic blood pressure x alcohol consumption interaction (2df test)
Allergic rhinitis x sex interaction
Lymphangioleiomyomatosis (sporadic)
Mental health study participation (provided email address)
Mental health study participation (completed survey)
Number of alcoholic drinks required to feel an effect (first five times drinking)
Number of alcoholic drinks required to feel an effect (long-term average)
Parental longevity (father's age at death or father's attained age)
Parental longevity (mother's age at death or mother's attained age)
Longevity
Retinal arteriolar tortuosity
Maximum retinal arteriolar tortuosity
Retinal venular tortuosity
Maximum retinal venular tortuosity
Central retinal arteriolar equivalent
Central retinal vein equivalent
Retinal arteriole-to-venule ratio
Optic disc radius
Early cardiac repolarization
Longitudinal cocaine use
Esotropia
Accommodative esotropia
Amblyopia
Hyperopia
Non-accommodative esotropia
White coat effect (clinic systolic blood pressure minus ambulatory systolic blood pressure)
White coat effect (clinic diastolic blood pressure minus ambulatory diastolic blood pressure)
Skin aging measurement
Diabetic nephropathy in type 1 diabetes
Macroalbuminuria in type 1 diabetes
End-stage renal disease in Type 1 diabetics
Kidney disease (end stage renal disease vs macroalbuminuria) in type 1 diabetes
Microalbuminuria in type 1 diabetes
Chronic kidney disease (reduced eGFR or end stage renal disease) in type 1 diabetes
Chronic kidney disease (end stage renal disease vs. normal eGFR) in type 1 diabetes
Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in type 1 diabetes
Kidney disease (end stage renal disease or albuminuria) in type 1 diabetes
Recurrence of malaria infection (mild or asymptomatic)
Recurrence of mild malaria attacks
Early onset periodontitis x smoking status interaction
Resistant hypertension
Basal metabolic rate
Caudal anterior-cingulate cortex volume
Caudal middle frontal gyrus volume
Cuneus cortex volume
Fusiform gyrus volume
Inferior parietal cortex volume
Inferior temporal gyrus volume
Isthmus-cingulate cortex volume
Lateral occipital cortex volume
Lateral orbital frontal cortex volume
Lingual gyrus volume
Medial orbital frontal cortex volume
Middle temporal gyrus volume
Parahippocampal gyrus volume
Paracentral lobule volume
Pars opercularis volume
Pars orbitalis volume
Pars triangularis volume
Pericalcarine cortex volume
Postcentral gyrus volume
Posterior-cingulate cortex volume
Precentral gyrus volume
Precuneus cortex volume
Rostral anterior cingulate cortex volume
Rostral middle frontal gyrus volume
Non-small cell lung cancer
Ankle-brachial index
Peripheral artery disease (borderline)
Superior frontal gyrus volume
Superior parietal cortex volume
Superior temporal gyrus volume
Supramarginal gyrus volume
Frontal pole volume
Temporal pole volume
Transverse temporal cortex volume
Insular cortex volume
Thalamus volume
Caudate nucleus volume
Putamen volume
Pallidum volume
Amygdala volume
Nucleus accumbens volume
Ventral diencephalon volume
Choroid plexus volume
Lateral ventricle volume
Lateral ventricle temporal horn volume
Third ventricle volume
Fourth ventricle volume
Corpus callosum posterior volume
Corpus callosum Mid-posterior volume
Corpus callosum central volume
Corpus callosum mid-anterior volume
"Dental caries (decayed, missing and filled tooth surfaces)"
"Dental caries (decayed, missing and filled teeth)"
Dental caries (decayed and filled deciduous teeth)
Dental caries (decayed and filled deciduous tooth surfaces)
Tendinopathy
BMI-adjusted waist-hip ratio variance
Body fat percentage variance
Basal metabolic rate variance
Body mass index variance
Waist circumference variance
Hip circumference variance
Waist-hip ratio variance
Height variance
Lung function (forced vital capacity) variance
Lung function (FEV1) variance
Lung function (FEV1/FVC) variance
Heel bone mineral density variance
Birth weight variance
Heel bone mineral density
Birth weight
Corpus callosum anterior volume
Cortex volume
Cerebral white matter volume
Sub-cortical grey matter volume
Total grey matter volume
Whole brain grey matter density
Total intracranial volume
Cerebellum white matter volume
Cerebellum cortex volume
Superior temporal sulcus banks volume
Frailty index
Gut microbiota (beta diversity)
Gut microbiota (alpha diversity)
Gut microbiota relative abundance (bacterial taxa)
Abstraction and mental flexibility
Emotional recognition
Face memory
Sensorimotor dexterity
Spatial memory
Spatial processing
California verbal learning test score
Degraded stimulus continuous performance test score
Letter-number span reordering
Prepulse inhibition of the startle response
Antisaccade task score
Age at suicide
Non-lobar intracerebral hemorrhage
Lobar intracerebral hemorrhage
Intracerebral hemorrhage (MTAG)
Non-lobar intracerebral hemorrhage (MTAG)
Lobar intracerebral hemorrhage (MTAG)
Intracerebral hemorrhage
Asthma (time to onset)
Estimated glomerular filtration rate reduction (30%)
Incident chronic kidney disease
Cognitive performance (processing speed)
Trastuzumab-induced cardiotoxicity in cancer
Leukocyte count in ischemic stroke
Immunogenicity to anti-TNF therapy in Crohn's disease
Joint damage in rheumatoid arthritis
FEV1 decline rate x corticosteroid treatment interaction in chronic obstructive pulmonary disease
Ischemic heart disease
Bilirubin levels
Type 1 diabetes
Maximum habitual alcohol consumption
Leukocyte telomere length
Depressive symptom (depressed mood) (binary trait)
Depressive symptom (sleep problems) (binary trait)
Depressive symptom (fatigue) (binary trait)
Depressive symptom (appetite changes) (binary trait)
Depressive symptom (low self-esteem) (binary trait)
Depressive symptom (concentration problems) (binary trait)
Depressive symptom (psychomotor changes) (binary trait)
Depressive symptom (suicidal ideation) (binary trait)
Depressive symptoms (binary sum-score)
Depressive symptoms (sum-score)
Depressive symptom (sleep problems) (ordinal trait)
Depressive symptom (fatigue) (ordinal trait)
Depressive symptom (appetite changes) (ordinal trait)
Depressive symptom (low self-esteem) (ordinal trait)
Depressive symptom (concentration problems) (ordinal trait)
Depressive symptom (psychomotor changes) (ordinal trait)
Depressive symptom (suicidal ideation) (ordinal trait)
Depressive symptom (anhedonia) (ordinal trait)
Depressive symptom (depressed mood) (ordinal trait)
Depressive symptom (anhedonia) (binary trait)
Triacylglyceride levels
Ceramide levels
Diacylglyceride levels
Lysophosphatidylcholine levels
Lysophosphatidylethanolamine levels
Phosphatidylcholine levels
Phosphatidylcholine-ether levels
Phosphatidylethanolamine levels
Phosphatidylethanolamine-ether levels
Phosphatidylinositol levels
Cholesteryl ester levels
Sphingomyelin levels
Sterol levels
Psychotic experience
Psychotic experience (multiple occurrences)
Psychotic experience (distressing)
Smoking behaviour (age at first cigarette)
Smoking behaviour (cigarettes smoked per day)
Smoking behaviour (cigarette pack-years)
Smoking initiation (ever regular vs never regular)
Keratinocyte cancer (MTAG)
Basal cell carcinoma
Alzheimer’s disease (clinical subgroup AD+)
Alzheimer’s disease (clinical subgroup AD++)
Alzheimer’s disease (clinical subgroup AD+++)
Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD++)
Neuritic plaque
Neurofibrillary tangles
"Parental longevity (combined parental attained age, Martingale residuals)"
Parental longevity (both parents in top 10%)
Parental longevity (mother's attained age)
Parental longevity (father's attained age)
Response to SSRI (symptom improvement)
Response to antidepressants (symptom improvement)
Response to SSRI (symptom remission)
Response to antidepressants (symptom remission)
Predicted visceral adipose tissue
Metabolite levels
Blood pressure
Glucose homeostasis traits
Hematology traits
Hormone measurements
Iron status biomarkers
Lipid traits
Liver disease biomarker
Anthropometric traits
T wave morphology restitution during exercise (MTAG)
T wave morphology restitution during exercise
T wave morphology restitution during recovery from exercise
T wave morphology restitution during recovery from exercise (MTAG)
Response to allopurinol in gout (change in serum uric acid levels)
Uveal melanoma
Uveal melanoma with any chromosomal aberration
Choroidal melanoma
Uveal melanoma with chromosome 3 loss
Uveal melanoma with epithelioid cells
Presence of epithelioid cells in uveal melanoma
Uveal melanoma (TNM stage 1 or 2)
Uveal melanoma (TNM stage 3 or 4)
Disease severity in uveal melanoma (TNM stage 3 or 4 vs TNM stage 1 or 2)
Verbal cognitive ability
Numerical cognitive ability
Figural/spatial cognitive ability
Mosaic loss of chromosome Y (Y chromosome dosage)
Hydrolysed wheat protein allergy
Exacerbation frequency in mepolizumab-treated chronic obstructive pulmonary disease
Frequency of exacerbations requiring hospitalisation in mepolizumab-treated chronic obstructive pulmonary disease
Asthma (adult onset)
Asthma and attention deficit hyperactivity disorder
Asthma and anxiety disorder
Asthma and major depressive disorder
Mental disorder
Psychiatric disorder without cannabis use disorder
Cannabis use disorder vs schizophrenia
Cannabis use disorder
Gout (combined type)
Gout (normal type)
Diastolic blood pressure x quantitative lifestyle risk score interaction (1df test)
Diastolic blood pressure x quantitative lifestyle risk score interaction (2df test)
Diastolic blood pressure x dichotomous lifestyle risk score interaction (1df test)
Diastolic blood pressure x dichotomous lifestyle risk score interaction (2df test)
Systolic blood pressure x quantitative lifestyle risk score interaction (1df test)
Systolic blood pressure x quantitative lifestyle risk score interaction (2df test)
Systolic blood pressure x dichotomous lifestyle risk score interaction (1df test)
Systolic blood pressure x dichotomous lifestyle risk score interaction (2df test)
Alanine aminotransferase levels
Hemoglobin A1c levels
Venous thromboembolism
Diabetic retinopathy (all NPDR and PDR)
Proliferative diabetic retinopathy (vs NPDR and no DR)
Diabetic retinopathy (moderate NPDR and PDR)
Proliferative diabetic retinopathy (vs no DR)
Impaired insulin sensitivity in response to n-3 PUFA supplementation
Brain age (difference between predicted and chronological age)
"19,155 disease classifications in UK Biobank (pleiotropy)"
Trunk fat mass adjusted for trunk lean mass
Femoral neck bone mineral density and trunk fat mass adjusted by trunk lean mass
Hallux valgus
Neck pain or shoulder pain
Externalizing behaviour score
Exfoliation syndrome
Kidney stones
Hospital contact for infections
Cortical surface area (visual PC2)
Cortical thickness (PC1)
Cortical thickness (PC2)
Cortical surface area (global PC1)
Leisure sedentary behaviour (television watching)
Leisure sedentary behaviour (computer use)
Driving (hours per day)
Levodopa wearing off effect (time symptoms uncontrolled) in Parkinson's disease (response to zonisamide)
Levodopa wearing off effect (motor symptom score change) in Parkinson's disease (response to zonisamide)
Inhibin B levels
Semen volume
Sperm concentration
Testis size
COVID-19 (RELEASE 5)
COVID-19 (very severe respiratory confirmed vs population) RELEASE 3
COVID-19 (hospitalized vs not hospitalized) RELEASE 3
COVID-19 (hospitalized vs population) RELEASE 3
COVID-19 (covid vs lab/self reported negative) RELEASE 3
COVID-19 (RELEASE 3)
COVID-19 (predicted from self-reported symptoms vs predicted or self-reported non-covid) RELEASE 3
COVID-19 (very severe respiratory confirmed vs population) RELEASE 5
COVID-19 (hospitalized vs not hospitalized) RELEASE 5
COVID-19 (hospitalized vs population) RELEASE 5
COVID-19 (RELEASE 4)
COVID-19 (very severe respiratory confirmed vs population) RELEASE 4
COVID-19 (hospitalized covid vs not hospitalized) RELEASE 4
COVID-19 (predicted covid from self-reported symptoms vs predicted or self-reported non-covid) RELEASE 4
Cotinine and 3'-hydroxycotinine levels in current smokers
Cotinine levels in current smokers
Smoking intensity (cotinine levels/cigarettes per day)
COVID-19 (hospitalized vs population) RELEASE 4
COVID-19 (covid vs lab/self reported negative) RELEASE 4
COVID-19 (very severe respiratory confirmed vs not hospitalized) RELEASE 4
Cutaneous melanoma or hair colour
Nevus count or cutaneous melanoma
Youthful appearance (self-reported)
Lung function (FVC) in asthma
Lung function (FEV1/FVC) in asthma
Post-bronchodilator lung function in asthma (FVC)
Lung function (FEV1) in asthma
Mastocytosis (KIT D816V positive)
Refractive error
White matter hyperintensities
White matter integrity (fractional anisotropy)
White matter integrity (mean diffusivity)
Neuroblastoma or malignant cutaneous melanoma
Diffuse plaques
Cerebral amyloid angiopathy
Microscopic brain infarct
Macroscopic brain infarct
Neuropathologic traits (pleiotropy)
Breslow thickness in cutaneous melanoma
COVID-19 (critical illness vs population)
Retinal detachment
Spherical equivalent
BMI in adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation
BMI in adult survivors of childhood acute lymphoblastic leukemia not treated with cranial radiation
BMI in adult survivors of childhood acute lymphoblastic leukemia
Testosterone levels x fluid intelligence interaction
Testosterone levels x alcohol consumption (drinks per week) interaction
Testosterone levels x smoking behaviour (cigarettes smoked per day) interaction
Bioavailable testosterone levels x smoking behaviour (cigarettes smoked per day) interaction
Bioavailable testosterone levels x alcohol consumption (drinks per week) interaction
Bioavailable testosterone levels x fluid intelligence interaction
Estradiol levels x smoking behaviour (cigarettes smoked per day) interaction
Estradiol levels x alcohol consumption (drinks per week) interaction
Estradiol levels x fluid intelligence interaction
Sex hormone-binding globulin levels x smoking behaviour (cigarettes smoked per day) interaction
Sex hormone-binding globulin levels x alcohol consumption (drinks per week) interaction
Sex hormone-binding globulin levels x fluid intelligence interaction
HDL cholesterol x physical activity interaction (2df test)
LDL cholesterol x physical activity interaction (2df test)
Triglycerides x physical activity interaction (2df test)
LDL cholesterol x physical activity interaction (1df test)
HDL cholesterol x physical activity interaction (1df test)
Triglycerides x physical activity interaction (1df test)
Lifetime anxiety disorder
Anxiety symptoms
Nonunion in individuals with fractures
Corneal astigmatism
Refractive astigmatism
Non-del(5q) myelodysplastic syndromes
Hallucinations in long-term cannabis use
Uric acid elevation in response to thiazide-like diuretic in hypertension
Intracranial aneurysm
Severe malarial anemia in Plasmodium falciparum infection
IgA nephropathy
C-peptide levels
Cirrhosis
Stroke and BMI (pleiotropy)
Maternal nondisjunction of chromosome 21 (mothers vs fathers)
Maternal nondisjunction of chromosome 21 (MI error vs fathers)
Maternal nondisjunction of chromosome 21 (MII error vs fathers)
Maternal nondisjunction of chromosome 21 (MI error vs MII error)
NASH resolution in nonalcoholic steatohepatitis
Pruritus in nonalcoholic steatohepatitis
Fibrosis improvement in nonalcoholic steatohepatitis
Blood protein levels in cardiovascular risk
Bone mineral content
T-cell acute lymphoblastic leukaemia
Asthma x air pollution interaction (2df)
Asthma x Hispanic interaction (2df)
Inflammatory biomarkers
Blood glucose levels
Renal complication in type 2 diabetes
Cryptosporidiosis
"Number of decayed, missing and filled tooth surfaces or use of dentures"
"Number of decayed, missing and filled tooth surfaces"
Number of decayed and filled tooth surfaces per available tooth surface
Bleeding gums
Painful gums
Dentures
Toothache
Mouth ulcers
Number of natural teeth
Loose teeth
Periodontitis or loose teeth
Alcohol dependence or heroin dependence or methamphetamine dependence
Epigenetic age acceleration in alcohol use disorder
Epilepsy
Childhood absence epilepsy
Juvenile absence epilepsy
Juvenile myoclonic epilepsy
"Epilepsy (generalized, with tonic-clonic seizures alone)"
Focal epilepsy (lesion negative)
Focal epilepsy (with hippocampal sclerosis)
Focal epilepsy (with lesion other than hippocampal sclerosis)
Focal epilepsy
Generalized epilepsy
B6 vitamer levels (multivariate analysis)
Cerebrospinal fluid pyridoxal phosphate levels
Plasma pyridoxal phosphate levels
Cerebrospinal fluid pyridoxal phosphate to pyridoxal ratio
Plasma pyridoxal phosphate to pyridoxal ratio
Plasma pyridoxic acid to pyridoxal phosphate ratio
Red vs. brown/black hair color
Blond vs. brown/black hair color
Brown vs. black hair color
Age-related hearing impairment (high minus low frequency)
Age-related hearing impairment
Age-related hearing impairment (low/mid frequency)
Age-related hearing impairment (high frequency)
Eosinophilic esophagitis
Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)
Eosinophilic granulomatosis with polyangiitis (ANCA negative)
Eosinophilic granulomatosis with polyangiitis
Minimum ankle–brachial index
Change in quality of life in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease
Response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease
Change in trough FEV1 in response to fluticasone propionate/salmeterol in chronic obstructive pulmonary disease
Serum platinum levels after completion of cisplatin chemotherapy
Change in neurofilament light levels
Cerebral microbleed progression
Cerebral microbleeds
Early spontaneous preterm birth
Moderate-to-late spontaneous preterm birth
Spontaneous preterm birth with premature rupture of membranes
Spontaneous preterm birth without premature rupture of membranes
Corneal resistance factor
Corneal hysteresis
Subpleural-predominant interstitial lung abnormalities
Interstitial lung abnormalities
Antipsychotic drug-induced weight gain in schizophrenia
Antipsychotic drug-induced weight gain in schizophrenia or autism
Latent naming speed
Rapid automised naming and rapid alternating stimulus test performance
Rapid automised naming of objects
Rapid automised naming of letters
Rapid alternating stimulus test for letters/numbers
Plasma anti-thyroid peroxidase levels
Plasma anti-thyroglobulin and anti-thyroid peroxidase levels (bivariate analysis)
Plasma anti-thyroglobulin levels
Epithelial ovarian cancer
High-grade serous ovarian cancer
Hepatitis C (spontaneous viral clearance)
Alloimmunization response to red blood cell transfusion in sickle cell anemia
Voxel-wise structural brain imaging measurements in Alzheimer’s disease
LDL cholesterol levels in current drinkers
HDL cholesterol levels in current drinkers
Triglyceride levels in current drinkers
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)
HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)
Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (1df)
LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)
LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)
HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)
Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (1df)
Hypotension and cognitive impairment
Knee pain
Phenylephrine infusion rate during anesthesia
Left planum temporale grey matter volume
Right planum temporale grey matter volume
Planum temporale asymmetry index
Heart failure
Nonischemic cardiomyopathy
3-month functional outcome in ischaemic stroke (modified Rankin score)
Cocaine use disorder
Cocaine use disorder x non-traditional parental care interaction
Cocaine use disorder x change in residence interaction
Cocaine use disorder x traumatic experience interaction
Cocaine use disorder x household drinking and illicit drug use interaction
Cocaine use disorder x household tobacco use interaction
Cytokine levels
Cytokine network levels (multivariate analysis)
Thoracic aortic calcification levels
Abdominal aortic calcification levels
Cancer
Gout vs. Hyperuricemia
Fagerstrӧm test for nicotine dependence
Time to smoke first cigarette in the morning
Infection persistence (>18 months) in genital human papillomavirus 16 infection
Uterine fibroids and heavy menstrual bleeding
Heavy menstrual bleeding
Uterine fibroids
Rate of ventricular enlargement
Systemic seropositive rheumatic diseases (Systemic sclerosis or systemic lupus erythematosus or rheumatoid arthritis or idiopathic inflammatory myopathies)
Erectile dysfunction
vWF and FVIII levels
Proliferative diabetic retinopathy
Bipolar I disorder
Bipolar II disorder
Schizoaffective disorder-bipolar type
Midline nonsyndromic craniosynostosis
Metopic nonsyndromic craniosynostosis
TPE interval (resting)
TPE interval (response to exercise)
TPE interval (recovery after exercise)
Survival in breast cancer (estrogen-receptor positive)
Salivary metabolite levels
Childhood maltreatment
Gastrointestinal infection
Idiopathic downbeat nystagmus
Relative fat intake
Relative protein intake
Relative carbohydrate intake
Relative sugar intake
Substance uses or psychiatric disorders (pleiotropy)
High-altitude pulmonary edema
OTU97_15 (Parasutterella) prevalence
OTU97_150 (Bacteroides) prevalence
OTU97_16 (Faecalibacterium) prevalence
OTU97_163 (Bacteroides) prevalence
OTU97_165 (Porphyromonadaceae) prevalence
OTU97_17 (Parabacteroides) prevalence
OTU97_173 (Bacteroides) prevalence
OTU97_19 (Bacteria) prevalence
OTU97_2 (Bacteroides) prevalence
OTU97_21 (Parasutterella) prevalence
OTU97_23 (Faecalibacterium) prevalence
OTU97_235 (Phascolarctobacterium) prevalence
OTU97_24 (Prevotella) prevalence
OTU97_257 (Mitsuokella) prevalence
OTU97_26 (Parasutterella) prevalence
OTU97_27 (Bacteroides) prevalence
OTU97_277 (Prevotella) prevalence
OTU97_3 (Bacteroides) prevalence
OTU97_30 (Roseburia) prevalence
OTU97_31 (Prevotella) prevalence
OTU97_33 (Holdemanella) prevalence
OTU97_34 (Ruminococcus) prevalence
OTU97_354 (Alloprevotella) prevalence
OTU97_38 (Alphaproteobacteria) prevalence
OTU97_39 (Proteobacteria) prevalence
G_Prevotella prevalence
G_Prevotellaceae prevalence
G_Ruminococcus prevalence
G_Sutterella prevalence
O_Selenomonadales prevalence
OTU97_1 (Bacteroides) prevalence
OTU97_100 (Ruminococcaceae) prevalence
OTU97_101 (Sutterella) prevalence
OTU97_102 (Prevotella) prevalence
OTU97_105 (Ruminococcaceae) prevalence
OTU97_106 (Ruminococcaceae) prevalence
OTU97_108 (Phascolarctobacterium) prevalence
OTU97_109 (Paraprevotella) prevalence
OTU97_11 (Parabacteroides) prevalence
OTU97_113 (Bacteroidales) prevalence
OTU97_117 (Ruminococcus) prevalence
OTU97_119 (Desulfovibrio) prevalence
OTU97_12 (Bacteroides) prevalence
OTU97_126 (Prevotella) prevalence
OTU97_13 (Subdoligranulum) prevalence
OTU97_130 (Butyrivibrio) prevalence
OTU97_137 (Catenibacterium) prevalence
OTU97_138 (Oscillibacter) prevalence
OTU97_140 (Bacteroides) prevalence
OTU99_30 (Parasutterella) prevalence
OTU99_8 (Ruminococcaceae) prevalence
OTU99_84 (Prevotella) prevalence
OTU99_85 (Alistipes) prevalence
OTU99_9 (Alistipes) prevalence
OTU99_92 (Ruminococcus) prevalence
OTU99_94 (Bacteroides) prevalence
OTU99_98 (Phascolarctobacterium) prevalence
TestASV_1 (Bacteroides) prevalence
TestASV_10 (Parabacteroides) prevalence
TestASV_11 (Lachnospiraceae) prevalence
TestASV_12 (Bacteroides) prevalence
TestASV_13 (Bacteroides) prevalence
TestASV_14 (Lachnospiraceae) prevalence
TestASV_15 (Bacteroides) prevalence
TestASV_16 (Bacteroides) prevalence
TestASV_17 (Bacteroides) prevalence
TestASV_18 (Prevotella) prevalence
TestASV_19 (Prevotella) prevalence
TestASV_2 (Bacteroides) prevalence
C_Actinobacteria abundance
C_Alphaproteobacteria abundance
C_Bacteroidia abundance
C_Betaproteobacteria abundance
C_Clostridia abundance
C_Erysipelotrichia abundance
OTU99_26 (Parasutterella) prevalence
OTU99_271 (Prevotella) prevalence
OTU99_298 (Phascolarctobacterium) prevalence
OTU99_3 (Bacteroides) prevalence
OTU99_32 (Prevotella) prevalence
OTU99_34 (Holdemanella) prevalence
OTU99_35 (Ruminococcus) prevalence
OTU99_39 (Alphaproteobacteria) prevalence
OTU99_4 (Alistipes) prevalence
OTU99_40 (Proteobacteria) prevalence
OTU99_45 (Faecalibacterium) prevalence
OTU99_47 (Prevotella) prevalence
OTU99_5 (Sutterella) prevalence
OTU99_53 (Aestuariispira) prevalence
OTU99_54 (Holdemanella) prevalence
OTU99_55 (Barnesiella) prevalence
OTU99_558 (Bacteroidales) prevalence
OTU99_58 (Bacteroides) prevalence
OTU99_59 (Prevotella) prevalence
OTU99_6 (Sutterella) prevalence
OTU99_62 (Ruminococcaceae) prevalence
OTU99_65 (Sutterellaceae) prevalence
OTU99_7 (Lachnospiraceae) prevalence
OTU99_72 (Parabacteroides) prevalence
OTU99_78 (Clostridiales) prevalence
OTU97_4 (Alistipes) prevalence
OTU97_46 (Lachnospiraceae) prevalence
OTU97_5 (Sutterella) prevalence
OTU97_50 (Aestuariispira) prevalence
OTU97_51 (Barnesiella) prevalence
OTU97_53 (Bacteroides) prevalence
OTU97_56 (Ruminococcaceae) prevalence
OTU97_58 (Sutterellaceae) prevalence
OTU97_6 (Sutterella) prevalence
OTU97_65 (Parabacteroides) prevalence
OTU97_69 (Clostridiales) prevalence
OTU97_7 (Lachnospiraceae) prevalence
OTU97_73 (Prevotella) prevalence
OTU97_74 (Alistipes) prevalence
OTU97_8 (Ruminococcaceae) prevalence
OTU97_80 (Ruminococcus) prevalence
OTU97_82 (Bacteroides) prevalence
OTU97_86 (Phascolarctobacterium) prevalence
OTU97_9 (Alistipes) prevalence
OTU97_95 (Cytophagales) prevalence
OTU97_97 (Clostridiales) prevalence
OTU99_1 (Bacteroides) prevalence
OTU99_106 (Barnesiella) prevalence
OTU99_108 (Cytophagales) prevalence
OTU99_11 (Parabacteroides) prevalence
TestASV_47 (Parasutterella) abundance
TestASV_48 (Sutterella) abundance
TestASV_49 (Parasutterella) abundance
TestASV_5 (Bacteroides) abundance
TestASV_6 (Subdoligranulum) abundance
TestASV_7 (Bacteroides) abundance
TestASV_8 (Bacteroides) abundance
TestASV_9 (Alistipes) abundance
C_Alphaproteobacteria prevalence
C_Negativicutes prevalence
F_Acidaminococcaceae prevalence
F_Prevotellaceae prevalence
G_Alloprevotella prevalence
G_Alphaproteobacteria prevalence
G_Bacteroidales prevalence
G_Bacteroidetes prevalence
G_Barnesiella prevalence
G_Catenibacterium prevalence
G_Coprococcus prevalence
G_Holdemanella prevalence
G_Parabacteroides prevalence
G_Paraprevotella prevalence
G_Parasutterella prevalence
G_Phascolarctobacterium prevalence
G_Porphyromonadaceae prevalence
OTU99_110 (Clostridiales) prevalence
OTU99_116 (Sutterella) prevalence
OTU99_12 (Bacteroides) prevalence
OTU99_120 (Ruminococcaceae) prevalence
OTU99_121 (Ruminococcaceae) prevalence
OTU99_123 (Phascolarctobacterium) prevalence
OTU99_124 (Paraprevotella) prevalence
OTU99_13 (Subdoligranulum) prevalence
OTU99_132 (Bacteroidales) prevalence
OTU99_137 (Ruminococcus) prevalence
OTU99_140 (Desulfovibrio) prevalence
OTU99_150 (Prevotella) prevalence
OTU99_155 (Butyrivibrio) prevalence
OTU99_157 (Barnesiella) prevalence
OTU99_16 (Faecalibacterium) prevalence
OTU99_166 (Prevotella) prevalence
OTU99_17 (Parabacteroides) prevalence
OTU99_171 (Bacteroides) prevalence
OTU99_19 (Bacteria) prevalence
OTU99_197 (Bacteroides) prevalence
OTU99_2 (Bacteroides) prevalence
OTU99_21 (Parasutterella) prevalence
OTU99_211 (Bacteroides) prevalence
OTU99_23 (Faecalibacterium) prevalence
OTU99_24 (Prevotella) prevalence
TestASV_23 (Barnesiella) abundance
TestASV_24 (Bacteroides) abundance
TestASV_25 (Sutterella) abundance
TestASV_26 (Phascolarctobacterium) abundance
TestASV_27 (Ruminococcaceae) abundance
TestASV_28 (Holdemanella) abundance
TestASV_29 (Barnesiella) abundance
TestASV_3 (Bacteroides) abundance
TestASV_30 (Paraprevotella) abundance
TestASV_31 (Ruminococcus) abundance
TestASV_32 (Ruminococcaceae) abundance
TestASV_33 (Paraprevotella) abundance
TestASV_34 (Phascolarctobacterium) abundance
TestASV_35 (Alphaproteobacteria) abundance
TestASV_36 (Aestuariispira) abundance
TestASV_37 (Ruminococcaceae) abundance
TestASV_38 (Ruminococcus) abundance
TestASV_39 (Bacteroides) abundance
TestASV_4 (Alistipes) abundance
TestASV_41 (Barnesiella) abundance
TestASV_42 (Alphaproteobacteria) abundance
TestASV_43 (Parasutterella) abundance
TestASV_44 (Parasutterella) abundance
TestASV_45 (Clostridiales) abundance
TestASV_46 (Sutterella) abundance
Vertical cup-disc ratio (adjusted for vertical disc diameter)
Vertical cup-disc ratio (multi-trait analysis)
Glaucoma
Glaucoma (multi-trait analysis)
Hematological and biochemical traits
Lung function
Cholesterol
Physiological traits
Serum immune biomarker levels
Cerebrospinal fluid immune biomarker levels
Obsessive compulsive disorder severity
Compulsion score in obsessive compulsive disorder
Obsession score in obsessive compulsive disorder
Graft survival time in renal transplantation (donor effect)
Graft survival time in renal transplantation (donor effect) x APOL1 genotype interaction
Angioedema in response to angiotensin-converting enzyme inhibitor and/or angiotensin receptor blocker
Parkinson's disease or schizophrenia
Smoking cessation (former vs current smokers)
OTU97_16 (Faecalibacterium) abundance
O_Coriobacteriales abundance
O_Erysipelotrichales abundance
O_Selenomonadales abundance
OTU97_17 (Parabacteroides) abundance
OTU97_100 (Ruminococcaceae) abundance
OTU97_19 (Bacteria) abundance
OTU97_102 (Prevotella) abundance
OTU97_105 (Ruminococcaceae) abundance
OTU97_106 (Ruminococcaceae) abundance
OTU97_23 (Faecalibacterium) abundance
OTU97_109 (Paraprevotella) abundance
OTU97_24 (Prevotella) abundance
OTU97_257 (Mitsuokella) abundance
OTU97_117 (Ruminococcus) abundance
OTU97_119 (Desulfovibrio) abundance
OTU97_12 (Bacteroides) abundance
OTU97_3 (Bacteroides) abundance
OTU97_13 (Subdoligranulum) abundance
OTU97_130 (Butyrivibrio) abundance
OTU97_31 (Prevotella) abundance
OTU97_138 (Oscillibacter) abundance
OTU97_140 (Bacteroides) abundance
OTU97_34 (Ruminococcus) abundance
OTU97_354 (Alloprevotella) abundance
OTU97_38 (Alphaproteobacteria) abundance
OTU97_39 (Proteobacteria) abundance
OTU97_4 (Alistipes) abundance
OTU97_46 (Lachnospiraceae) abundance
OTU97_5 (Sutterella) abundance
OTU99_120 (Ruminococcaceae) abundance
OTU97_51 (Barnesiella) abundance
OTU99_123 (Phascolarctobacterium) abundance
OTU99_124 (Paraprevotella) abundance
OTU97_56 (Ruminococcaceae) abundance
OTU99_132 (Bacteroidales) abundance
OTU97_6 (Sutterella) abundance
OTU99_140 (Desulfovibrio) abundance
OTU97_69 (Clostridiales) abundance
OTU99_155 (Butyrivibrio) abundance
OTU99_157 (Barnesiella) abundance
OTU99_16 (Faecalibacterium) abundance
OTU99_166 (Prevotella) abundance
OTU97_8 (Ruminococcaceae) abundance
OTU99_171 (Bacteroides) abundance
OTU97_82 (Bacteroides) abundance
OTU99_197 (Bacteroides) abundance
OTU97_95 (Cytophagales) abundance
OTU99_21 (Parasutterella) abundance
OTU99_1 (Bacteroides) abundance
OTU99_23 (Faecalibacterium) abundance
P_Actinobacteria abundance
OTU99_24 (Prevotella) abundance
OTU99_110 (Clostridiales) abundance
OTU99_116 (Sutterella) abundance
OTU99_12 (Bacteroides) abundance
OTU97_50 (Aestuariispira) abundance
OTU99_121 (Ruminococcaceae) abundance
OTU97_53 (Bacteroides) abundance
OTU99_13 (Subdoligranulum) abundance
OTU97_58 (Sutterellaceae) abundance
OTU99_137 (Ruminococcus) abundance
OTU97_65 (Parabacteroides) abundance
OTU99_150 (Prevotella) abundance
OTU97_7 (Lachnospiraceae) abundance
OTU97_73 (Prevotella) abundance
OTU97_74 (Alistipes) abundance
OTU99_17 (Parabacteroides) abundance
OTU97_80 (Ruminococcus) abundance
OTU99_19 (Bacteria) abundance
OTU97_86 (Phascolarctobacterium) abundance
OTU97_9 (Alistipes) abundance
OTU99_2 (Bacteroides) abundance
OTU97_97 (Clostridiales) abundance
OTU99_211 (Bacteroides) abundance
OTU99_106 (Barnesiella) abundance
OTU99_108 (Cytophagales) abundance
OTU99_11 (Parabacteroides) abundance
OTU99_26 (Parasutterella) abundance
OTU99_8 (Ruminococcaceae) abundance
OTU99_84 (Prevotella) abundance
OTU99_85 (Alistipes) abundance
OTU99_9 (Alistipes) abundance
OTU99_92 (Ruminococcus) abundance
OTU99_94 (Bacteroides) abundance
OTU99_98 (Phascolarctobacterium) abundance
P_Bacteroidetes abundance
P_Firmicutes abundance
P_Proteobacteria abundance
TestASV_1 (Bacteroides) abundance
TestASV_10 (Parabacteroides) abundance
TestASV_11 (Lachnospiraceae) abundance
TestASV_12 (Bacteroides) abundance
TestASV_13 (Bacteroides) abundance
TestASV_14 (Lachnospiraceae) abundance
TestASV_15 (Bacteroides) abundance
TestASV_16 (Bacteroides) abundance
TestASV_17 (Bacteroides) abundance
TestASV_18 (Prevotella) abundance
TestASV_19 (Prevotella) abundance
TestASV_2 (Bacteroides) abundance
TestASV_20 (Phascolarctobacterium) abundance
TestASV_21 (Ruminococcaceae) abundance
TestASV_22 (Sutterella) abundance
OTU99_271 (Prevotella) abundance
OTU99_298 (Phascolarctobacterium) abundance
OTU99_3 (Bacteroides) abundance
OTU99_30 (Parasutterella) abundance
OTU99_32 (Prevotella) abundance
OTU99_34 (Holdemanella) abundance
OTU99_35 (Ruminococcus) abundance
OTU99_39 (Alphaproteobacteria) abundance
OTU99_4 (Alistipes) abundance
OTU99_40 (Proteobacteria) abundance
OTU99_45 (Faecalibacterium) abundance
OTU99_47 (Prevotella) abundance
OTU99_5 (Sutterella) abundance
OTU99_53 (Aestuariispira) abundance
OTU99_54 (Holdemanella) abundance
OTU99_55 (Barnesiella) abundance
OTU99_558 (Bacteroidales) abundance
OTU99_58 (Bacteroides) abundance
OTU99_59 (Prevotella) abundance
OTU99_6 (Sutterella) abundance
OTU99_62 (Ruminococcaceae) abundance
OTU99_65 (Sutterellaceae) abundance
OTU99_7 (Lachnospiraceae) abundance
OTU99_72 (Parabacteroides) abundance
OTU99_78 (Clostridiales) abundance
O_Clostridiales abundance
OTU97_163 (Bacteroides) abundance
OTU97_165 (Porphyromonadaceae) abundance
OTU97_1 (Bacteroides) abundance
OTU97_173 (Bacteroides) abundance
OTU97_101 (Sutterella) abundance
OTU97_2 (Bacteroides) abundance
OTU97_21 (Parasutterella) abundance
OTU97_108 (Phascolarctobacterium) abundance
OTU97_235 (Phascolarctobacterium) abundance
OTU97_11 (Parabacteroides) abundance
OTU97_113 (Bacteroidales) abundance
OTU97_26 (Parasutterella) abundance
OTU97_27 (Bacteroides) abundance
OTU97_277 (Prevotella) abundance
OTU97_126 (Prevotella) abundance
OTU97_30 (Roseburia) abundance
OTU97_137 (Catenibacterium) abundance
OTU97_33 (Holdemanella) abundance
OTU97_15 (Parasutterella) abundance
OTU97_150 (Bacteroides) abundance
Bipolar disorder or body mass index
Bipolar disorder or type 2 diabetes
Anxiety
Anxiety disorders
Chronic postoperative pain
Low HDL-cholesterol levels
High fasting blood glucose
Refractive error (age-at-onset of spectacle wearing-inferred)
Refractive error (autorefraction measured)
Adventurousness
Automobile speeding propensity
Number of sexual partners
General risk tolerance (MTAG)
Risk-taking tendency (4-domain principal component model)
General risk tolerance
Cardioembolic stroke (CCSp classification)
Cardioembolic stroke (TOAST classification)
Cardioembolic stroke (CCS and TOAST classification)
Cardioembolic stroke (CCS or TOAST classification)
Large artery stroke (CCSc classification)
Large artery stroke (CCSp classification)j
Large artery stroke (TOAST classification)
Large artery stroke (CCS and TOAST classification)
Large artery stroke (CCS or TOAST classification)
Small vessel stroke (CCSc classification)
Small vessel stroke (CCSp classification)
Small vessel stroke (TOAST classification)
Small vessel stroke (CCS and TOAST classification)
Small vessel stroke (CCS or TOAST classification)
Cardioembolic stroke (CCSc classification)
White matter hyperintensity volume
HDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)
Polycystic ovary syndrome (reproductive subtype)
Polycystic ovary syndrome (metabolic subtype)
Polycystic ovary syndrome (indeterminate subtype)
Adult onset Still's disease
Lifetime smoking index
Systolic blood pressure response to thiazide and thiazide-like diuretics in hypertension
Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension
Systolic blood pressure response to chlorthalidone in hypertension
Diastolic blood pressure response to chlorthalidone in hypertension
Carotid intima media thickness (mean)
Carotid intima media thickness (maximum)
Carotid intima media thickness (mean-maximum)
HDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)
HDL cholesterol levels in current smokers
HDL cholesterol levels in non smokers
HDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)
HDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)
HDL cholesterol levels in ever smokers
HDL cholesterol levels in never smokers
LDL cholesterol levels x smoking (current vs non smokers) interaction (1df test)
LDL cholesterol levels x smoking (current vs non smokers) interaction (2df test)
LDL cholesterol levels in current smokers
LDL cholesterol levels in non smokers
LDL cholesterol levels x smoking (ever vs never smokers) interaction (1df test)
LDL cholesterol levels x smoking (ever vs never smokers) interaction (2df test)
LDL cholesterol levels in ever smokers
LDL cholesterol levels in never smokers
Triglyceride levels x smoking (current vs non smokers) interaction (1df test)
Triglyceride levels x smoking (current vs non smokers) interaction (2df test)
Triglyceride levels in current smokers
Triglyceride levels in non smokers
Triglyceride levels x smoking (ever vs never smokers) interaction (2df test)
Triglyceride levels x smoking (ever vs never smokers) interaction (1df test)
Triglyceride levels in ever smokers
Triglyceride levels in never smokers
fetal weight (maternal genotype effect)
Bone mineral density or trunk lean mass (pleiotropy)
Trunk lean mass
Aortic valve area
Peak weight velocity
Age at adiposity peak
BMI at adiposity peak
Age at adiposity rebound
BMI at adiposity rebound
Peak height velocity
G_Holdemanella abundance
G_Lachnospiraceae abundance
G_Oscillibacter abundance
G_Parabacteroides abundance
G_Paraprevotella abundance
G_Parasutterella abundance
G_Phascolarctobacterium abundance
G_Porphyromonadaceae abundance
G_Prevotella abundance
G_Prevotellaceae abundance
G_Roseburia abundance
G_Ruminococcaceae abundance
G_Ruminococcus abundance
G_Ruminococcus2 abundance
G_Subdoligranulum abundance
G_Sutterella abundance
O_Bacteroidales abundance
O_Burkholderiales abundance
TestASV_20 (Phascolarctobacterium) prevalence
TestASV_21 (Ruminococcaceae) prevalence
TestASV_22 (Sutterella) prevalence
TestASV_23 (Barnesiella) prevalence
TestASV_24 (Bacteroides) prevalence
TestASV_25 (Sutterella) prevalence
TestASV_26 (Phascolarctobacterium) prevalence
TestASV_27 (Ruminococcaceae) prevalence
TestASV_28 (Holdemanella) prevalence
TestASV_29 (Barnesiella) prevalence
TestASV_3 (Bacteroides) prevalence
TestASV_30 (Paraprevotella) prevalence
TestASV_31 (Ruminococcus) prevalence
TestASV_32 (Ruminococcaceae) prevalence
TestASV_33 (Paraprevotella) prevalence
TestASV_34 (Phascolarctobacterium) prevalence
TestASV_35 (Alphaproteobacteria) prevalence
TestASV_36 (Aestuariispira) prevalence
TestASV_37 (Ruminococcaceae) prevalence
TestASV_38 (Ruminococcus) prevalence
TestASV_39 (Bacteroides) prevalence
TestASV_4 (Alistipes) prevalence
TestASV_40 (Barnesiella) prevalence
TestASV_41 (Barnesiella) prevalence
TestASV_42 (Alphaproteobacteria) prevalence
TestASV_43 (Parasutterella) prevalence
TestASV_44 (Parasutterella) prevalence
TestASV_45 (Clostridiales) prevalence
TestASV_46 (Sutterella) prevalence
TestASV_47 (Parasutterella) prevalence
TestASV_48 (Sutterella) prevalence
TestASV_49 (Parasutterella) prevalence
C_Gammaproteobacteria abundance
C_Negativicutes abundance
F_Acidaminococcaceae abundance
F_Bacteroidaceae abundance
F_Coriobacteriaceae abundance
F_Erysipelotrichaceae abundance
F_Lachnospiraceae abundance
F_Porphyromonadaceae abundance
F_Prevotellaceae abundance
F_Rikenellaceae abundance
F_Ruminococcaceae abundance
F_Sutterellaceae abundance
G_Alistipes abundance
G_Alloprevotella abundance
G_Alphaproteobacteria abundance
G_Bacteroidales abundance
G_Bacteroides abundance
G_Bacteroidetes abundance
G_Barnesiella abundance
G_Catenibacterium abundance
G_Clostridiales abundance
G_Clostridium_XlVa abundance
G_Coprococcus abundance
G_Faecalibacterium abundance
G_Firmicutes abundance
TestASV_5 (Bacteroides) prevalence
TestASV_6 (Subdoligranulum) prevalence
TestASV_7 (Bacteroides) prevalence
TestASV_8 (Bacteroides) prevalence
TestASV_9 (Alistipes) prevalence
Depression
Suicidal or self-harm ideation
Ebbinghaus illusion (underestimation)
Ebbinghaus illusion (overestimation)
Fat-free mass
Brain imaging measurements (variance)
Brain imaging measurements (mean)
LDL cholesterol change in response to niacin in statin-treated individuals
Triglycerides levels in response to niacin in statin-treated individuals
Total cholesterol change in response to niacin in statin-treated individuals
Lipoprotein (a) levels in response to niacin in statin-treated individuals
HDL cholesterol change in response to niacin in statin-treated individuals
Response to adalimumab in hidradenitis suppurativa (abscess and inflammatory nodule count increase)
Age-related cognitive decline (global cognition) (slope of z-scores)
Age-related cognitive decline (executive function) (slope of z-scores)
Age-related cognitive decline (language) (slope of z-scores)
Age-related cognitive decline (memory) (slope of z-scores)
Age-related cognitive decline (visuospatial skill) (slope of z-scores)
Age-related cognitive decline (attention/processing speed) (slope of z-scores)
Pancreatic ductal adenocarcinoma
Response to ketamine in bipolar disorder or major depression (antidepressant effects)
Response to ketamine in bipolar disorder or major depression (dissociation effects)
Cognitive performance (language ability)
Cognitive performance (processing speed) x major depressive disorder status interaction
Cognitive performance (language ability) x major depressive disorder status interaction
Cognitive performance (processing speed) x major depressive disorder type interaction
Cognitive performance (processing speed) in major depressive disorder
Anti-helicobacter pylori IgG seropositivity
Severe gastric atrophy
Pepsinogen-I levels
Pepsinogen I/II ratio
Gastric atrophy
Response to beta blocker use in hypertension (systolic blood pressure)
Response to beta blocker use in hypertension (diastolic blood pressure)
Childhood obesity
Response to antiepileptic drugs in genetic generalized epilepsy
Response to valproic acid in genetic generalized epilepsy
Response to lamotrigine in genetic generalized epilepsy
Response to levetiracetam in genetic generalized epilepsy
Response to lamotrigine and valproic acid in genetic generalized epilepsy
Protein level change in low calorie diet obesity intervention
Protein levels in obesity
Complement factor H binding to malondialdehyde
Hip bone size
Bone mineral density (hip) and hip bone size
Buruli ulcer
Buruli ulcer (age at onset)
Retinal detachment or retinal break
Retinal detachment with retinal break
High myopia
Cataracts (operation)
Cortical thickness
HDL cholesterol levels x long total sleep time interaction (2df test)
Triglyceride levels x long total sleep time interaction (1df test)
HDL cholesterol levels x short total sleep time interaction (2df test)
LDL cholesterol levels x long total sleep time interaction (2df test)
LDL cholesterol levels x short total sleep time interaction (2df test)
Triglyceride levels x long total sleep time interaction (2df test)
Triglyceride levels x short total sleep time interaction (2df test)
HDL cholesterol levels x long total sleep time interaction (1df test)
Triglyceride levels x short total sleep time interaction (1df test)
HDL cholesterol levels x short total sleep time interaction (1df test)
LDL cholesterol levels x long total sleep time interaction (1df test)
LDL cholesterol levels x short total sleep time interaction (1df test)
Colorectal cancer x BMI interaction (2df)
Vascular endothelial growth factor levels in major depressive disorder
Head and neck squamous cell carcinoma
Basophil count
Fasting blood glucose
Fasting blood insulin
Birth length (MTAG)
Infant head circumference (MTAG)
Birth weight (MTAG)
Lung function in heavy smokers (low FEV1 vs high FEV1)
Lung function in never smokers (high FEV1 vs average FEV1)
Lung function in heavy smokers (high FEV1 vs average FEV1)
Lung function in never smokers (low FEV1 vs average FEV1)
Lung function in heavy smokers (low FEV1 vs average FEV1)
Smoking status (heavy vs never)
Lung function (low FEV1 vs high FEV1) x smoking interaction
Lung function (low FEV1 vs high FEV1)
Lung function in never smokers (low FEV1 vs high FEV1)
Occipital lobe volume
Parietal lobe volume
Temporal lobe volume
Frontal lobe volume
Skin pigmentation (conditioned on rs1426654 and rs35397)
Brainstem volume
Serum sclerostin levels
JT interval
Chronic rhinosinusitis
Sortilin levels
Lipoprotein lipase levels
Serine/threonine-protein kinase 4 levels
Tyrosine-protein kinase Mer levels
Protein-glutamine gamma-glutamyltransferase 2 levels
NF-kappa-B essential modulator levels
Thrombopoietin levels
Proteinase-activated receptor 1 levels
Thrombomodulin levels
Platelet-derived growth factor subunit B levels
Tumor necrosis factor receptor superfamily member 11A levels
Placenta growth factor levels
Polymeric immunoglobulin receptor levels
Prolargin levels
V-set and immunoglobulin domain-containing protein 2 levels
Prostasin levels
CD166 antigen levels
Aminopeptidase N levels
Tyrosine-protein kinase receptor UFO levels
Azurocidin levels
Bleomycin hydrolase levels
Stem cell factor levels
C-C motif chemokine 15 levels
SLAM family member 7 levels
"Superoxide dismutase [Mn],mitochondrial levels"
Leptin levels
Spondin-2 levels
Macrophage receptor MARCO levels
Tissue factor levels
Matrix metalloproteinase-12 levels
Matrix metalloproteinase-7 levels
Thrombospondin-2 levels
Pappalysin-1 levels
Angiopoietin-1 receptor levels
Poly [ADP-ribose] polymerase 1 levels
Tumor necrosis factor receptor superfamily member 10A levels
Programmed cell death 1 ligand 2 levels
Tumor necrosis factor receptor superfamily member 13B levels
TNF-related apoptosis-inducing ligand receptor 2 levels
vascular endothelial growth factor D levels
Serine protease 27 levels
XCL1 levels
P-selectin glycoprotein ligand 1 levels
Pentraxin-related protein PTX3 levels
Receptor for advanced glycosylation end products levels
Renin levels
Caspase-3 levels
Serpin A12 levels
C-C motif chemokine 16 levels
C-C motif chemokine 24 levels
C-type lectin domain family 5 member A levels
CXADR-like membrane protein levels
Calsyntenin-2 levels
Clusterin-like protein 1 levels
Catechol O-methyltransferase levels
Crk-like protein levels
Pro-cathepsin H levels
Cathepsin O levels
Aromatic-L-amino-acid decarboxylase levels
Dipeptidyl peptidase 2 levels
Gamma-enolase levels
Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 levels
Ectonucleoside triphosphate diphosphohydrolase 5 levels
Protein FAM3C levels
"Fructose-1,6-bisphosphatase 1 levels"
Fc receptor-like protein 1 levels
Peptidyl-prolyl cis-trans isomerase FKBP4 levels
Galanin peptide levels
Glutaredoxin-1 levels
GRB2-related adapter protein 2 levels
Insulin-like growth factor-binding protein-like 1 levels
Integrin beta-7 levels
Kallikrein-10 levels
Kynurenine-oxoglutarate transaminase 1 levels
Leukocyte immunoglobulin-like receptor subfamily A member 5 levels
Leucine-rich repeats and immunoglobulin-like domains protein 1 levels
Low-density lipoprotein receptor-related protein 11 levels
Multiple coagulation factor deficiency protein 2 levels
Meprin A subunit beta levels
Meteorin-like protein levels
NAD kinase levels
Nectin-2 levels
Nodal modulator 1 levels
Neural proliferation differentiation and control protein 1 levels
Neuronal pentraxin receptor levels
Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 levels
Paired immunoglobulin-like type 2 receptor beta levels
Protein phosphatase inhibitor 2 levels
Dihydropteridine reductase levels
Regenerating islet-derived protein 4 levels
Eosinophil cationic protein levels
Inactive tyrosine-protein kinase transmembrane receptor ROR1 levels
Reticulon-4 receptor levels
Protein S100-A12 levels
Syndecan-4 levels
Semaphorin-3F levels
Serpin B6 levels
Serpin B8 levels
Sialic acid-binding Ig-like lectin 7 levels
Synaptosomal-associated protein 23 levels
Tartrate-resistant acid phosphatase type 5 levels
Urokinase-type plasminogen activator levels
Urokinase plasminogen activator surface receptor levels
Lysophosphatidic acid phosphatase type 6 levels
Adhesion G protein-coupled receptor E2 levels
Adhesion G-protein coupled receptor G2 levels
Retinal dehydrogenase 1 levels
Angiopoietin-2 levels
Angiopoietin-related protein 1 levels
Angiopoietin-related protein 7 levels
DNA-(apurinic or apyrimidinic site) lyase levels
Amyloid-like protein 1 levels
Arginase-1 levels
Large proline-rich protein BAG6 levels
Carbonic anhydrase 13 levels
Soluble calcium-activated nucleotidase 1 levels
Coiled-coil domain-containing protein 80 levels
Sialomucin core protein 24 levels
T-cell surface glycoprotein CD1c levels
CD2-associated protein levels
B-cell antigen receptor complex-associated protein beta chain levels
Cadherin-2 levels
Cadherin-related family member 5 levels
Chordin-like protein 2 levels
Platelet endothelial cell adhesion molecule levels
Peptidoglycan recognition protein 1 levels
Elafin levels
Perlecan levels
Paraoxonase activity
Myeloblastin levels
Pulmonary surfactant-associated protein D levels
Retinoic acid receptor responder protein 2 levels
Resistin levels
Secretoglobin family 3A member 2 levels
E-selectin levels
P-selectin levels
Tyrosine-protein phosphatase non-receptor type substrate 1 levels
Spondin-1 levels
ST2 protein levels
Metalloproteinase inhibitor 4 levels
Trem-like transcript 2 protein levels
Tumor necrosis factor receptor 1 levels
Tumor necrosis factor receptor 2 levels
Tumor necrosis factor receptor superfamily member 10C levels
Tumor necrosis factor receptor superfamily member 14 levels
Tumor necrosis factor ligand superfamily member 13B levels
Tissue-type plasminogen activator levels
Transferrin receptor protein 1 levels
Scavenger receptor cysteine-rich type 1 protein M130 levels
Complement component C1q receptor levels
Cadherin-5 levels
Chitinase-3-like protein 1 levels
Chitotriosidase-1 levels
Contactin-1 levels
Collagen alpha-1 (I) chain levels
Carboxypeptidase A1 levels
Carboxypeptidase B levels
Cystatin-B levels
Cathepsin D levels
Cathepsin Z levels
C-X-C motif chemokine 16 levels
Protein delta homolog 1 levels
Epidermal growth factor levels
epithelial cell adhesion molecule levels
Ephrin type-B receptor 4 levels
"Fatty acid-binding protein, adipocyte levels"
Tumor necrosis factor receptor superfamily member 6 levels
Galectin-3 levels
Galectin-4 levels
Granulins levels
Intercellular adhesion molecule 2 levels
Insulin-like growth factor-binding protein 1 levels
Insulin-like growth factor-binding protein 2 levels
Interleukin-1 receptor type 2 levels
Interleukin-2 receptor subunit alpha levels
Interleukin-6 receptor subunit alpha levels
Integrin beta-2 levels
Junctional adhesion molecule A levels
Kallikrein-6 levels
Low-density lipoprotein receptor levels
Lymphotoxin-beta receptor levels
Myoglobin levels
Monocyte chemoattractant protein-1 levels
Matrix extracellular phosphoglycoprotein levels
Matrix metalloproteinase-2 levels
Matrix metalloproteinase-3 levels
Matrix metalloproteinase-9 levels
Myeloperoxidase levels
Neurogenic locus notch homolog protein 3 levels
Osteoprotegerin levels
Osteopontin levels
Plasminogen activator inhibitor-1 (PAI-1) levels
Proprotein convertase subtilisin/kexin type 9 levels
Platelet-derived growth factor subunit A levels
Insulin-like growth factor-binding protein 7 levels
Interleukin-17 receptor A levels
Interleukin-18-binding protein levels
Interleukin-1 receptor type 1 levels
Response to serotonin-norepinephrine reuptake inhibitors (responders vs non-responders)
Response to norepinephrine-dopamine reuptake inhibitors (responders vs non-responders)
Response to antidepressants (non-treatment-resistant vs treatment-resistant depression)
Response to SSRI (responders vs non-responders)
Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-30 minutes)
Glucagon levels in response to oral glucose tolerance test (decremental area under the curve for 0-120 minutes)
Glucagon levels in response to oral glucose tolerance test (30 minutes)
Sclerostin levels
Scavenger receptor cysteine-rich domain-containing group B protein levels
Sulfatase-modifying factor 2 levels
Trefoil factor 2 levels
Thimet oligopeptidase levels
Thyrotropin subunit beta levels
Thioredoxin domain-containing protein 5 levels
Thymidine phosphorylase levels
Tyrosine-protein kinase receptor TYRO3 levels
Ubiquitin carboxyl-terminal hydrolase 8 levels
Versican core protein levels
Angiotensin-converting enzyme 2 levels
A disintegrin and metalloproteinase with thrombospondin motifs 13 levels
Agouti-related protein levels
Protein AMBP levels
Angiopoietin-1 levels
Bone morphogenetic protein 6 levels
Brother of CDO levels
"Carbonic anhydrase 5A,mitochondrial levels"
C-C motif chemokine 17 levels
C-C motif chemokine 3 levels
T-cell surface glycoprotein CD4 levels
CD40 ligand levels
SLAM family member 5 levels
Carcinoembryonic antigenrelated cell adhesion molecule 8 levels
Chymotrypsin C levels
Cathepsin L1 levels
C-X-C motif chemokine 1 levels
Decorin levels
"2,4-dienoyl-CoA reductase,mitochondrial levels"
Dickkopf-related protein 1 levels
"Fatty acid-binding protein,intestinal levels"
Fibroblast growth factor 21 levels
Fibroblast growth factor 23 levels
Follistatin levels
Galectin-9 levels
Growth/differentiation factor 2 levels
Growth hormone levels
Gastric intrinsic factor levels
Lactoylglutathione lyase levels
Gastrotropin levels
Hydroxyacid oxidase 1 levels
Proheparin-binding EGF-like growth factor levels
Heme oxygenase 1 levels
Osteoclast-associated immunoglobulin-like receptor levels
Heat shock 27 kDa protein levels
Alpha-L-iduronidase levels
Low affinity immunoglobulin gamma Fc region receptor II-b levels
Pro-interleukin-16 levels
Interleukin-17D levels
Interleukin-18 levels
Interleukin-1 receptor-like 2 levels
Interleukin-27 levels
Interleukin-4 receptor subunit alpha levels
Kidney Injury Molecule levels
Nucleoside diphosphate kinase A levels in hepatocellular carcinoma
Fasting glucose
Fasting insulin
Appendicular lean mass
Plasma free amino acid levels (adjusted for twenty other PFAAs)
Plasma free amino acid levels (adjusted for one other PFAA)
Plasma free proline levels
Plasma free asparagine levels
Plasma free amino acid levels
Eye color (saturation)
Eye color
Eye color (brightness)
Eye color (hue)
"Skin, hair and eye pigmentation (multivariate analysis)"
Meat-related diet
Pork consumption
Poultry consumption
Raw vegetable consumption
Cooked vegetable consumption
Fruit consumption
Oily fish consumption
Non-oily fish consumption
Lamb consumption
Processed meat consumption
Fish- and plant-related diet
Beef consumption
Physiological dysregulation (Mahalanobis distance)
Hand grip strength (Mahalanobis distance)
"Multiple traits (2,148)"
"Multiple traits (2,173)"
Type 2 diabetes (adjusted for BMI)
Parkinson's disease or first degree relation to individual with Parkinson's disease
Glaucoma (primary open-angle)
Panic disorder
Urinary incontinence
Stress urinary incontinence
Urgency urinary incontinence
Stress urinary incontinence and urgency urinary incontinence
Fecal incontinence
Severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis
Moderate or severe prolonged lymphopenia in dimethyl fumarate-treated relapsing-remitting multiple sclerosis
Disability (impaired activities of daily living)
B-cell acute lymphoblastic leukaemia
B-cell acute lymphoblastic leukaemia (high-hyperdiploidy)
B-cell acute lymphoblastic leukaemia (ETV6-RUNX1 positive)
Circulating leptin levels in high cardiovascular risk
Circulating leptin levels x sex interaction in high cardiovascular risk
Hippocampal atrophy rate
LDL cholesterol levels x loop diuretics use interaction
Triglyceride levels x loop diuretics use interaction
HDL cholesterol levels x thiazide or thiazide-like diuretics use interaction
LDL cholesterol levels x thiazide or thiazide-like diuretics use interaction
Triglyceride levels x thiazide or thiazide-like diuretics use interaction
HDL cholesterol levels x loop diuretics use interaction
Circulating leptin levels or fasting insulin levels
Circulating leptin levels or HOMA-B
Circulating leptin levels or HOMA-IR
Circulating leptin levels or type 2 diabetes
Bipolar disorder or intelligence (pleiotropy)
Schizophrenia or intelligence (pleiotropy)
Parkinson's disease in GBA mutation carriers
Parkinson's disease in GBA mutation carriers (age at onset)
Serum total polyunsaturated fatty acid concentration in metabolic syndrome
Serum omega-3 polyunsaturated fatty acid concentration in metabolic syndrome
Serum omega-6 polyunsaturated fatty acid concentration in metabolic syndrome
Serum docosahexaenoic fatty acid concentration in metabolic syndrome
Serum linoleic acid concentration in metabolic syndrome
Serum omega-6 to omega-3 polyunsaturated fatty acid ratio in metabolic syndrome
Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome
Serum polyunsaturated fatty acid concentration x Mediterranean diet adherence interaction in metabolic syndrome
Severe aplastic anemia
Cutaneous squamous cell carcinoma
Midgestational total 25-hydroxyvitamin D levels (maternal genetic effect)
Neonatal total 25-hydroxyvitamin D levels (maternal genetic effect)
Midgestational total 25-hydroxyvitamin D levels (fetal genetic effect)
Neonatal total 25-hydroxyvitamin D levels (fetal genetic effect)
Blood pressure x alcohol consumption interaction
Response to statins (LDL cholesterol percent change)
Low density lipoprotein cholesterol levels (on statin treatment)
Response to statins (LDL cholesterol change)
Uterine fibroids (MTAG)
Endometriosis (MTAG)
Ovarian cancer
Ovarian cancer (MTAG)
Endometrial cancer (MTAG)
Gynecologic disease
Cervical cancer (MTAG)
Gynecologic disease (multivariate analysis)
Chloride levels
Iron levels
Potassium levels
Sodium levels
Bicarbonate levels
Creatine kinase levels
Activated partial thromboplastin time
Prothrombin time
International normalisation ratio
Diabetic macular edema in type 2 diabetes
Proliferative diabetic retinopathy in type 2 diabetes
Glycemic traits (multi-trait analysis)
Sitting height
Short-term memory (digit-span task)
Short-term memory (visuospatial task)
Short-term memory (shared component of digit-span and visuospatial tasks)
Long-term memory (delayed word recall task)
Refractory celiac disease type II
Airflow obstruction in ever smokers
Body fat distribution (arm fat ratio)
Body fat distribution (leg fat ratio)
Body fat distribution (trunk fat ratio)
Bipolar disorder or major depressive disorder
Cerebrospinal fluid neurofilament light levels
Opioid use cessation
Memory decline
Acute respiratory distress syndrome in sepsis
Longitudinal brain connectivity change (Louvain modularity)
Longitudinal brain connectivity change (transitivity)
Longitudinal brain connectivity change (global efficiency)
Longitudinal brain connectivity change (characteristic path length)
Opioid use disorder
Hepatocellular carcinoma in hepatitis B infection
Coffee consumption
Green tea consumption
Milk consumption
Yoghurt consumption
Cheese consumption
Natto consumption
Tofu consumption
Fish intake frequency
Small whole fish consumption
Vegetable consumption
Meat consumption
Serum creatinine levels
Clinical remission in asthma
Complete remission in asthma
Pro B-type natriuretic peptide
Iron status biomarkers (total iron binding capacity)
Unsaturated iron binding capacity
Total bilirubin levels
Uric acid levels
Serum folate levels
Homocysteine levels
Vitamin B12 levels
Maximum cranial length
Cephalic index
Maximum cranial width
Spontaneous coronary artery dissection
Apolipoprotein A1 levels
Drug-induced liver injury in interferon-beta-treated multiple sclerosis
Age at loss of ambulation in Duchenne muscular dystrophy
Hirschsprung disease
Red blood cell traits (multivariate analysis)
Dermatomyositis or juvenile dermatomyositis
Infective endocarditis in Staphylococcus aureus infection
Huntington's disease (age at onset)
Glioblastoma
Non-glioblastoma glioma
Cerebrospinal fluid beta-site APP cleaving enzyme levels
Circulating odd-numbered chain saturated fatty acid levels (C15:0)
Circulating odd-numbered chain saturated fatty acid levels (C17:0)
Circulating odd-numbered chain saturated fatty acid levels (C15:0+C17:0)
Circulating odd-numbered chain saturated fatty acid levels (C19:0)
Circulating odd-numbered chain saturated fatty acid levels (C23:0)
Basal ganglia growth
White matter growth
Cerebellum growth
Cerebral cortical growth
Right lateral prefrontal cortical growth
Plasma neurofilament light levels
Death
Diabetes mellitus
Plasma proprotein convertase subtilisin/kexin type 9 levels in stable coronary artery disease
Non-small cell lung cancer in heavy smokers
Meningioma
Executive function in ADHD
Serum metabolite levels (CMS)
Change in serum metabolite levels
Change in serum metabolite levels (CMS)
Serum metabolite levels
Blue vs. green eyes
Burning and freckling
Freckles
Skin sensitivity to sun
Blond vs. brown hair color
Red vs. non-red hair color
C-reactive protein
Homeostasis model assessment of insulin resistance
Homeostasis model assessment of beta-cell function
Response to hepatitis C treatment
AIDS
End-stage renal disease
Response to citalopram treatment
Platelet aggregation
Adiposity
Cutaneous nevi
Glomerulosclerosis
Cardiac hypertrophy
Breast cancer (survival)
Drug-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)
Sudden cardiac arrest
HIV-1 control
Myocardial infarction in coronary artery disease
Nevus count
Angiotensin-converting enzyme activity
Response to antipsychotic treatment
Brachial circumference
Malignant pleural mesothelioma
Essential tremor
Renal function-related traits (BUN)
Renal function-related traits (sCR)
Renal function-related traits (eGRFcrea)
Renal function-related traits (urea)
Pit-and-Fissure caries
Smooth-surface caries
Lipid metabolism phenotypes
Response to diuretic therapy
Cognitive performance
Chronic hepatitis C infection
Protein quantitative trait loci
Malaria
Response to TNF antagonist treatment
Attention deficit hyperactivity disorder and conduct disorder
Keloid
Life threatening arrhythmia
Interstitial lung disease
DNA methylation (parent-of-origin)
DNA methylation (variation)
Bipolar disorder and schizophrenia
Ulcerative colitis or Crohn's disease
Airflow obstruction
Obesity
Axial length
Bipolar disorder (Negative mood delusions)
Metabolite levels (HVA/5-HIAA ratio)
Metabolite levels (HVA-5-HIAA Factor score)
Metabolite levels (HVA)
Metabolite levels (5-HIAA)
Metabolite levels (MHPG)
Metabolite levels (5-HIAA/ MHPG Ratio)
Metabolite levels (HVA/MHPG ratio)
Head circumference (infant)
Amyotrophic lateral sclerosis (age of onset)
Amyotrophic lateral sclerosis (C9orf72 mutation interaction)
Amyotrophic lateral sclerosis in C9orf72 mutation negative individuals
Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals
Non-albumin protein levels
Age-related macular degeneration (wet)
Type 2 diabetes and 6 quantitative traits
Urinary albumin excretion
Intelligence (childhood)
Suicide risk
Fetal hemoglobin levels
Cognitive decline
Osteonecrosis of the jaw
Testicular germ cell cancer
Premature ovarian failure
Eye color traits
Corneal structure
Memory (short-term)
Brain structure (hippocampal volume)
Brain structure (temporal lobe volume)
Mathematical ability
Metabolic syndrome (bivariate traits)
Waist Circumference - Triglycerides (WC-TG)
HDL Cholesterol - Triglycerides (HDLC-TG)
Triglycerides-Blood Pressure (TG-BP)
IgG glycosylation
Prostate cancer (SNP x SNP interaction)
Glaucoma (exfoliation)
Inflammatory bowel disease
Obesity (early onset extreme)
Hepatocellular carcinoma
RR interval (heart rate)
Rhegmatogenous retinal detachment
Alzheimer's disease biomarkers
Vitamin D insufficiency
Biomedical quantitative traits
F-cell distribution in sickle cell anaemia
Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction)
Obesity-related traits
Kawasaki disease
Quantitative traits
Type 2 diabetes nephropathy
Asparaginase hypersensitivity in acute lymphoblastic leukemia
Common variable immunodeficiency
Cortisol secretion
Response to antidepressant treatment
Optic disc parameters
Suicidal ideation
Educational attainment (college completion)
Educational attainment (years of education)
Brain structure
Autism spectrum disorders (language delay)
Response to interferon beta therapy
Social and non-social autistic-like traits
Acenocoumarol maintenance dosage
Asthma or atopy (farm exposure interaction)
Cerebrospinal T-tau levels
Cerebrospinal P-tau181p levels
N-glycan levels
Smoking behavior
Primary tooth development (number of teeth)
Primary tooth development (time to first tooth eruption)
Hearing impairment
Volumetric brain MRI
Cognitive test performance
Heart rate variability traits
Electrocardiographic traits
Glioma (high-grade)
Lipoprotein-associated phospholipase A2 activity and mass
Optic nerve measurement (cup area)
Optic nerve measurement (rim area)
Optic nerve measurement (disc area)
Optic nerve measurement (cup-to-disc ratio)
Attention deficit hyperactivity disorder motor coordination
Iron deficiency
Functional MRI
Insulin-like growth factors
Carotenoid and tocopherol levels
Cardiac muscle measurement
Response to acetaminophen (hepatotoxicity)
Osteoarthritis
Myocardial infarction (early onset)
Parkinson's disease (familial)
Bipolar disorder (age of onset and psychotic symptoms)
Carotid atherosclerosis in HIV infection
Natriuretic peptide levels
Atrial fibrillation/atrial flutter
Osteoporosis
Beta-trace protein levels
Neuromyelitis optica
Glycemic control in type 1 diabetes (HbA1c)
Osteosarcoma
Myopia (pathological)
Celiac disease
Serum selenium levels
Insulin-related traits
Pulmonary function (smoking interaction)
Urinary bladder cancer
Femoral neck bone geometry
Osteoporosis-related phenotypes
Folate pathway vitamin levels
Sphingolipid levels
Diabetic retinopathy
Event-related brain oscillations
Response to platinum-based chemotherapy in non-small-cell lung cancer
Erectile dysfunction and prostate cancer treatment
Atrioventricular conduction
Biochemical measures
Orofacial clefts (maternal alcohol consumption interaction)
Alcohol consumption (transferrin glycosylation)
Environmental confusion in the home
Multiple sclerosis (age of onset)
Normalized brain volume
Brain lesion load
Multiple sclerosis (severity)
Congenital heart malformation
Response to lithium treatment in bipolar disorder
Ovarian cancer in BRCA1 mutation carriers
Behcet's disease
Preeclampsia
Sunburns
Non-melanoma skin cancer
Erythrocyte sedimentation rate
QT interval (drug interaction)
Hypertrophic cardiomyopathy
Stroke (ischemic)
Liver enzyme levels (alanine transaminase)
Liver enzyme levels (alkaline phosphatase)
Liver enzyme levels (gamma-glutamyl transferase)
IgM levels
Response to gemcitabine in pancreatic cancer
Coronary arterial lesions in patients with Kawasaki disease
Age at smoking initiation in chronic obstructive pulmonary disease
Smoking cessation in chronic obstructive pulmonary disease
Current cigarettes per day in chronic obstructive pulmonary disease
Lifetime average cigarettes per day in chronic obstructive pulmonary disease
Small-cell lung cancer (survival)
Neuroblastoma
Response to bleomycin (chromatid breaks)
Urinary metabolites
Self-employment
Hemostatic factors and hematological phenotypes
Comprehensive strength and appendicular lean mass
Molar-incisor hypomineralization
Anxiety in major depressive disorder
Anxiety and major depressive disorder
Periodontitis (DPAL)
Periodontitis (PAL4Q3)
Periodontitis (Mean PAL)
Periodontitis (CDC/AAP)
Thyroid function
Vascular dementia
"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)"
Crohn's disease and celiac disease
Drinking behavior
Response to angiotensin II receptor blocker therapy
Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
Economic and political preferences
Economic and political preferences (environmentalism)
Economic and political preferences (fairness)
Economic and political preferences (feminism/equality)
Economic and political preferences (immigration/crime)
Economic and political preferences (time)
Dietary macronutrient intake
Dialysis-related mortality
Immune reponse to smallpox (secreted IL-12p40)
Immune reponse to smallpox (secreted IL-2)
Immune reponse to smallpox (secreted IL-10)
Immune reponse to smallpox (secreted IL-1beta)
Immune response to smallpox vaccine (IL-6)
Immune reponse to smallpox (secreted TNF-alpha)
Immune reponse to smallpox (secreted IFN-alpha)
Fat distribution (HIV)
Phosphorus levels
Left ventricular internal dimension in diastole
Left ventricular internal dimension in systole
Relative wall thickness
Fractional shortening
Ejection fraction
Interventricular septum thickness
Posterior wall thickness
Left ventricular mass index
E/A ratio
Blood sugar levels
Immunoglobulin measurement (zinc sulfate turbidity test)
Ankle injury
Thiopurine methyltransferase activity in acute lymphoblastic leukemia patients treated with mercaptopurines
Lumbar spinal stenosis
Cranial base width
Lower facial height
Facial depth
Thiopurine-induced leukopenia in inflammatory bowel disease
Joint destruction and growth retardation
Response to methylphenidate treatment in attention-deficit/hyperactivity disorder
Straight vs curly hair
Forearm bone mineral density
Self-reported risk-taking behaviour
Intracranial haemorrhage in renal transplantation (donors)
End stage renal failure in renal transplantation (recipient effect)
Graft survival time in renal transplantation (recipient effect)
Graft survival time in renal transplantation (donor-recipient interaction)
Acute graft rejection in renal transplantation (recipient effect)
Acute graft rejection in renal transplantation (donor effect)
Acute graft rejection in renal transplantation (donor-recipient interaction)
Major depressive disorder (exposed to adversity)
Major depressive disorder (unexposed to adversity)
Headache
Serum C3d:C3 ratio (systemic complement activation)
Dimensional psychopathology (Negative)
Dimensional psychopathology (Positive)
Dimensional psychopathology (Arousal)
Dimensional psychopathology (Social)
Dimensional psychopathology (Cognitive)
Hip minimal joint space width
Excitement-seeking behaviour
Platelet-to-lymphocyte ratio
Neutrophil-to-lymphocyte ratio
Early childhood caries
Autoimmune hepatitis in primary sclerosing cholangitis
Primary sclerosing cholangitis (small duct vs large duct)
Liver transplant-free survival in primary sclerosing cholangitis (time to event)
Colectomy in primary sclerosing cholangitis
Cholangiocarcinoma in primary sclerosing cholangitis
Cholangiocarcinoma in primary sclerosing cholangitis (time to event)
Colorectal carcinoma in primary sclerosing cholangitis
Gallbladder carcinoma in primary sclerosing cholangitis
Hepatocellular carcinoma in primary sclerosing cholangitis
Neurociticism
Irritable mood
Feeling lonely
Feeling miserable
Experiencing mood swings
Feeling guilty
Worry too long after an embarrassing experience
Feeling fed-up
Feeling nervous
Suffering from nerves
Feeling worry
Feeling hurt
Feeling tense
Mortality
Fasting growth hormone levels
Early age at menarche
Late age at menarche
Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (mean antibody levels)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (area under the curve for the first two years)
Neutralising antibody response to interferon beta therapy in multiple sclerosis (maximum antibody levels)
Total body bone mineral density
Total body bone mineral density (age 45-60)
Stimulated C-peptide levels in type I diabetes
Fasting C-peptide levels in type I diabetes
Random C-peptide levels in type I diabetes
C-peptide levels in type I diabetes
Giant cell arteritis
Hepatitis B virus-related hepatocellular carcinoma
Survival in endocrine treated breast cancer (estrogen-receptor positive)
Serum uric acid levels
Coronary artery disease and/or body mass index (pleiotropy)
Premature menopause in childhood cancer survivors
Bronchopulmonary dysplasia in preterm infants
Systemic lupus erythematosus or rheumatoid arthritis
Primary spontaneous pneumothorax
Albumin-globulin ratio
Lactate dehydrogenase levels
Acute kidney injury in critical illness
Response to antipsychotic treatment in schizophrenia
Response to haloperidol in schizophrenia
Response to perphenazine in schizophrenia
Response to ziprazidone in schizophrenia
Response to quetiapine in schizophrenia
Response to aripiprazole in schizophrenia
Response to risperidone in schizophrenia
Response to olanzapine in schizophrenia
Binge eating behaviour in bipolar disorder
Binge eating behaviour and bipolar disorder
Fractures (vertebral)
Osteoporosis or obesity (pleiotropy)
Depression in response to interferon-based therapy in chronic hepatitis C
Left ventricular QRS voltage
Survival in sporadic amyotrophic lateral sclerosis
Serum sulfate level
Blood pressure (parental or offspring effect)
Branched-chain amino acid levels (Isoleucine)
Branched-chain amino acid levels (Leucine)
Branched-chain amino acid levels (Valine)
Cardiometabolic and hematological traits
Cirrhosis (alcohol related)
Event free survival in diffuse large B-cell lymphoma treated with immunochemotherapy
Sporadic neuroblastoma
Common carotid intima-media thickness in HIV negative individuals
Common carotid intima-media thickness in HIV infection
Common carotid intima-media thickness
Rubella-specific interferon-gamma secretion
Rubella-specific interleukin-6 secretion
Pyridoxal levels
4-pyridoxic acid levels
Pyridoxal 5'-phosphate levels
Palmar length-width ratio in Kashin-Beck disease
Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL)
Surgical necrotising enterocolitis in extremely premature birth
Heparin-induced thrombocytopenia
Cerebrospinal fluid biomarker levels
Erosive tooth wear (severe vs non-severe)
Erosive tooth wear (severe vs none or mild)
Accelerometer-based physical activity measurement (fraction of time with accelerations >425 milli-gravities)
Moderate to vigorous physical activity levels
Vigorous physical activity
Strenuous sports or other exercises
Accelerometer-based physical activity measurement (average acceleration)
Liver disease severity in Alagille syndrome
Factor XI
Asthma or allergic disease (pleiotropy)
Hematoma volume in lobar spontaneous intracerebral hemorrhage
Hematoma volume in non-lobar spontaneous intracerebral hemorrhage
Cough in response to angiotensin-converting enzyme inhibitor drugs
Hyperthyroidism
Bitter taste perception (multivariate analysis)
Bitter taste perception
Osteoarthritis (hip)
Suicide attempts
Predicted suicide risk
Hyperuricemia
Alcoholic hepatitis
Pseudoexfoliation syndrome
GLP-1-stimulated insulin secretion
Offspring birth weight
Acute respiratory distress syndrome
Rheumatoid arthritis (ACPA-negative)
Rheumatoid arthritis (ACPA-positive)
Heart rate response to exercise
Heart rate response to recovery post exercise
Sulfasalazine-induced agranulocytosis
Antiepileptic drug-induced maculopapular exanthema
Carbamazepine-induced maculopapular exanthema
Lamotrigine-induced maculopapular exanthema
Phenytoin-induced maculopapular exanthema
Epstein Barr virus nuclear antigen 1 IgG levels
Epstein Barr virus nuclear antigen 1 IgG seropositivity
Viral capsid antigen IgG levels
Viral capsid antigen IgG seropositivity
Epstein-Barr virus immune response (multivariate analysis)
Limited cutaneous systemic scleroderma
Diffuse cutaneous systemic sclerosis
Systemic sclerosis (anti-centromere-positive)
Systemic sclerosis (anti-topoisomerase-positive)
Paternal history of Alzheimer's disease
Family history of Alzheimer's disease
Alzheimer's disease or family history of Alzheimer's disease
Maternal history of Alzheimer's disease
Curve progression in adolescent idiopathic scoliosis
Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia
ADAMTS13 levels
Cortisol levels (saliva)
diarrhoeal disease at age 1
diarrhoeal disease at age 1 with doctor diagnosis
diarrhoeal disease at age 2
diarrhoeal disease at age 2 with doctor diagnosis
Persistent hepatitis B virus infection
Osteoarthritis of the hip or knee (with total joint replacement)
Osteoarthritis of the hip or knee
Osteoarthritis of the hip (with total joint replacement)
Osteoarthritis of the knee (with total joint replacement)
Antipsychotic drug-induced QTc interval change in schizophrenia
Decline in glucose metabolism in posterior cingulate cortex
Breast milk fatty acid composition (maternal genotype effect)
Breast milk fatty acid composition (infant genotype effect)
Bone mineral density x blood lead interaction in current smokers (2df test)
Bone mineral density x blood lead interaction in current smokers (1df test)
Change in glucose in response to thiazide diuretic treatment in hypertension
FEV1
Urinary haptoglobin levels in type 2 diabetes
Plasma haptoglobin levels in type 2 diabetes
Plasma trimethyllysine levels
Virologic severity in Herpes simplex virus type 2 infection
Esophageal adenocarcinoma x smoking interaction
Esophageal adenocarcinoma x pack-years of smoking exposure interaction
Esophageal adenocarcinoma x gastroesophageal reflux disease interaction
Barrett's esophagus x BMI interaction
Barrett's esophagus x pack-years of smoking exposure interaction
Barrett's esophagus x smoking interaction
Barrett's esophagus x gastroesophageal reflux disease interaction
Esophageal adenocarcinoma x BMI interaction
Normal facial asymmetry (angle of surface orientation score)
Normal facial asymmetry (angle of deformation score)
Normal facial asymmetry (deformation magnitude)
Serum bilirubin levels in metabolic syndrome
Serum bilirubin levels x sex interaction in metabolic syndrome
Serum bilirubin levels x Mediterranean diet adherence interaction in metabolic syndrome
Nonobstructive coronary artery disease
Response to inhaled corticosteroid treatment in asthma (change in FEV1)
Atopic march
Cisplatin-induced ototoxicity
Fast beta electroencephalogram
Late-onset Alzheimer's disease
Severe progression in rheumatoid arthritis
Colorectal cancer (alcohol consumption interaction)
Colorectal cancer (smoking interaction)
Aortic valve stenosis
Calcific aortic valve stenosis
Thiopurine-induced severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)
Thiopurine-induced leukopenia in inflammatory bowel disease (conditioned on rs116855232)
Thiopurine-induced severe leukopenia in inflammatory bowel disease
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease
Thiopurine-induced alopecia in inflammatory bowel disease
Thiopurine-induced severe alopecia in inflammatory bowel disease
Thiopurine-induced pancreatitis in inflammatory bowel disease
Thiopurine-induced fever in inflammatory bowel disease
Thiopurine-induced digestive symptoms in inflammatory bowel disease
Thiopurine-induced infection in inflammatory bowel disease
Thiopurine-induced liver dysfunction in inflammatory bowel disease
Thiopurine-induced skin symptoms in inflammatory bowel disease
Thiopurine-induced alopecia in inflammatory bowel disease (conditioned on rs116855232)
Thiopurine-induced acute severe leukopenia in inflammatory bowel disease (conditioned on rs116855232)
Thiopurine-induced severe alopecia in inflammatory bowel disease (conditioned on rs116855232)
Age at first sexual intercourse
Empathy quotient
Broad depression or major depressive disorder (self-reported)
Broad depression or major depressive disorder (recurrent)
Broad depression or bipolar disorder
Broad depression or schizophrenia
Cleft lip with or without cleft palate (maternal periconceptional vitamin use interaction)
Cleft lip with or without cleft palate (maternal periconceptional cigarette smoking interaction)
Cleft lip with or without cleft palate (maternal periconceptional alcohol intake interaction)
Smoking behaviour (maximum cigarettes in a 24 hour period)
Nicotine dependence symptom count
Nicotine withdrawal symptom count
Nicotine withdrawal
Angiotensin-converting enzyme inhibitor intolerance
Serum metabolite concentrations in chronic kidney disease
Urinary metabolite ratios in chronic kidney disease
Serum metabolite ratios in chronic kidney disease
Urinary metabolite levels in chronic kidney disease
Fractional excretion of metabolites in chronic kidney disease
Lichen planus in hepatitis C
IgG glycosylation patterns
Gait speed in old age
Cognitive decline (age-related)
Poor prognosis in Crohn's disease
Depressive symptom measurement or major depressive disorder
Disease progression in age-related macular degeneration
Disease progression to geographic atrophy form in age-related macular degeneration
Disease progression to choroidal neovascularization form in age-related macular degeneration
Disease progression in age-related macular degeneration (adjusted for baseline)
Epstein-Barr virus copy number in lymphoblastoid cell lines
Neovascular age-related macular degeneration
Very large HDL particle concentration
Phospholipid levels in very large HDL
Total cholesterol levels in very large HDL
Cholesterol ester levels in very large HDL
Free cholesterol levels in very large HDL
Triglyceride levels in very large HDL
Large HDL particle concentration
Phospholipid levels in large HDL
Total cholesterol levels in large HDL
Free cholesterol levels in large HDL
Medium HDL particle concentration
Phospholipid levels in medium HDL
Total cholesterol levels in medium HDL
Cholesterol ester levels in medium HDL
Free cholesterol levels in medium HDL
Small HDL particle concentration
Triglyceride levels in small HDL
Chylomicron and largest VLDL particle concentration
Phospholipid levels in chylomicrons and largest VLDL
Triglyceride levels in chylomicrons and largest VLDL
Intracranial volume
Alcohol dependence symptom count
Sciatica
Sarcoidosis (non-Lofgren's syndrome)
Sarcoidosis (non-Lofgren's syndrome without extrapulmonary manifestations)
Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome)
Sarcoidosis (Lofgren's syndrome)
B cell acute lymphoblastic leukaemia (normal cytogenetics)
B cell acute lymphoblastic leukaemia (hyperdiploid negative)
B cell acute lymphoblastic leukaemia (Philadelphia chromosome negative)
B cell acute lymphoblastic leukaemia (abnormal cytogenetics)
Acute lymphoblastic leukemia in childhood (B cell precursor)
B cell acute lymphoblastic leukaemia in young adulthood
B cell acute lymphoblastic leukaemia in adulthood
Acute lymphoblastic leukemia (B-cell precursor)
Brain volume in infants (white matter)
Brain volume in infants (cerebrospinal fluid)
Brain volume in infants (grey matter)
Brain volume in infants (intracranial brain volume)
Sotalol-induced IKr potassium channel inhibition (T wave peak and end interval change)
Sotalol-induced IKr potassium channel inhibition (T wave maximal amplitude change)
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization duration change)
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC2)
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC3)
Sotalol-induced IKr potassium channel inhibition (ventricular repolarization changes PC1)
Sotalol-induced IKr potassium channel inhibition (T wave morphology notching)
Docetaxel-induced peripheral neuropathy in metastatic castrate-resistant prostate cancer
Sleep latency
Mortality in heart failure
Mortality in sepsis
Glaucoma (primary angle closure)
Overall survival in osteosarcoma
Remission after antidepressant treatment in major depression
Vitiligo (late onset)
Vitiligo (early onset)
Deliberate self-harm
Suicidality (suicidal ideation/attempts)
Suicidality
Brain glucose metabolism (fluorodeoxyglucose uptake)
Ischemic stroke (small-vessel)
Attention deficit hyperactivity disorder or cannabis use
Anti-Toxoplasma gondii IgG seropositivity
Hashimoto thyroiditis versus Graves' disease
Inflammatory skin disease
Arsenic metabolism
Cardiovascular disease risk factors
Eating disorders
Weight loss (gastric bypass surgery)
Temperament
Adverse response to chemotherapy in breast cancer (alopecia)
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+doxorubicin+/-5FU)
Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
Adverse response to chemotherapy in breast cancer (alopecia) (docetaxel)
Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
Multiple myeloma (hyperdiploidy)
Multiple myeloma (IgH translocation)
Graves' disease
Liver enzyme levels (aspartate transaminase)
Fasting blood insulin (BMI interaction)
Fasting blood glucose (BMI interaction)
Wegener's granulomatosis
Colorectal cancer (calcium intake interaction)
Serologic markers in systemic lupus erythematosus
Political ideology
Opioid sensitivity
Tourette's syndrome or obsessive-compulsive disorder
Lung Cancer (DNA repair capacity)
Cotinine glucuronidation
Nicotine glucouronidation
"Bone mineral density (paediatric, upper limb)"
"Bone mineral density (paediatric, total body less head)"
"Bone mineral density (paediatric, lower limb)"
"Bone mineral density (paediatric, skull)"
Bronchopulmonary dysplasia
Skin fluorescence
Asthma and hay fever
AIDS progression
Response to efavirenz-containing treatment in HIV 1 infection (virologic failure)
Response to abacavir-containing treatment in HIV-1 infection (virologic failure)
CYP3A4 enzyme activity
Red blood cell traits
Personality traits in bipolar disorder
Hypospadias
Amyotrophic lateral sclerosis or frontotemporal dementia
Bipolar disorder (body mass index interaction)
Fetal hemoglobin levels in sickle cell anemia
Thyroid peroxidase antibody positivity
Plasma thyroid-stimulating hormone levels
Apolipoprotein Levels
Cholesterol and Triglycerides
Age-related hearing impairment (SNP x SNP interaction)
Response to antipsychotic therapy (extrapyramidal side effects)
Blood metabolite ratios
Acute urticaria and angioedema (non-steroidal anti-inflammatory drug-induced)
Inflammatory biomarkers in Kawasaki disease
Lupus nephritis in systemic lupus erythematosus
Methotrexate phramacokinetics (acute lymphoblastic leukemia)
Response to taxane treatment (placlitaxel)
Response to taxane treatment (docetaxel)
Infantile hypertrophic pyloric stenosis
Cytomegalovirus antibody response
Protein biomarker
Allergic sensitization
Sasang constitutional medicine type
Febrile seizures
Febrile seizures (MMR vaccine-unrelated)
Febrile seizures (MMR vaccine-related)
Mesial temporal lobe epilepsy with hippocampal sclerosis
Elevated serum carcinoembryonic antigen levels
Lung cancer (smoking interaction)
PR segment duration
Response to methotrexate in juvenile idiopathic arthritis
Cardiac Troponin-T levels
Asthma (bronchodilator response)
Prostate cancer (early onset)
Heschl's gyrus morphology
Coffee consumption (cups per day)
Follicular lymphoma
Age-related nuclear cataracts
Maximal oxygen uptake response
Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complications
Gallstone disease
Early-onset Parkinson's disease
Opioid dependence
beta-nerve growth factor levels
CTACK levels
Eotaxin levels
Fibroblast growth factor basic levels
Granulocyte-colony stimulating factor levels
Growth-regulated protein alpha levels
Hepatocyte growth factor levels
Interferon gamma levels
Interleukin-1-beta levels
Interleukin-2 levels
Interleukin-2 receptor antagonist levels
Interleukin-4 levels
Interleukin-5 levels
Interleukin-7 levels
Interleukin-8 levels
Interleukin-9 levels
Interleukin-13 levels
Interleukin-17 levels
Macrophage Migration Inhibitory Factor levels
Interferon gamma-induced protein 10 levels
Idiopathic dilated cardiomyopathy
Complex regional pain syndrome
Circulating chromogranin peptide levels
Subclinical trait of interstitial lung disease (basilar percentage of high attenuation areas on CT scan)
Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan)
Subclinical trait of interstitial lung disease (percentage of high attenuation areas on CT scan)
Food allergy (parent-of-origin effect)
Peanut allergy (parent-of-origin effect)
Milk allergy (parent-of-origin effect)
Egg allergy (parent-of-origin effect)
Food allergy (maternal genetic effects)
Peanut allergy (maternal genetic effects)
Milk allergy (maternal genetic effects)
Egg allergy (maternal genetic effects)
ACPA-negative rheumatoid arthritis (smoking interaction)
ACPA-positive rheumatoid arthritis (smoking interaction)
Idiopathic osteonecrosis of the femoral head
Systolic blood pressure change trajectory
Multiple system atrophy (pathologically confirmed)
Sperm motility
Heart rate increase in response to exercise
Heart rate response to recovery post exercise (30 sec)
Heart rate response to recovery post exercise (40 sec)
Heart rate response to recovery post exercise (50 sec)
Heart rate response to recovery post exercise (10 sec)
Heart rate response to recovery post exercise (20 sec)
Multiple keratinocyte cancers
Response to clopidogrel therapy in coronary heart disease
Ovarian disease with few adhesions
Deep ovarian and/or rectovaginal disease with dense adhesions
Interleukin-12p70 levels
Interleukin-16 levels
Monocyte chemoattractant protein-3 levels
Macrophage colony stimulating factor levels
Monokine induced by gamma interferon levels
Macrophage inflammatory protein 1a levels
Macrophage inflammatory protein 1b levels
Platelet-derived growth factor BB levels
RANTES levels
Stem cell growth factor beta levels
Stromal-cell-derived factor 1 alpha levels
Tumor necrosis factor alpha levels
Tumor necrosis factor beta levels
TRAIL levels
Attention deficit hyperactivity disorder or educational attainment (years of education) (pleiotropy)
Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)
Neuritic plaques or neurofibrillary tangles (pleiotropy)
Neuritic plaques or cerebral amyloid angiopathy (pleiotropy)
Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy)
Drug-induced liver injury (terbinafine)
Drug-induced hepatocellular liver injury
Drug-induced liver injury (statins)
Drug-induced cholestatic/mixed liver injury
Drug-induced liver injury (nitrofurantoin)
Drug-induced liver injury (diclofenac)
Drug-induced liver injury (anti-tuberculosis drugs)
Drug-induced liver injury (fluoroquinolones)
Drug-induced liver injury (nonsteroidal anti-inflammatory drugs)
Response to paliperidone in schizophrenia (positive Marder score)
Response to paliperidone in schizophrenia (negative Marder score)
Response to paliperidone in schizophrenia (PANSS score)
Response to paliperidone in schizophrenia (Multivariate)
Response to paliperidone in schizophrenia (CGI-S score)
L-arginine levels
Trans-epidermal water loss
Chronic venous disease
Sjögren's syndrome
Heart rate response to beta blockers (atenolol monotherapy)
Heart rate response to beta blockers (atenolol add-on therapy)
Heart rate response to beta blockers
Low-grade serous and serous borderline ovarian cancer
Ovarian cancer in BRCA2 mutation carriers
Ovarian clear cell cancer
Endometrioid ovarian cancer
Serous invasive ovarian cancer
Serous borderline ovarian cancer
Low-grade serous ovarian cancer
Invasive epithelial ovarian cancer
Systolic blood pressure x educational attainment (some college) interaction (2df)
Systolic blood pressure x educational attainment (graduated college) interaction (2df)
Diastolic blood pressure x educational attainment (some college) interaction (2df)
Diastolic blood pressure x educational attainment (graduated college) interaction (2df)
Mean arterial pressure x educational attainment (some college) interaction (2df)
Mean arterial pressure x educational attainment (graduated college) interaction (2df)
Pulse pressure x educational attainment (some college) interaction (2df)
Pulse pressure x educational attainment (graduated college) interaction (2df)
Depressive symptoms x herpes simplex 1 infection interaction
Depression x herpes simplex 1 infection interaction
Sweet taste preference
Attention deficit hyperactivity disorder (inattention symptoms)
Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)
Response to antiepileptic mood-stabilizing treatment in bipolar disorder
Autoimmune thyroid disease
Peak expiratory flow
Matrix metalloproteinase levels
Matrix metalloproteinase-10 levels
Neurotrophin-3 levels
Oncostatin-M levels
PD-L1 levels
Sirtuin-2 levels
SLAMF1 levels
Sulfotrasferase 1A1 levels
STAM binding protein levels
Transforming growth factor-alpha levels
Tumor necrosis factor receptor superfamily member 9 levels
Tumor necrosis factor ligand superfamily member 14 levels
Tumor necrosis factor ligand superfamily member 10 levels
Tumor necrosis factor ligand superfamily member 11 levels
Tumor necrosis factor ligand superfamily member 12 levels
Vascular endothelial growth factor A levels
CXCL6 levels
CXCL9 levels
DNER levels
EN-RAGE levels
Fibroblast growth factor 19 levels
Fibroblast growth factor 5 levels
Flt3L levels
Interleukin-10 receptor B levels
Interleukin-12 subunit B levels
interleukin 15 receptor subunit alpha levels
interleukin-18 receptor 1 levels
Transforming growth factor-beta levels
Leukemia inhibitory factor receptor levels
Monocyte chemoattractant protein-2 levels
Monocyte chemoattractant protein-4 levels
4E-BP1 levels
Adenosine Deaminase levels
Axin-1 levels
Caspase 8 levels
CCL11 levels
CCL19 levels
CCL20 levels
CCL23 levels
CCL25 levels
CCL28 levels
CCL3 levels
CCL4 levels
CD244 levels
CD40 levels
CD5 levels
CD6 levels
CDCP1 levels
Colony stimulating factor levels
Cystatin D levels
CX3CL1 levels
CXCL1 levels
CXCL10 levels
CXCL11 levels
CXCL5 levels
Alzheimer's disease in depression
Cognitive function in depression
Cognitive impairment in depression
Cognitive decline in depression
"CV-A6-associated hand, foot, and mouth disease (severe vs mild)"
Receptive language ability
Parent of origin effect on receptive language ability (paternal)
Parent of origin effect on receptive language ability (maternal)
Response to radiotherapy in nasopharyngeal carcinoma (acute oral mucositis)
Thrombin-induced platelet aggregation
Peginterferon alfa-2a treatment response in chronic hepatitis B infection
Migraine and/or diastolic blood pressure
Migraine and/or systolic blood pressure
Migraine and/or pulse pressure
Migraine with aura and/or diastolic blood pressure
Migraine with aura and/or systolic blood pressure
Migraine with aura and/or pulse pressure
Migraine without aura and/or diastolic blood pressure
Migraine without aura and/or systolic blood pressure
Migraine without aura and/or pulse pressure
Acute anterior uveitis in ankylosing spondylitis
Rate of cognitive decline in Alzheimer's disease
Autism and major depressive disorder (MTAG)
Autism and schizophrenia (MTAG)
Autism and educational attainment (MTAG)
Thiopurine-induced myelosuppression in inflammatory bowel disease
Nephrotoxicity in tacrolimus-treated kidney transplant patients (time to event)
Nephrotoxicity in cyclosporine-treated kidney transplant patients (time to event)
Anemia in mycophenolic acid treated kidney transplant patients (time to event)
Leukopenia in mycophenolic acid treated kidney transplant patients (time to event)
New onset diabetes in calcineurin inhibitor treated kidney transplant patients (time to event)
Erythrocyte methylated 6-mercaptopurine metabolite concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia
DNA-incorporated thioguanine levels in 6-mercaptopurine-treated acute lymphoblastic leukaemia
DNA-incorporated thioguanine to erythrocyte thioguanine ratio in 6-mercaptopurine-treated acute lymphoblastic leukaemia
Erythrocyte thioguanine concentration in 6-mercaptopurine-treated acute lymphoblastic leukaemia
Serum urea levels
Cortical surface area
Left ventricular mass x antihypertensive treatment interaction
Relative wall thickness x antihypertensive treatment interaction
Anthracycline-induced cardiotoxicity in early breast cancer
Drug-induced liver injury (flucloxacillin)
Drug-induced liver injury (isoxazolyl penicillins)
Drug-induced liver injury (amoxicillin)
Nasal polyps
Benign childhood epilepsy with centro-temporal spikes
Cardiorespiratory fitness (800m run time)
Essential hypertension (time to event)
Abdominal hernia (time to event)
Hyperlipidemia (time to event)
Osteoarthrosis (time to event)
Cardiac dysrhythmias (time to event)
Asthma (time to event)
Cataract (time to event)
Coronary atherosclerosis (time to event)
Type 2 diabetes (time to event)
Parkinson's disease (time to event)
Alzheimer's disease (time to event)
Schizophrenia (time to event)
Urine 6-bromotryptophan levels in chronic kidney disease
Brain amyloid deposition (PET imaging)
Chronotype (sMEQ score)
Evening vs. morning chronotype (sMEQ score)
Evening vs. morning chronotype (self-assessed)
Recurrence of Clostridium difficile infection x bezlotuxumab treatment interaction (2df test)
Major depressive disorder in trauma exposed individuals
Major depressive disorder in trauma-unexposed individuals
Trauma exposure
Trauma exposure in major depressive disorder
Trauma exposure in major depressive disorder-negative individuals
Obese vs. thin
Obesity (extreme)
Normal body mass index vs. thin
Glycated hemoglobin levels in type 1 diabetes
Alzheimer's disease or posttraumatic stress syndrome (pleiotropy)
Monoclonal gammopathy of undetermined significance
Nontraumatic osteonecrosis of the femoral head
L-selectin levels
Antibody-deficiency-associated primary immunodeficiency
Lung cancer (survival time) in never smokers
Lung adenocarcinoma (survival time) in never smokers
Cardiovascular death or myocardial infarction in response to clopidogrel treatment
"Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment"
Stent thrombosis in response to clopidogrel treatment
Platelet reactivity in response to clopidogrel treatment
Fractures
Hip bone mineral content accrual during adolescent growth spurt
Peak hip bone mineral content
Diabetic neuropathy in type 2 diabetes
Macrovascular complications in type 2 diabetes
Ophthalmic complications in type 2 diabetes
Migraine (chronic vs episodic)
Migraine (proposed chronic vs episodic)
Thrombosis in response to liver transplant
N-acyl ethanolamine levels
Sporadic miscarriage
Multiple consecutive miscarriage
"Gut microbiota (bacterial taxa, hurdle binary method)"
"Gut microbiota (bacterial taxa, rank normal transformation method)"
Brain region volumes
Crohn's disease (time to progression)
Crohn's disease (time to first abdominal surgery)
Crohn's disease (indolent vs progressive)
Modic changes
Thyroxine levels
Triiodothyronine levels
Triiodothyronine/thyroxine ratio
Insomnia symptoms (never/rarely vs. sometimes/usually)
Insomnia symptoms (never/rarely vs. usually)
Crohn's disease or systemic sclerosis
Tourette syndrome
Lactose tolerance test
Behavioural changes in frontotemporal lobe dementia
Frontotemporal dementia (age at onset)
Frontotemporal dementia with GRN mutation
Frontotemporal dementia with GRN mutation (age at onset)
Memory dysfunction in frontotemporal lobe dementia
Language impairment in frontotemporal lobe dementia
Parkinsonism in frontotemporal lobe dementia
Mucinous adenocarcinoma in colorectal cancer
Cerebrospinal fluid α-synuclein levels
Osteoarthritis of the hand
Opioid dependence in opioid exposure
Opioid exposure
Body surface area-indexed left ventricular end-diastolic volume
Body surface area-indexed left ventricular end-systolic volume
Body surface area-indexed left ventricular stroke volume
Allergic rhinitis
Eczema
Hay fever and/or eczema
Ocular sarcoidosis
Ocular sarcoidosis in sarcoidosis
Alzheimer's disease or fasting glucose levels (pleiotropy)
Alzheimer's disease or fasting insulin levels (pleiotropy)
Alzheimer's disease or HDL levels (pleiotropy)
Meconium ileus in cystic fibrosis
Attention deficit hyperactivity disorder or hippocampal volume (pleiotropy)
Attention deficit hyperactivity disorder or nucleus accumbens volume (pleiotropy)
Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy)
Attention deficit hyperactivity disorder or intracranial volume (pleiotropy)
Attention deficit hyperactivity disorder or putamen volume (pleiotropy)
Attention deficit hyperactivity disorder or amygdala volume (pleiotropy)
Attention deficit hyperactivity disorder or pallidum volume (pleiotropy)
Attention deficit hyperactivity disorder or thalamus volume (pleiotropy)
Estimated glomerular filtration rate in coronary artery disease and impaired kidney function
Anthracycline-induced cardiotoxicity
Household income
IgG N-glycosylation phenotypes (multivariate analysis)
Erosive esophagitis
Thyroid volume in Hashimoto’s thyroiditis
Creativity
treatment failure in response to intravesical BCG therapy in non-muscle invasive bladder cancer
Adverse response to inhaled corticosteroid treatment x age interaction in asthma
Weight gain in amisulpride-treated first-episode psychosis
Acute cholecystitis
Cholelithiasis
Carotid intima media thickness x smoking interaction
Attention deficit hyperactivity disorder (persistent)
Attention deficit hyperactivity disorder (childhood)
Endometriosis or migraine
Creatine kinase levels in statin users
Creatine kinase levels in off-statin users
Lactate dehydrogenase levels in statin users
Lactate dehydrogenase levels in off-statin users
Drug eruption
Pollinosis
Cerebral aneurysm
Congestive heart failure
Pulmonary tuberculosis
Biliary tract cancer
Esophageal cancer
Hematological malignancy
Periodontal disease
Urolithiasis
Arrhythmia
Cataracts
Nephrotic syndrome
Anti-anoctamin 2 antibody levels
Schizophrenia or parental lifespan (pleiotropy)
Bipolar disorder or parental lifespan (pleiotropy)
Adverse response to chemotherapy (amenorrhea) in breast cancer
Percentage of invited food questionnaires completed
Acceptance of an invitation to wear a physical activity monitor
Acceptance of an invitation to participate in a mental health questionnaire
Completion of the aide-memoire
Participation in an health questionnaire (not invited vs invited)
Urine specific gravity measurement
Glucosuria (moderate to severe)
Glucosuria (mild)
Ketonuria
Ketonuria (moderate to severe)
Ketonuria (mild)
Proteinuria
Proteinuria (moderate to severe)
Proteinuria (mild)
Hematuria
Hematuria (moderate to severe)
Hematuria (mild)
Urine pH measurement
Low urine pH
Signs of urinary tract infection (nitrites and leukocyte esterase)
Glucosuria
Interstitial lung diseases in rheumatoid arthritis
Social deprivation
Chemerin levels
Gut microbiota alpha diversity (Chao1 index)
Gut microbiota alpha diversity (PD_whole_tree index)
Gut microbiota alpha diversity (Shannon index)
Gut microbiota beta diversity (weighted UniFrac distance)
Blood cell traits (multivariate analysis)
Breast cancer (male)
Particulate matter induced DNA damage
Fractures (paediatric)
Trigger finger
Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG levels
Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG levels
Anti-Kaposi's sarcoma associated herpesvirus ORF73 IgG levels
Anti-Kaposi's sarcoma associated herpesvirus K10.5 IgG levels
Anti-Kaposi's sarcoma associated herpesvirus K8.1 IgG levels
Bone mineral density or leg lean mass (pleiotropy)
Arm lean mass
Leg lean mass
Self-rated health
Ceramide levels (C24:0)
Ceramide levels (C22:0)
Carboplatin drug response (IC50)
Ara-C drug response (AUC)
Capecitabine drug response (AUC)
Cisplatin drug response (IC50)
Daunorubicin drug response (IC50)
Etoposide drug response (IC50)
Paclitaxel drug response (AUC)
Pemetrexed drug response (AUC)
Cortical volume
Post-traumatic stress disorder (re-experiencing symptoms)
Body mass index and systolic blood pressure (bivariate analysis)
Body mass index and diastolic blood pressure (bivariate analysis)
Systolic blood pressure and diastolic blood pressure (bivariate analysis)
Mortality in COVID-19
Intraocular pressure (corneal compensated)
Intraocular pressure (Goldman correlated)
Corneal endothelial cell density
Corneal endothelial cell size variation coefficient
Corneal endothelial cell shape (percentage of hexagonally shaped cells)
Anorectal malformation
Length of menstrual cycle
Toxicity response to radiotherapy in prostate cancer (rectal bleeding) (time to event)
Toxicity response to radiotherapy in prostate cancer (hematuria) (time to event)
Toxicity response to radiotherapy in prostate cancer (increased urinary frequency) (time to event)
Sudden cardiac arrest in coronary artery disease
Obsessive-compulsive traits
Male puberty timing (early vs. average onset facial hair)
Male puberty timing (late vs. average onset facial hair)
Male puberty timing (early vs. average onset voice breaking)
Male puberty timing (late vs. average onset voice breaking)
Male puberty timing (age at voice breaking MTAG)
Opioid overdose severity score
Visual contour integration
Mitochondrial DNA copy number
Mitochondrial DNA copy number (white blood cells)
Viral basal core promoter double mutation in hepatitis B virus surface antigen (HBsAg) seropositivity
Gut microbiota relative abundance (Bifidobacterium)
Gut microbiota relative abundance (Bacteroides)
Gut microbiota relative abundance (Parabacteroides)
Gut microbiota relative abundance (Prevotella)
Gut microbiota relative abundance (Streptococcus)
Gut microbiota relative abundance (unclassified genus belonging to family Clostridiaceae)
Gut microbiota relative abundance (unclassified genus belonging to the order Clostridiales)
Gut microbiota relative abundance (Ruminococcus belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (unclassified genus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (Blautia)
Gut microbiota relative abundance (Coprococcus)
Gut microbiota relative abundance (Dorea)
Gut microbiota relative abundance (unassigned genus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (unclassified genus belonging to family Ruminococcaceae)
Gut microbiota relative abundance (Faecalibacterium)
Gut microbiota relative abundance (Oscillospira)
Gut microbiota relative abundance (Ruminococcus belonging to family Lachnospiraceae)
Gut microbiota relative abundance (unassigned genus belonging to family Clostridiales)
Gut microbiota relative abundance (Eubacterium belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (unclassified genus belonging to family Erysipelotrichaceae)
Gut microbiota relative abundance (Sutterella)
Factor VII activity
Carbamazepine-induced liver injury
Carbamazepine-induced reaction with eosinophilia and systemic symptoms
Carbamazepine-induced Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN)
Carbamazepine-induced serious cutaneous adverse reaction
Factor VII activity or levels
Airway obstruction (FEV1/FVC<70%) in never smokers
Airway obstruction (FEV1/FVC<lower limit of normal) in ever smokers
Airway obstruction (FEV1/FVC<lower limit of normal) in never smokers
Airway obstruction (FEV1/FVC<70%) in ever smokers
Cognitive impairment and C-reactive protein levels (pleiotropy)
Cognitive impairment and LDL levels (pleiotropy)
Cognitive impairment and total cholesterol levels (pleiotropy)
Cognitive impairment
"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)"
Early chronic obstructive pulmonary disease in never smokers
Early chronic obstructive pulmonary disease
Nocturnal enuresis
Smoking status (current vs mixed)
Cigarettes smoked per day (current)
Cigarettes smoked per day (past)
Smoking status (current vs never)
Fasting glucose in pregnancy (gestational week 14-16)
Fasting glucose in pregnancy (gestational week 30-32)
Two-hour glucose in pregnancy (gestational week 14-16)
Two-hour glucose in pregnancy (gestational week 30-32)
General glucose level in pregnancy (gestational week 14-16)
General glucose level in pregnancy (gestational week 30-32)
Timing of glucose curve peak in pregnancy (gestational week 14-16)
Timing of glucose curve peak in pregnancy (gestational week 30-32)
Chronic periodontitis
Chronic periodontitis (slight)
Chronic periodontitis (severe)
Chronic periodontitis (generalised)
Chronic periodontitis (localised)
Nose wing breadth
Nose length
Nosetip height
Nasal root breadth
Nasal root height
Eye length
Interorbital distance
Labial fissure length
Lip thickness
Lower face length
Brow ridge morphology (principal component model)
Eye morphology (principal component model)
Side of face morphology (principal component model)
Cheek morphology (principal component model)
Nose morphology (principal component model)
Mouth morphology (principal component model)
Brow ridge morphology (partial least square model)
Eye morphology (partial least square model)
Side of face morphology (partial least square model)
Cheek morphology (partial least square model)
Nose morphology (partial least square model)
Mouth morphology (partial least square model)
Adenocarcinoma in never smokers
Hypospadias (moderate to severe)
Glycosuria in pregnancy (maternal genotype effect)
Glycosuria in pregnancy (offspring genotype effect)
Glycosuria in pregnancy (maternal and offspring genotype effect)
Sphingolipid d18:1/d18:2 ratio
Pulse rate
Sodium levels in epilepsy
Carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy
Severe carbamazepine- or oxcarbazepine-induced hyponatremia in epilepsy
Carbamazepine-induced hyponatremia in epilepsy
Oxcarbazepine-induced hyponatremia in epilepsy
"Carbamazepine metabolism (carbamazepine-10,11-diol to carbamazepine ratio) in epilepsy"
Anti-sp100 seropositivity in primary biliary cholangitis
Anti-gp210 seropositivity in primary biliary cholangitis
Metabolic coherence (transcriptomic)
Attention deficit hyperactivity disorder (MTAG)
Autism spectrum disorder (MTAG)
Bipolar disorder (MTAG)
Major depressive disorder (MTAG)
Schizophrenia (MTAG)
Neuropsychiatric disorders
Hyperglycemia
Hyperglycemia in obesity
Hyperglycemia in non-obese individuals
Hyperglycemia in lower physical activity
Hyperglycemia in higher physical activity
Hyperglycemia in more-fat diet
Hyperglycemia in less-fat diet
Homeostasis model assessment of insulin resistance in obesity
Homeostasis model assessment of insulin resistance in non-obese individuals
Homeostasis model assessment of insulin resistance in higher physical activity
Homeostasis model assessment of insulin resistance in lower physical activity
Homeostasis model assessment of insulin resistance in more-fat diet
Homeostasis model assessment of insulin resistance in less-fat diet
Hyperglycemia x BMI interaction
Hyperglycemia x physical activity interaction
Hyperglycemia x saturated fatty acids interaction
Hyperinsulinemia
Hyperinsulinemia x BMI interaction
Homeostasis model assessment of insulin resistance x BMI interaction
Hyperinsulinemia x physical activity interaction
Homeostasis model assessment of insulin resistance x physical activity interaction
Hyperinsulinemia x saturated fatty acids interaction
Homeostasis model assessment of insulin resistance x saturated fatty acids interaction
Hyperinsulinemia in obesity
Red blood cell folate levels
Plasma homocysteine levels
Intra-individual response time variability (response selection)
Intra-individual response time variability (selective attention)
IgA levels
Composite immunoglobulin trait (IgA x IgG x IgM)
Composite immunoglobulin trait (IgA x IgG/IgM)
Composite immunoglobulin trait (IgA x IgG)
Composite immunoglobulin trait (IgA/IgG)
Composite immunoglobulin trait (IgA/IgM)
Composite immunoglobulin trait (IgG/IgM)
Ulna and radius bone mineral density
Post-bronchodilator FEV1 x air pollution (CO) interaction in childhood asthma
Post-bronchodilator FEV1 x air pollution (NO2) interaction in childhood asthma
Lung function x fine particulate matter exposure levels interaction
PAr index (pyridoxic acid/(pyridoxal 5′-phosphate + pyridoxal))
Asthma (time to childhood onset) in early life tobacco smoke exposure
Asthma (time to childhood onset) x early life tobacco smoke interaction
Diverticular disease
Keratoconus
Microscopic colitis in proton-pump inhibitor treatment
Microscopic colitis
Chronic pain or major depressive disorder (pleiotropy)
Dysmenorrheic pain severity
Menstruation quality of life impact (dysmenorrhea)
Pain medicine use during menstruation
Menstruation quality of life impact (fever)
Heavy vaginal discharge
Menstruation quality of life impact (acne)
Menstruation quality of life impact (aggressiveness)
Menstruation quality of life impact (increased appetite)
Menstruation quality of life impact (bowel movement)
Menstruation quality of life impact (depression)
Menstruation quality of life impact (edema)
Menstruation quality of life impact (headache)
Menstruation quality of life impact (joint pain)
Menstruation quality of life impact (loss of concentration)
Menstruation quality of life impact (nervousness)
Menstruation quality of life impact (pressure in breast)
Menstruation quality of life impact (sleepiness)
Menstruation quality of life impact (stiff neck)
Vaginal discharge (itching)
Vaginal discharge (metrorrhagia)
Vaginal discharge (smell)
Lung cancer x radon exposure interaction (1df)
Schizophrenia or schizoaffective disorder
Double-edged eyelids
Thick vs thin eyebrows
Excessive hairiness
Excessive sweating
Age spots
Childhood onset systemic lupus erythematosus
Serum alpha-fetoprotein levels
Serum carcinoembryonic antigen levels
Serum cancer antigen 15.3 levels
Serum cancer antigen 19.9 levels
Serum cancer antigen 125 levels
Osteoporosis-related phenotypes (MTAG)
Follicle stimulating hormone levels
Follicle stimulating hormone in healthy women
Luteinizing hormone levels in healthy women
Luteinizing hormone levels
Spontaneous adipocyte lipolysis
Stimulated adipocyte lipolysis
Pelvic organ prolapse
Opioid dependence x sex interaction
Optic disc size
Disease free survival in colon cancer
Survival in colon cancer
Anti-chlamydia trachomatis IgG seropositivity
Ewing sarcoma
Café-au-lait macule number in neurofibromatosis type1
Response to anti-VEGF treatment in neovascular age-related macular degeneration (visual acuity)
Depressed affect
Worry
Conjunctival UV autofluorescence (CUVAF)
Prostate cancer aggressiveness (high vs low)
Prostate cancer aggressiveness (high vs low/intermediate)
Prostate cancer (advanced vs non-advanced)
Prostate cancer (advanced)
Prostate cancer (Gleason score)
"Obstructive sleep apnea trait (apnea hypopnea index, change over time)"
Anhedonia
Bone mineral density (total hip)
High bone mineral density
Myopia (age of diagnosis)
Spherical equivalent or myopia (age of diagnosis)
Coronary artery disease in diabetes
Penicillin allergy
Alzheimer's disease (onset at age over 80)
Alzheimer's disease (onset between ages 58 and 79)
Cleft lip with or without cleft palate x maternal periconceptional alcohol use interaction (parent of origin effect)
Cleft lip with or without cleft palate x maternal periconceptional smoking interaction (parent of origin effect)
Cleft lip with or without cleft palate x maternal periconceptional vitamin use interaction (parent of origin effect)
Reading disability
Advanced age-related macular degeneration
Cannabis use (age at onset)
Hepatitis B surface antigen seroclearance in chronic hepatitis B infection
Systolic blood pressure night-to-day ratio in hypertension
Diastolic blood pressure night-to-day ratio in hypertension
Elevated fasting plasma glucose
Exacerbations requiring hospitalisation in asthma
Nephrolithiasis
Urinary calcium excretion
Urinary magnesium excretion
Urinary uric acid excretion
Urinary volume
Rosacea symptom severity
Optic nerve head parameters (multi-trait analysis)
Intraocular pressure and central corneal thickness (multi-trait analysis)
Neuromyelitis optica (AQP4-IgG-positive)
Neuromyelitis optica (AQP4-IgG-negative)
Thyroid autoantibody positivity (anti-thyroglobulin (TgAb) and/or anti-thyroid peroxidase (TPOAb) levels)
Low tan response
End stage renal disease x APOL1 genotype interaction
End stage renal disease in APOL1 risk genotype-negative individuals
End stage renal disease in APOL1 risk genotype-positive individuals
Type 1 diabetes in high risk HLA genotype individuals (time to event)
Type 1 diabetes autoantibodies in high risk HLA genotype individuals (time to event)
Lean mass index
Low density lipoprotein triglyceride levels
Maternal chorioamnionitis
Fish consumption
Falling risk
Plasma renin activity levels
Response to hepatitis B vaccine
Facial wrinkles
Immunoglobulin M against phosphorylcholine (IgM anti-PC) levels
Extremely high intelligence
Eye movement (horizontal position gain)
Eye movement in schizophrenia (scanpath length)
Eye movement (scanpath length)
Eye movement in schizophrenia (duration of fixations)
Eye movement (duration of fixations)
Eye movement in schizophrenia (integrated eye movement score)
Eye movement (integrated eye movement score)
Eye movement in schizophrenia (horizontal position gain)
Eudaimonic well-being
Hedonic well-being
Major depressive disorder (probable)
Major depressive disorder (ICD-10 coded)
Depression (broad)
Small subcortical brain infarct
Brain infarct
Healthspan
Response to lurasidone in schizophrenia
Myopic maculopathy
Endometrial cancer (endometrioid histology)
Endometrial cancer (Non-endometrioid histology)
Life satisfaction
Positive affect
Well-being spectrum (multivariate analysis)
Waldenström macroglobulinemia / lymphoplasmacytic lymphoma
Brain imaging measurements
Affective disorder and suicide attempts
Metabolic syndrome (multivariate analysis)
Anthropometric traits (multi-trait analysis)
Disorders of lipid metabolism
Skin pigmentation traits
Hair morphology traits
Handedness
Delirium
Response to TNF inhibitor in rheumatoid arthritis (erythrocyte sedimentation rate)
Response to TNF inhibitor in rheumatoid arthritis (change in swollen 28-joint count)
Response to TNF inhibitor in rheumatoid arthritis (change in patient global heath assessment score)
Response to TNF inhibitor in rheumatoid arthritis (change in tender 28-joint count)
Response to TNF inhibitor in rheumatoid arthritis (change in disease activity score)
Response to ranibizumab in age-related macular degeneration (exudative)
Oral cavity cancer
Oropharynx cancer
Hypopharyngeal or laryngeal cancer
Simvastatin-induced myopathy
Atorvastatin-induced myopathy
Statin-induced myopathy (severe)
Statin-induced myopathy
same-sex sexual behaviour
proportion of same-sex sexual behaviour among non-heterosexuals
Hypersomnia (HLA-DQB1*06:02 negative)
Postburn scar height
Postburn scar pliability
Seasonality in depression
Seasonality and depression
Body size at age 10
Adult body size
Cerebral microbleeds (lobar)
Cerebral microbleeds (mixed)
Hip bone mineral density and total body fat mass (bivariate analysis)
Change in HbA1c levels in response to metformin treatment in type 2 diabetes
Peptic ulcer disease
Gastroesophageal reflux disease
Irritable bowel syndrome
"Gastroesophageal reflux disease, peptic ulcer disease and/or corresponding medications and treatment"
Bronchodilator response x age interaction in asthma
Cutaneous leishmaniasis
Psychological resilience (outcome-based) in high deployment stress exposure
Psychological resilience (self-assessed)
Psychological resilience (outcome-based)
Asthma with severe exacerbations
Coronary artery disease in type 1 diabetes
Carotid intima media thickness in rheumatoid arthritis
Cardiovascular event in rheumatoid arthritis
Ischemic heart disease in rheumatoid arthritis
Carotid plaques in rheumatoid arthritis
Disruptive behavior disorder in attention deficit hyperactivity disorder
Disruptive behavior disorder and attention deficit hyperactivity disorder
Declining hemoglobin trajectory in blood donors
Left ventricular global circumferential strain
Left ventricular global radial strain
Left ventricular global longitudinal strain
Hypertrophic cardiomyopathy (MTAG)
Left ventricular ejection fraction (MTAG)
Left ventricular mass to end-diastolic volume ratio (MTAG)
Left ventricular mass (MTAG)
Left ventricular end-diastolic volume (MTAG)
Left ventricular end-systolic volume (MTAG)
Left ventricular global circumferential strain (MTAG)
Left ventricular global radial strain (MTAG)
Left ventricular global longitudinal strain (MTAG)
Left ventricle wall thickness (MTAG)
Alzheimer's disease or cardiovascular risk factors (pleiotropy)
Fasting plasma glycodeoxycholate 3-O-glucuronide concentration
Fasting plasma glycochenodeoxycholate 3-O-glucuronide concentration
Frontal fibrosing alopecia
Triiodothyronine levels and thyroxine levels
Sleep duration (short sleep)
Sleep duration (long sleep)
Carpal tunnel syndrome
Urinary albumin excretion (no hypertensive medication)
Digit length ratio (right hand)
Digit length ratio
Digit length ratio (left hand)
Remission after SSRI treatment in major depression
Lung cancer (SNP x SNP interaction)
Circulating fibroblast growth factor 23 levels
Bronchodilator response in asthma
Hashimoto thyroiditis
Total hippocampal volume
Presubiculum volume (corrected for total hippocampal volume)
Subiculum volume (corrected for total hippocampal volume)
Hippocampal subfield CA1 volume (corrected for total hippocampal volume)
Hippocampal subfield CA3 volume (corrected for total hippocampal volume)
Hippocampal subfield CA4 volume (corrected for total hippocampal volume)
Dentate gyrus granule cell layer volume (corrected for total hippocampal volume)
Dentate gyrus molecular layer volume (corrected for total hippocampal volume)
Hippocampal fissure volume (corrected for total hippocampal volume)
Hippocampal tail volume (corrected for total hippocampal volume)
Fimbria volume (corrected for total hippocampal volume)
HATA volume (corrected for total hippocampal volume)
Parasubiculum volume (corrected for total hippocampal volume)
Presubiculum volume
Subiculum volume
Hippocampal subfield CA1 volume
Hippocampal subfield CA3 volume
Hippocampal subfield CA4 volume
Dentate gyrus granule cell layer volume
Dentate gyrus molecular layer volume
Hippocampal fissure volume
Hippocampal tail volume
Fimbria volume
HATA volume
Parasubiculum volume
High IL-1beta levels in gingival crevicular fluid
Vestibular neuritis
Post bronchodilator percent predicted FEV1 in smoking
Post bronchodilator FEV1/FVC ratio in smoking
Severe cutaneous adverse drug reactions
Relative amplitude of rest-activity cycles
Disrupted circadian rhythm (low relative amplitude of rest-activity cycles)
Guillain-Barré syndrome
Uterine fibroid size (maximum dimension)
Response to platinum-based chemotherapy in non-small-cell lung cancer (progression)
Prostate cancer mortality
Type 2 diabetes or coronary artery disease (pleiotropy)
Nicotine dependence and major depression (severity of comorbidity)
Serum erythropoietin levels
Anorexia nervosa or obsessive-compulsive disorder
Pulmonary function (FEV1) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)
Pulmonary function (FVC) x omega-3 PUFA (docosapentaenoic acid) interaction (2df)
Pulmonary function (FVC) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)
Pulmonary function (FEV1) x omega-3 PUFA (docosahexaenoic acid) interaction (2df)
Diffusing capacity of the lung for carbon monoxide traits
Anti-cytomegalovirus IgG seropositivity
Anti-Epstein-Barr virus nuclear antigen (EBNA) IgG seropositivity
Anti-Epstein-Barr virus viral capsid antigen (VCA) IgG seropositivity
Anti-Epstein-Barr virus early antigen (EA) IgG seropositivity
Anti-herpes simplex virus 1 IgG seropositivity
Anti-herpes simplex virus 2 IgG seropositivity
Anti-varicella zoster virus IgG seropositivity
Anti-influenza A virus IgG seropositivity
Anti-measles virus IgG seropositivity
Anti-mumps virus IgG seropositivity
Anti-rubella virus IgG seropositivity
Anti-hepatitis B virus surface antigen (HBs) IgG seropositivity
Anti-hepatitis B virus core antigen (HBc) IgG seropositivity
IgE levels
Anti-cytomegalovirus IgG levels
Anti-Epstein-Barr virus early antigen (EA) IgG levels
Anti-herpes simplex virus 1 IgG levels
Anti-herpes simplex virus 2 IgG levels
Anti-varicella zoster virus IgG levels
Anti-helicobacter pylori IgG levels
Anti-Toxoplasma gondii IgG levels
Anti-influenza A virus IgG levels
Anti-measles virus IgG levels
Anti-mumps virus IgG levels
Anti-rubella virus IgG levels
Anti-hepatitis B virus surface antigen (HBs) IgG levels
Anti-hepatitis B virus core antigen (HBc) IgG levels
Socioeconomic status of place of residence
Population density of place of residence
Upper eyelid sagging severity
Response to opioid analgesics in cancer (pain decrease)
Initial alcohol sensitivity
Brain morphology (MOSTest)
Cortical thickness (MOSTest)
Subcortical volume (MOSTest)
Brain morphology (min-P)
Cortical surface area (MOSTest)
Subcortical volume (min-P)
Cortical surface area (min-P)
Cortical thickness (min-P)
Developmental dysplasia of the hip
Severe aortic features in Marfan syndrome
Major depressive episode treated with electroconvulsive therapy
Major depressive disorder and major depressive episode treated with electroconvulsive therapy
Hip shape (DXA scan)
Parkinson's disease (age at diagnosis)
Hyperinsulinemia in non-obese individuals
Hyperinsulinemia in higher physical activity
Hyperinsulinemia in lower physical activity
Hyperinsulinemia in more-fat diet
Hyperinsulinemia in less-fat diet
D-dimer levels in HIV infection
Interleukin-6 levels in HIV infection
High-sensitivity C-reactive protein levels in HIV infection
Severe diabetic retinopathy in type 2 diabetes
HIgh-sensitivity cardiac troponin T levels (high vs low)
High-sensitivity cardiac troponin T levels
Homocysteine level response to multivitamin in cerebral infarction
Plasma cortisol levels (morning)
interferon-related traits
Testicular cancer
Oral cavity and pharyngeal cancer
Esophageal or stomach cancer
Lymphocytic leukemia
Kidney cancer
Non-Hodgkin's lymphoma
Cancer (pleiotropy)
Cancer (pleiotropy)(bidirectional)
BRCA1/2-negative high-risk breast cancer
Alcohol use disorder (total score)
Alcohol use disorder (consumption score)
Alcohol use disorder (dependence and problematic use scores)
Carotenoid levels
Diabetes biomarker traits
Circulating inorganic ion levels
Lipid or lipoprotein levels
Renal system biomarkers
Vitamin levels
Femoral neck bone mineral density or type 2 diabetes (pleiotropy)
Serum urate levels in chronic kidney disease
Gout in chronic kidney disease
Preeclampsia (fetal genotype effect)
Preeclampsia (maternal genotype effect)
Cardiovascular disease in systemic lupus erythematosus
Liver fat content (MRI proton density fat fraction measure)
Liver fibrosis and steatohepatitis severity (MRI cT1 measure)
Septic shock (28-day mortality)
Septic shock (90-day mortality)
Septic shock resolution
Septic shock
FEV1/FVC ratio x pack-years of smoking interaction (2df test)
"Aging traits (healthspan, parental lifespan or longevity) (multivariate analysis)"
Tau burden
Morningness
Lysine levels
N-acetyl neuraminic acid levels
N-methyl-2-pyridone-5-carboxamide levels
N-methylnicotinic acid levels
N-methylpicolinic acid levels
N1-methyl-nicotinamide levels
P-cresol sulfate levels
P-hydroxyphenylacetate levels
Pantothenic acid levels
Proline betaine levels
Scyllo-inositol levels
Succinate levels
Sucrose levels
Taurine levels
Trimethylamine levels
Trimethylamine oxide levels
Tyrosine levels
Valine levels
Caffeine consumption from coffee
Caffeine consumption from tea
Caffeine consumption from coffee or tea
White matter hyperintensity volume x hypertension interaction (2df)
White matter hyperintensity volume (adjusted for hypertension)
Systemic mastocytosis
Cutaneous mastocytosis
Cutaneous mastocytosis (adult)
Mastocytosis
Cutaneous mastocytosis (childhood)
2-hydroxyisobutyrate levels
3-aminoisobutyrate levels
3-hydroxybutyrate + 3-aminoisobutyrate levels
3-hydroxyisobutyrate levels
3-hydroxyisovalerate levels
3-Indoxylsulfate levels
4-deoxyerythronic acid levels
4-deoxythreonic acid levels
5-oxoproline levels
Acetate levels
Acetone levels
Alanine levels
Carnitine levels
Citrate levels
Creatine levels
Dimethylamine levels
Formate levels
Glucose levels
Glutamine levels
Glycine levels
Hippurate levels
Isoleucine levels
Lactate levels
Leucine levels
Triglyceride levels in HIV infection
LDL cholesterol levels in HIV infection
HDL cholesterol levels in HIV infection
First year height change in growth hormone-treated short stature
Distal/Left-sided colorectal cancer
Proximal colorectal cancer
Distal colorectal cancer
Severe COVID-19 infection with respiratory failure (analysis I)
Severe COVID-19 infection with respiratory failure (analysis II)
Percent liver fat
Plasma selenium concentration
Response to selenium supplementation (change in plasma selenium concentration)
Major depressive disorder (lifetime)
Major depressive disorder (lifetime with recurrence)
Help-seeking from a GP
Help-seeking from a psychiatrist
Major depressive disorder symptoms (low mood or anhedonia)
Help-seeking from a GP (without major depressive disorder symptoms)
Depression or depression symptoms
Leg fat mass (lean adjusted)
Leg lean mass (fat adjusted)
Leg fat mass and leg lean mass (pleiotropy)
Diabetic retinopathy in type 2 diabetes
Cognitive function in longevity
Systolic blood pressure (baseline)
Diastolic blood pressure change trajectory
Diastolic blood pressure (baseline)
Metabolically unhealthy in obesity
Metabolically unhealthy in normal weight
Coronary artery disease and insomnia (pleiotropy)
Coronary artery disease and sleep duration (pleiotropy)
Coronary artery disease and chronotype (pleiotropy)
Lateral ventricular volume in normal aging
Chronic back pain
joint destruction in rheumatoid arthritis (rapid vs slow)
Academic attainment (English)
Academic attainment (maths)
Academic attainment (science)
Vesicoureteral reflux
Autoimmune pulmonary alveolar proteinosis
Addison's disease
Emotional support seeking
Positive reappraisal
Problem solving
Disengagement
Emotional coping (emotional expression/emotional support seeking)
Approach coping (positive reappraisal/problem solving)
Perceived stress
Emotional expression
Emotional lability
Lack of behavioral control
Type A behavior
Locus of control over disease
Psychoticism
Asthma-chronic obstructive pulmonary disease overlap syndrome in asthma
Asthma-chronic obstructive pulmonary disease overlap syndrome
Motor composite score
Mental composite score
Serum galactose-deficient IgA1 levels in IgA nephropathy
Chronic kidney disease x type 2 diabetes interaction
Peripheral arterial disease x type 2 diabetes interaction
Coronary heart disease x type 2 diabetes interaction
Acute ischemic stroke x type 2 diabetes interaction
Retinopathy x type 2 diabetes interaction
Neuropathy x type 2 diabetes interaction
Early age-related macular degeneration
Diverticulitis
Cotinine levels in smokers with chronic obstructive pulmonary disease
Exhaled carbon monoxide levels in smokers with chronic obstructive pulmonary disease
Facial pigmentation measurement (UV light)
Facial pigmentation measurement (polar light)
Latent autoimmune diabetes
Latent autoimmune diabetes vs. type 2 diabetes
Latent autoimmune diabetes vs. type 1 diabetes
Triglyceride levels (parental genotype effect)
Triglyceride levels in response to fenofibrate treatment (parental genotype effect)
Triglyceride change in response to fenofibrate (parental genotype effect)
Triglyceride levels in response to fenofibrate
Triglyceride change in response to fenofibrate treatment
Paediatric migraine
Arterial stiffness (carotid-femoral pulse wave velocity)
Arterial stiffness (brachial-femoral pulse wave velocity)
Arterial stiffness (brachial-ankle pulse wave velocity)
Total carotid plaque area (excess vs minimal atherosclerosis)
Alcohol use disorder
Problematic alcohol use (MTAG)
Alcohol consumption (drinks per week) (MTAG)
Problematic alcohol use
Facial morphology traits (59 NSCL/P endophenotypic segments)
Adverse response to chemotherapy (fluoropyrimidines)
Early-onset ischemic stroke
Postoperative nausea and vomiting
Neuroblastoma (pediatric)
Shoulder impingement syndrome
Multiple severe cisplatin-induced neurotixicitiies in testicular cancer survivors
Concussion
Tumor necrosis factor levels
Vaginal microbiome composition (L. iners)
Vaginal microbiome composition (G. vaginalis)
Vaginal microbiome composition (Shannon diversity index)
Vaginal microbiome composition (community state type)
Vaginal microbiome composition (L. crispatus)
Persistent chemotherapy-induced alopecia in breast cancer
Myocardial fractal dimension (slice 1)
Myocardial fractal dimension (slice 2)
Myocardial fractal dimension (slice 3)
Myocardial fractal dimension (slice 4)
Myocardial fractal dimension (slice 5)
Myocardial fractal dimension (slice 6)
Myocardial fractal dimension (slice 7)
Myocardial fractal dimension (slice 8)
Myocardial fractal dimension (slice 9)
Myocardial fractal dimension (slices 1-9)
Hepatic steatosis in non-alcoholic fatty liver disease
Liver fibrosis in non-alcoholic fatty liver disease
Non-alcoholic steatohepatitis activity score in non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease activity score in non-alcoholic fatty liver disease
Nonalcoholic steatohepatitis
Severe liver fibrosis and non-alcoholic fatty liver disease
Combined resilience (covariance of educational attainment with residual cognitive resilience)
Residual cognitive resilience
Serum C-reactive protein concentration
Serum C-reactive protein concentration in non-obese individuals
Serum C-reactive protein concentration in obesity
Serum C-reactive protein concentration in inactive individuals
Serum C-reactive protein concentration in low fat diet
Serum C-reactive protein concentration in high fat diet
Serum C-reactive protein concentration in visceral obesity (waist-hip ratio)
Serum C-reactive protein concentration in visceral obesity (waist circumference)
Serum interleukin-6 concentration
Serum interleukin-6 concentration in non-visceral-obese individuals
Serum interleukin-6 concentration in high fat diet
Serum interleukin-6 concentration in active individuals
Pancreatic beta-cell glucose sensitivity
Aspartate aminotransferase levels x alcohol consumption interaction
Gamma glutamyl transferase levels x alcohol consumption interaction
Alanine aminotransferase levels x alcohol consumption interaction
Aspartate aminotransferase to alanine aminotransferase ratio x alcohol consumption interaction
prednisolone sensitivity in B-cell precursor acute lymphoblastic leukaemia
dexamethasone sensitivity in B-cell precursor acute lymphoblastic leukaemia
Theta EEG coherence
Pancreas fat
Pancreas volume
Liver volume
Metabolic biomarkers (multivariate analysis)
Aerodigestive squamous cell cancer (pleiotropy)
DNA methylation-estimated granulocyte proportions
DNA methylation GrimAge acceleration
DNA methylation Hannum age acceleration
DNA methylation-estimated plasminogen activator inhibitor-1 levels
DNA methylation PhenoAge acceleration
Hematological parameters
Autoimmune thyroid diseases (Graves disease or Hashimoto's thyroiditis)
Nonatopic asthma
Atopic asthma
Adult onset asthma and/or BMI
Nonatopic asthma and/or BMI
Adult onset asthma and/or waist-to-hip ratio adjusted for BMI
Nonatopic asthma and/or waist-to-hip ratio adjusted for BMI
Adult onset asthma or type 2 diabetes
Nonatopic asthma or type 2 diabetes
Adult onset asthma or fasting insulin levels
Nonatopic asthma or fasting insulin levels
Adult onset asthma or fasting glucose levels
Nonatopic asthma or fasting glucose levels
Sortilin levels (ELISA)
Sortilin levels (OLINK)
Late-onset Alzheimer’s disease in APOEe4 carriers
Late-onset Alzheimer’s disease in APOEe4 non-carriers
Schizophrenia x sex interaction
Bipolar disorder x sex interaction
Major depressive disorder x sex interaction
Recurrent major depressive disorder x sex interaction
"Schizophrenia, bipolar disorder or major depressive disorder x sex interaction"
"Schizophrenia, bipolar disorder or major depressive disorder"
"Schizophrenia, bipolar disorder or major depressive disorder x sex interaction (3df)"
"Schizophrenia, bipolar disorder or recurrent major depressive disorder x sex interaction"
"Schizophrenia, bipolar disorder or recurrent major depressive disorder"
"Schizophrenia, bipolar disorder or recurrent major depressive disorder x sex interaction (3df)"
Trypanosoma cruzi infection
Chagas cardiomyopathy in Tripanosoma cruzi seropositivity
Cystatin C levels
Serum phosphate levels
Direct low density lipoprotein cholesterol levels
Alanine aminotransferase levels x BMI interaction
Aspartate aminotransferase levels x BMI interaction
Cocaine dependence (time to event)
Opioid dependence (time to event)
Response to levetiracetam in focal epilepsy
Response to sodium channel-Active anticonvulsant in focal epilepsy
Response to lamotrigine in focal epilepsy
Response to carbamazepine in focal epilepsy
Response to oxcarbazepine in focal epilepsy
Response to phenytoin in focal epilepsy
Response to calcium-channel-Active anticonvulsants in focal epilepsy
Response to valproic acid in focal epilepsy
Response to levetiracetam in epilepsy
Response to lamotrigine in epilepsy
Response to calcium-channel-Active anticonvulsants in epilepsy
Response to valproic acid in epilepsy
Response to sodium channel-Active anticonvulsants in focal epilepsy
Extrahepatic cholangiocarcinoma
Stimulant dependence
Stroke (hemorhagic)
Brain functional connectivity measurement (global efficiency)
Brain functional connectivity measurement (characteristic path length)
Brain functional connectivity measurement (louvain modularity)
Brain functional connectivity measurement (transitivity)
Brain functional connectivity measurement (local efficiency default)
Brain functional connectivity measurement (local efficiency dorsal attention)
Brain functional connectivity measurement (local efficiency frontoparietal)
Brain functional connectivity measurement (local efficiency limbic)
Brain functional connectivity measurement (local efficiency salience)
Brain functional connectivity measurement (local efficiency somatomotor)
Brain functional connectivity measurement (local effieiency visual)
Brain functional connectivity measurement (strength default)
Brain functional connectivity measurement (strength dorsal attention)
Brain functional connectivity measurement (strength frontoparietal)
Brain functional connectivity measurement (strength limbic)
Brain functional connectivity measurement (strength salience)
Brain functional connectivity measurement (strength somatomotor)
Brain functional connectivity measurement (strength visual)
Frozen shoulder
Human milk oligosaccharide concentration (sialyl-lacto-N-tetraose c)
Human milk oligosaccharide concentration (sialyl-lacto-N-tetraose c) in non-secretors
Visceral adipose tissue volume
Abdominal subcutaneous adipose tissue volume
Liver iron content
Pancreas iron content
Human milk oligosaccharide concentration (2'-fucosyllactose)
Human milk oligosaccharide concentration (3'-fucosyllactose)
Human milk oligosaccharide concentration (3'-fucosyllactose) in secretors
Human milk oligosaccharide concentration (3'-sialyllactose)
Human milk oligosaccharide concentration (6'-sialyllactose)
Human milk oligosaccharide concentration (difucosyllacto-N-hexaose)
Human milk oligosaccharide concentration (difucosyllacto-N-hexaose) in non-secretors
Human milk oligosaccharide concentration (difucosyllacto-N-tetrose)
Human milk oligosaccharide concentration (difucosyllacto-N-tetrose) in secretors
Human milk oligosaccharide concentration (difucosyllactose)
Human milk oligosaccharide concentration (disialyllacto-N-hexaose)
Human milk oligosaccharide concentration (disialyllacto-N-tetraose)
Human milk oligosaccharide concentration (fucodisialyllacto-N-hexaose)
Human milk oligosaccharide concentration (fucosyllacto-N-hexaose)
Human milk oligosaccharide concentration (lacto-N-fucopentaose I)
Human milk oligosaccharide concentration (lacto-N-fucopentaose I) in secretors
Human milk oligosaccharide concentration (lacto-N-fucopentaose II)
Human milk oligosaccharide concentration (lacto-N-fucopentaose II) in secretors
Human milk oligosaccharide concentration (lacto-N-fucopentaose III)
Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in non-secretors
Human milk oligosaccharide concentration (lacto-N-fucopentaose III) in secretors
Human milk oligosaccharide concentration (lacto-N-hexaose)
Human milk oligosaccharide concentration (lacto-N-neotetraose)
Human milk oligosaccharide concentration (lacto-N-tetrose)
Human milk oligosaccharide concentration (sialyl-lacto-N-tetraose b)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Neutropenia)"
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Neutropenia)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Hand foot syndrome)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Hand foot syndrome)"
Adverse response to chemotherapy in colorectal cancer (XELOX)
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Sepsis)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Sepsis)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Rash)
"Adverse response to chemotherapy in colorectal cancer (XELOX, Cetuximab) (Rash)"
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Rash)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Neutropenia)
Adverse response to chemotherapy in colorectal cancer (XELOX) (Hand foot syndrome)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Hand foot syndrome)"
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX, Cetuximab)"
Cisplatin-induced hearing loss in childhood cancer
Low testosterone levels
Tinnitus in cranial radiation therapy-treated pediatric cancer survivors
Hearing loss in cranial radiation therapy-treated pediatric cancer survivors
Hypertension in type 2 diabetes
Age at peak height velocity
Height at time of age with peak height velocity
Motor coordination
Adverse response to chemotherapy in colorectal cancer (XELOX) (Peripheral Neuropathy)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Peripheral Neuropathy)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Peripheral Neuropathy)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Peripheral Neuropathy)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Stomatitis)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Stomatitis)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Stomatitis)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Stomatitis)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Nausea)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Nausea)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Nausea)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Nausea)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Vomiting)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Vomiting)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Vomiting)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Vomiting)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Diarrhoea)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Diarrhoea)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Diarrhoea)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Diarrhoea)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Lethargy)
"Adverse response to chemotherapy in colorectal cancer (XELOX,Cetuximab) (Lethargy)"
Adverse response to chemotherapy in colorectal cancer (FOLFOX) (Lethargy)
"Adverse response to chemotherapy in colorectal cancer (FOLFOX,Cetuximab) (Lethargy)"
Adverse response to chemotherapy in colorectal cancer (XELOX) (Neutropenia)
Coagulation factor Xa measurement
Interleukin-2 receptor subunit alpha measurement
Interleukin-7 receptor subunit alpha measurement
Complement C2 measurement
Prothrombin measurement
Interleukin-1 receptor antagonist protein measurement
GDP-fucose protein O-fucosyltransferase 1 measurement
Antithrombin-III measurement
Coagulation factor XIII B chain measurement
von Willebrand factor A domain-containing protein 1 measurement
Protein FAM162A measurement
Plasminogen measurement
von Willebrand factor A domain-containing protein 2 measurement
Complement factor H measurement
ERO1-like protein beta measurement
KDEL motif-containing protein 2 measurement
Sulfhydryl oxidase 2 measurement
Complement C1s subcomponent measurement
Endoplasmic reticulum lectin 1 measurement
Monocyte differentiation antigen CD14 measurement
Palmitoyl-protein thioesterase 1 measurement
Neuronal pentraxin-1 measurement
Lactadherin measurement
Gelsolin measurement
Inter-alpha-trypsin inhibitor heavy chain H4 measurement
Coagulation factor IX measurement
Coagulation Factor X measurement
Coagulation Factor V measurement
D-dimer measurement
O-phosphoseryl-tRNA(Sec) selenium transferase measurement
Heme oxygenase 1 measurement
"Electron transfer flavoprotein subunit alpha, mitochondrial measurement"
Catechol O-methyltransferase measurement
Amino-terminal enhancer of split measurement
Prostaglandin E synthase 2 measurement
Serum amyloid A-2 protein measurement
Ras-related protein Rab-1A measurement
Protein Z-dependent protease inhibitor measurement
Coagulation Factor VIII measurement
AP-2 complex subunit alpha-2 measurement
NADPH--cytochrome P450 reductase measurement
Immunoglobulin G measurement
Apolipoprotein A-I measurement
Rap1 GTPase-GDP dissociation stimulator 1 measurement
Interleukin-1 receptor type 2 measurement
Complement component C8 gamma chain measurement
Interleukin-17 receptor A measurement
Serum amyloid A-1 protein measurement
Haptoglobin measurement
Alpha-galactosidase A measurement
Glutathione peroxidase 1 measurement
Interleukin-6 receptor subunit alpha measurement
Collagen alpha-1(VI) chain measurement
Ras-related protein Rab-2A measurement
"Monocyte differentiation antigen CD14, soluble measurement"
Coagulation factor XIII measurement
"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial measurement"
Fibrinogen gamma chain measurement
Galectin-3-binding protein measurement
Coagulation factor VII measurement
Coagulation factor IXab measurement
Insulin-degrading enzyme measurement
Complement C1r subcomponent measurement
Procollagen galactosyltransferase 1 measurement
Angiostatin measurement
Creatine kinase M-type:Creatine kinase B-type heterodimer measurement
Complement factor B measurement
"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 measurement"
"GrpE protein homolog 1, mitochondrial measurement"
Thrombin measurement
Inter-alpha-trypsin inhibitor heavy chain H3 measurement
Serotransferrin measurement
Interleukin-1 receptor-like 1 measurement
dCTP pyrophosphatase 1 measurement
C-reactive protein measurement
Growth/differentiation factor 15 measurement
Peptidyl-prolyl cis-trans isomerase FKBP7 measurement
Scavenger receptor class A member 5 measurement
Phospholipase D3 measurement
"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement"
SPARC-related modular calcium-binding protein 1 measurement
Coagulation Factor XI measurement
Tissue-type plasminogen activator measurement
Complement component C8 measurement
Interleukin-6 receptor subunit beta measurement
Vitamin K-dependent protein S measurement
Interleukin-1 Receptor accessory protein measurement
Plakophilin-2 measurement
Fibrinogen measurement
Plasminogen activator inhibitor 1 measurement
Vitamin K-dependent protein C measurement
Interleukin-1 receptor type 1 measurement
Stromal cell-derived factor 2 measurement
Interleukin-1 receptor-like 2 measurement
von Willebrand factor measurement
Fibulin-5 measurement
Lipopolysaccharide-binding protein measurement
Interleukin-2 receptor subunit beta measurement
Complement C1r subcomponent-like protein measurement
Gamma-glutamyl hydrolase measurement
Vesicular integral-membrane protein VIP36 measurement
Eukaryotic translation initiation factor 4E type 2 measurement
MAP/microtubule affinity-regulating kinase 3 measurement
Plasma p-tau181 levels
Type 1 diabetes with low genetic risk score
Bipolar disorder (early vs late onset)
Bullous pemphigoid
Neuroticism conditioned on cognitive performance (multi-trait conditioning and joint analysis)
Neuroticism conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)
Neuroticism conditioned on educational attainment (multi-trait conditioning and joint analysis)
Neuroticism conditioned on highest math class (multi-trait conditioning and joint analysis)
Neuroticism conditioned on average household income before tax (multi-trait conditioning and joint analysis)
Neuroticism conditioned on self-rated math ability (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on cognitive performance (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on Townsend deprivation index (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on educational attainment (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on highest math class (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on average household income before tax (multi-trait conditioning and joint analysis)
Subjective wellbeing conditioned on self-rated math ability (multi-trait conditioning and joint analysis)
hemolysis of donated blood (osmotic)
hemolysis of donated blood (oxidative)
hemolysis of donated blood (cold-storage)
Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)(time to event)
Response to tofacitinib treatment in psoriasis (herpes zoster)(time to event)
Response to tofacitinib treatment in rheumatoid arthritis (herpes zoster)
Response to tofacitinib treatment in psoriasis (herpes zoster)
Response to tofacitinib treatment (herpes zoster)(time to event)
Response to tofacitinib treatment (herpes zoster)
Anterior thalamic nuclei volume
Lateral thalamic nuclei volume
Ventral thalamic nuclei volume
Intralaminar thalamic nuclei volume
Medial thalamic nuclei volume
Posterior thalamic nuclei volume
Symptoms in placebo-treated COVID-19 outpatients at risk of severe disease (time to remission)
COVID-19 (hospitalized vs not hospitalized)
Symptoms in COVID-19 outpatients at risk of severe disease (time to remission)
X-linked dystonia-parkinsonism
Serum urate levels
Psychosis in Alzheimer's disease
Executive function (trail making test B) x time interaction
Executive function (trail making test B)
Executive function (verbal digit span backwards test) x time interaction
Executive function (verbal digit span backwards test)
Left inferior frontal gyrus (orbital part) cortical thickness
Left parahippocampal gyrus cortical thickness
Neonatal white matter microstructure
Adolescent idiopathic scoliosis (Cobb angle)
Pernicious anemia
Polymyalgia rheumatica
Hearing function (left/right asymmetry)
Sleep quality
Serum 25-Hydroxyvitamin D levels in type 2 diabetes
"1,25-dihydroxycholecalciferol levels in type 2 diabetes"
Serum vitamin D-binding protein levels in type 2 diabetes
Bioavailable vitamin D levels in type 2 diabetes
Intact parathyroid hormone levels in type 2 diabetes
Thoracic volumetric BMD in type 2 diabetes
Lumbar volumetric BMD in type 2 diabetes
Anti-BK polyomavirus IgG seropositivity
BK polyomavirus VP1 antibody levels
Anti-JC polyomavirus IgG seropositivity
JC polyomavirus VP1 antibody levels
Anti-Merkel cell polyomavirus IgG seropositivity
Merkel cell polyomavirus VP1 antibody levels
Severe COVID-19 infection
Asymptomatic COVID-19 infection
Mean reticulocyte volume
Mean sphered cell volume
Heel bone mineral density T score
Direct bilirubin levels
Unilateral cleft lip and palate (left vs right)
Left unilateral cleft lip and palate
Unilateral cleft lip (left vs right)
Right unilateral cleft lip
Left unilateral cleft lip
Right unilateral cleft lip and palate
Cleft lip with or without cleft palate (bilateral vs unilateral)
Idiopathic central precocious puberty
HTLV-1 associated myelopathy
Adverse cardiovascular outcome x beta blockers interaction in hypertension
Adverse cardiovascular outcome x calcium channel blockers interaction in hypertension
Adverse cardiovascular outcome x ACE inhibitors/ARBs interaction in hypertension
Adverse cardiovascular outcome x thiazide/thiazide-like diuretics interaction in hypertension
Pulmonary mycobacterium avium complex disease
Plasma amyloid beta peptide concentrations (ABx-40)
Plasma amyloid beta peptide concentrations (ABx-42)
Plasma amyloid beta peptide concentration (ABx-40/ABx-42 ratio)
Android fat/gynoid fat ratio
Trunk fat/peripheral fat ratio
Android total mass
Gynoid total mass
Arm total mass
Leg total mass
Trunk total mass
Total bone mineral content
Total fat mass
Total lean mass
Total mass
Android fat mass
Gynoid fat mass
Arm fat mass
Leg fat mass
Visceral adipose tissue mass
Android lean mass
Gynoid lean mass
Android bone mass
Gynoid bone mass
Arm bone mineral content
Leg bone mineral content
Trunk bone mineral content
Nausea incidence in varenicline-treated smokers
Thoracic aortic aneurysms
Candida albicans stimulated MCP-2 levels
Candida albicans stimulated CCL3 levels
Candida albicans stimulated MMP-1 levels
Candida albicans stimulated IL-8 levels
Survival in candidemia
Type 1 diabetes (age at diagnosis)
Biological age (BioAge)
Biological age (PhenoAge)
Two-hour glucose
Sociability score
Frequency of friend / family visits
Attending social / leisure activities
Non-hodgkin's lymphoma in HIV infection
Facial skin colour (CIELAB index L* value)
Facial skin colour (CIELAB index a* value)
Facial skin colour (CIELAB index b* value)
Externalizing behaviour (multivariate analysis)
Age at menopause
Ultradistal forearm bone mineral density
Functional dyspepsia
"Bilirubin (z,z) levels"
Cholesterol levels
Pyroglutamine levels
Cortisol levels
Sulfate levels
"1,5-anhydroglucitol (1,5-ag) levels"
Kynurenine levels
Asparagine levels
Proline levels
Ornithine levels
Citrulline levels
Acetoacetate levels
"Sphingomyelin (d18:1/14:0, d16:1/16:0) levels"
"Sphingomyelin (d18:1/18:1, d18:2/18:0) levels"
"Sphingomyelin (d18:1/20:0, d16:1/22:0) levels"
"Sphingomyelin (d18:1/20:1, d18:2/20:0) levels"
"Sphingomyelin (d18:1/22:1, d18:2/22:0, d16:1/24:1) levels"
"Sphingomyelin (d18:1/24:1, d18:2/24:0) levels"
"Sphingomyelin (d18:2/16:0, d18:1/16:1) levels"
"Sphingomyelin (d18:2/24:1, d18:1/24:2) levels"
Allantoin levels
Alpha-ketoglutarate levels
Dimethylglycine levels
Glucuronate levels
Glycerol 3-phosphate levels
Hypoxanthine levels
3-indoxyl sulfate levels
Inosine levels
Malate levels
Uridine levels
Xanthine levels
Phosphate levels
(N(1) + N(8))-acetylspermidine levels
"1,2-dipalmitoyl-gpc (16:0/16:0) levels"
1-(1-enyl-palmitoyl)-2-arachidonoyl-gpc (p-16:0/20:4) levels
1-(1-enyl-palmitoyl)-2-oleoyl-gpc (p-16:0/18:1) levels
1-arachidonoyl-gpc (20:4n6) levels
1-linoleoyl-gpc (18:2) levels
1-methylhistidine levels
1-methylnicotinamide levels
1-myristoyl-2-palmitoyl-gpc (14:0/16:0) levels
1-oleoyl-gpc (18:1) levels
X-23308 levels
Ethyl beta-glucopyranoside levels
X-23587 levels
X-23590 levels
X-23593 levels
X-23639 levels
X-23644 levels
X-23652 levels
X-23739 levels
X-24228 levels
X-24295 levels
3-(3-amino-3-carboxypropyl)uridine levels
X-24337 levels
X-24431 levels
X-24452 levels
X-24686 levels
X-24699 levels
3-amino-2-piperidone levels
X-24813 levels
X-24952 levels
X-25109 levels
N6-methyllysine levels
X-11795 levels
X-12007 levels
X-12015 levels
X-12100 levels
X-12101 levels
X-12104 levels
Ascorbic acid 3-sulfate levels
X-12411 levels
X-12906 levels
1-carboxyethylvaline levels
X-13728 levels
X-14056 levels
1-methyl-5-imidazoleacetate levels
X-15245 levels
1-carboxyethylphenylalanine levels
X-15674 levels
"N,n,n-trimethyl-alanylproline betaine (tmap) levels"
X-18887 levels
X-19438 levels
X-21286 levels
Butyrate (4:0) levels
X-21733 levels
2-o-methylascorbic acid levels
X-22162 levels
4-chlorobenzoic acid levels
Response to tolvaptan in hepatic ascites (body weight gain)
1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels
1-palmitoyl-2-docosahexaenoyl-gpc (16:0/22:6) levels
1-palmitoyl-2-linoleoyl-gpc (16:0/18:2) levels
1-palmitoyl-2-oleoyl-gpc (16:0/18:1) levels
1-palmitoyl-2-palmitoleoyl-gpc (16:0/16:1) levels
1-palmitoyl-2-stearoyl-gpc (16:0/18:0) levels
1-ribosyl-imidazoleacetate levels
1-stearoyl-2-arachidonoyl-gpc (18:0/20:4) levels
1-stearoyl-2-docosahexaenoyl-gpc (18:0/22:6) levels
1-stearoyl-2-linoleoyl-gpc (18:0/18:2) levels
1-stearoyl-2-oleoyl-gpc (18:0/18:1) levels
1-stearoyl-gpc (18:0) levels
2'-deoxyuridine levels
2'-o-methylcytidine levels
"2,3-dihydroxy-2-methylbutyrate levels"
"2,3-dihydroxyisovalerate levels"
2-aminobutyrate levels
2-aminophenol sulfate levels
2-hydroxy-3-methylvalerate levels
2-hydroxyadipate levels
2-hydroxybutyrate/2-hydroxyisobutyrate levels
2-hydroxyglutarate levels
2-oxoadipate levels
2-piperidinone levels
5-methylcytidine levels
6-oxopiperidine-2-carboxylate levels
7-methylguanine levels
7-methylxanthine levels
Alpha-ketoglutaramate levels
Alpha-tocopherol levels
Arabinose levels
Ascorbate (vitamin c) levels
5-hydroxyindoleacetate levels
Acetylcarnitine (c2) levels
Arabitol/xylitol levels
Arabonate/xylonate levels
Arachidonate (20:4n6) levels
Argininate levels
Arginine levels
5-methylthioadenosine (mta) levels
5-methyluridine (ribothymidine) levels
7-alpha-hydroxy-3-oxo-4-cholestenoate (7-hoca) levels
Acisoga levels
Adenine levels
"Adenosine 3',5'-cyclic monophosphate (camp) levels"
Alpha-hydroxyisocaproate levels
Alpha-hydroxyisovalerate levels
Argininosuccinate levels
3-(4-hydroxyphenyl)lactate levels
3-carboxy-4-methyl-5-propyl-2-furanpropanoate (cmpf) levels
3-hydroxy-2-ethylpropionate levels
3-hydroxy-3-methylglutarate levels
3-hydroxybutyrate (bhba) levels
3-hydroxyhexanoate levels
3-hydroxyoctanoate levels
3-hydroxypyridine sulfate levels
3-hydroxystachydrine levels
3-methoxytyramine sulfate levels
3-methoxytyrosine levels
3-methyl-2-oxobutyrate levels
3-methyl-2-oxovalerate levels
3-methylglutaconate levels
3-methylglutarylcarnitine (2) levels
3-methylhistidine levels
3-methylxanthine levels
3-ureidopropionate levels
4-acetamidobutanoate levels
4-methyl-2-oxopentanoate levels
4-methylcatechol sulfate levels
"5,6-dihydrothymine levels"
"5,6-dihydrouridine levels"
5-acetylamino-6-amino-3-methyluracil levels
5-hydroxyhexanoate levels
Behenoyl sphingomyelin (d18:1/22:0) levels
Benzoate levels
Beta-alanine levels
Beta-citrylglutamate levels
Beta-hydroxyisovalerate levels
Betaine levels
C-glycosyltryptophan levels
Caffeine levels
Carboxyethyl-gaba levels
Catechol sulfate levels
Choline levels
Choline phosphate levels
Citramalate levels
Cortisone levels
"Cys-gly, oxidized levels"
Cysteine levels
Cysteinylglycine levels
Cysteinylglycine disulfide levels
Cytidine levels
Deoxycarnitine levels
Diglycerol levels
Dimethyl sulfone levels
Peak oxygen uptake response following exercise training
Dimethylarginine (sdma + adma) levels
Dimethylmalonic acid levels
Dopamine 3-o-sulfate levels
Ergothioneine levels
Erythritol levels
Erythronate levels
Ethylmalonate levels
Fructose levels
Galactonate levels
Galactosylglycerol levels
Gamma-glutamyl-alpha-lysine levels
Gamma-glutamylglutamine levels
Gamma-glutamylleucine levels
Gamma-glutamylphenylalanine levels
Gamma-glutamylthreonine levels
Gamma-glutamylvaline levels
Gluconate levels
Glutamate levels
Glutarylcarnitine (c5-dc) levels
Glycerate levels
Glycerol levels
Glycerophosphoinositol levels
Guaiacol sulfate levels
Guanosine levels
Gulonate levels
Histidine levels
Homoarginine levels
Homocarnosine levels
Homostachydrine levels
Homovanillate (hva) levels
Hydroxy-cmpf levels
Hydroxyasparagine levels
Indoleacetate levels
Isobutyrylcarnitine (c4) levels
Isocitrate levels
Isovalerate (i5:0) levels
Kynurenate levels
Maleate levels
Mannitol/sorbitol levels
Mannose levels
Methionine levels
Methionine sulfone levels
Methionine sulfoxide levels
Methyl glucopyranoside (alpha + beta) levels
Methylmalonate (mma) levels
Methylsuccinate levels
Methylsuccinoylcarnitine levels
Myo-inositol levels
N-acetyl-3-methylhistidine levels
N-acetyl-aspartyl-glutamate (naag) levels
N-acetyl-beta-alanine levels
N-acetyl-isoputreanine levels
N-acetylalanine levels
N-acetylarginine levels
N-acetylasparagine levels
N-acetylaspartate (naa) levels
N-acetylglucosamine/n-acetylgalactosamine levels
N-acetylglutamate levels
N-acetylglutamine levels
N-acetylglycine levels
N-acetylhistidine levels
N-acetylisoleucine levels
N-acetylleucine levels
N-acetylmethionine levels
N-acetylneuraminate levels
N-acetylphenylalanine levels
N-acetylputrescine levels
N-acetylserine levels
N-acetyltaurine levels
N-acetylthreonine levels
N-acetylvaline levels
N-delta-acetylornithine levels
N-formylanthranilic acid levels
N-formylmethionine levels
N-trimethyl 5-aminovalerate levels
N1-methyl-2-pyridone-5-carboxamide levels
N1-methyladenosine levels
N1-methylinosine levels
"N2,n2-dimethylguanosine levels"
"N6,n6,n6-trimethyllysine levels"
N6-carbamoylthreonyladenosine levels
N6-succinyladenosine levels
Nicotinamide riboside levels
O-sulfo-l-tyrosine levels
Octanoylcarnitine (c8) levels
Orotate levels
Orotidine levels
Oxalate (ethanedioate) levels
Palmitoyl dihydrosphingomyelin (d18:0/16:0) levels
Palmitoyl sphingomyelin (d18:1/16:0) levels
Pantothenate levels
Phenol sulfate levels
Phenylacetylglutamine levels
Phenylalanine levels
Phenyllactate (pla) levels
Pipecolate levels
Propionylcarnitine (c3) levels
Pseudouridine levels
Pyridoxate levels
Pyruvate levels
Quinate levels
Ribitol levels
Ribonate levels
Ribulonate/xylulonate levels
S-1-pyrroline-5-carboxylate levels
S-methylcysteine levels
Salicylate levels
Serine levels
Spermidine levels
Stachydrine levels
Stearoyl sphingomyelin (d18:1/18:0) levels
Succinimide levels
Succinylcarnitine (c4-dc) levels
Tartarate levels
Tartronate (hydroxymalonate) levels
Theobromine levels
Theophylline levels
Thioproline levels
Threonate levels
Threonine levels
Excessive alcohol consumption
Cerebrospinal fluid progranulin levels
QT dynamics during exercise
QT dynamics during recovery from exercise
Tinnitus
Congenital heart disease
Congenital heart disease (transposition of the great arteries)
Congenital right-sided heart lesions
Congenital left-sided heart lesions
Congenital heart disease (septal defects)
Congenital heart disease (anomalies of thoracic arteries and veins)
Biological sex
Biological sex (age adjusted)
P3 amplitude reduction
P3 genetic factor
Antisaccade tracking error rate
Skin conductance level
Electrodermal activity factor
Overall startle response
Aversive difference startle modulation
Pleasant difference startle modulation
Skin conductance response frequency
Skin conductance response amplitude
Alpha electroencephalogram power
Beta electroencephalogram power
Theta electroencephalogram power
Delta electroencephalogram power
Total electroencephalogram power
Alpha electroencephalogram power O1O2
Alpha electroencephalogram frequency O1O2
Sun-seeking behavior
Hypertrophic cardiomyopathy (sarcomere positive)
Hypertrophic cardiomyopathy (sarcomere negative)
Response to buprenorphine in opioid use disorder
Perceptual and visual search speed (trail making test A)
Disability level (impaired activities of daily living)
Global cognition (Clinical Dementia Rating Scale Sum of Boxes)
Cognitive impairment level
Anxious temperament
Cyclothymic temperament
Depressive temperament
Irritable temperament
Hyperthymic temperament
Degenerative rotator cuff disease surgery
Conotruncal heart defects with normally related great vessels (without 22q.11.2 deletion syndrome)
Conotruncal heart defects with normally related great vessels
Lung cancer prognosis in former smokers
Relative brain age
COVID-19
Hand osteoarthritis severity (hand Klsum)
Finger osteoarthritis severity (hand Klsum)
Thumb osteoarthritis severity (hand Klsum)
Hypoalbuminemia
Parkinson's disease motor subtype (tremor dominant vs postural instability/gait difficulty)
Parkinson's disease motor subtype (tremor to postural instability/gait difficulty score ratio)
Kidney injury 5 years post-surgery in obstructive uropathies
Left atrial active emptying fraction
Left atrial passive emptying fraction
Left atrial total emptying fraction
COVID-19 (covid vs negative)
COVID-19 (hospitalized covid vs population)
COVID-19 (covid pneumonia vs population)
COVID-19 (covid respiratory support vs population)
COVID-19 (severe respiratory symptoms vs population)
Estimated glomerular filtration rate (creatinine)
sarcopenia
Asthma and eczema
Longevity (100 years and older)
Amyloid beta positivity
Sarcoidosis (non-Lofgren's syndrome) (smoking status interaction)
Sarcoidosis (Lofgren's syndrome) (smoking status interaction)
Hearing function (0.5 kHz)
Hearing function (1 kHz)
Hearing function (2 kHz)
Hearing function (4 kHz)
Hearing function (8 kHz)
Progression free survival in epithelial ovarian cancer treated with carboplatin and paclitaxel
Progression free survival in epithelial ovarian cancer
Progression free survival in serous epithelial ovarian cancer
Overall survival in epithelial ovarian cancer treated with carboplatin and paclitaxel
Overall survival in epithelial ovarian cancer
Overall survival in serous epithelial ovarian cancer
Severe exacerbations in childhood asthma
Tea consumption
Obstructive sleep apnea
Obstructive sleep apnea (BMI adjusted)
Endometriosis or depression (pleiotropy)
Cervical intraepithelial neoplasia grade 3
Invasive cervical cancer
Cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
Severe coronary stenosis (family history of CAD interaction)
Severe coronary stenosis (young age of onset interaction)
Severe coronary stenosis
Suicide attempt severity in mood disorders
Suicidality in mood disorders
Opioid use disorder vs exposed controls
Rheumatoid arthritis or schizophrenia
Severe skin toxicity response to cetuximab in stage 3 colon cancer
Retinitis pigmentosa
Response to antioxidants and zinc in age-related macular degeneration (disease progression)
Type 1 or type 2 diabetes (pleiotropy)
Cerebral amyloid angiopathy in APOEe4 carrier Alzheimer’s disease
Cerebral amyloid angiopathy in APOEe4 non-carrier Alzheimer’s disease
Cerebral amyloid angiopathy x sex interaction in Alzheimer’s disease
Cerebral amyloid angiopathy x APOEe4 status interaction in Alzheimer’s disease
Cerebral amyloid angiopathy in Alzheimer’s disease
Facial morphology (segment 1)
Facial morphology (segment 2)
Facial morphology (segment 3)
Facial morphology (segment 4)
Facial morphology (segment 5)
Facial morphology (segment 6)
Facial morphology (segment 7)
Facial morphology (segment 8)
Facial morphology (segment 9)
Facial morphology (segment 10)
Facial morphology (segment 11)
Facial morphology (segment 12)
Facial morphology (segment 13)
Facial morphology (segment 14)
Facial morphology (segment 15)
Facial morphology (segment 16)
Facial morphology (segment 17)
Facial morphology (segment 18)
Facial morphology (segment 19)
Facial morphology (segment 20)
Facial morphology (segment 21)
Facial morphology (segment 22)
Facial morphology (segment 23)
Facial morphology (segment 24)
Facial morphology (segment 25)
Low white blood cell count
Lung function (FEV1) and body mass index
Lung function (FEV1) and waist to hip ratio adjusted for BMI
Lung function (FEV1) and waist circumference adjusted for BMI
Lung function (FVC) and body mass index
Lung function (FVC) and waist to hip ratio adjusted for BMI
Lung function (FVC) and waist circumference adjusted for BMI
Lung function (FEV1/FVC) and body mass index
Disease free survival in colorectal cancer
Recurrence-free survival in colorectal cancer
Therapy-related myelodysplastic syndrome
De novo myelodysplastic syndrome
Therapy-related acute myeloid leukemia
De novo acute myeloid leukemia (normal cytogenetics)
De novo acute myeloid leukemia (abnormal cytogenetics)
Acute myeloid leukemia or myelodysplastic syndrome (pleiotropy)
Osteoarthritis (with total hip replacement)
Osteoarthritis (with total knee replacement)
Finger osteoarthritis
Thumb osteoarthritis
Spine osteoarthritis
Early-onset osteoarthritis
Idiopathic achalasia
Schizophrenia (SNP x SNP interaction)
Response to idarubicin
Response to mitoxantrone
Response to topotecan
Response to paclitaxel
Response to vinblastine
Response to vincristine sulfate
Response to vinorelbine
Response to azacytidine
Response to cladaribine
Response to cytosine beta-D-arabinoside
Response to fludarabine
Response to cytidine analogues (gemcitabine)
Response to 5-fluorouracil
Response to fluoro-deoxyuridine
Response to arsenic trioxide
Response to oxaliplatin
Response to apatinib
Response to axitinib
Response to cabozantinib
Response to crizotinib
Response to dasatinib
Response to dovitinib
Response to erlotinib
Body mass index in childhood asthma
Waist-to-hip ratio adjusted for BMI (recessive genetic model)
Waist-to-hip ratio adjusted for BMI (additive genetic model)
Anhedonia in major depressive disorder
Plasma parathyroid hormone levels
Cognitive flexibility
Midgestational cytokine/chemokine levels (maternal genetic effect)
Neonatal cytokine/chemokine levels (maternal genetic effect)
Midgestational cytokine/chemokine levels (fetal genetic effect)
Neonatal cytokine/chemokine levels (fetal genetic effect)
Progressive supranuclear palsy
Obesity without metabolic disease
Thyroid nodules
Thrombocytopenia in coronary artery bypass surgery
Leisure-time exercise behaviour
Leisure-time exercise behaviour (age-stratified)
Biliary atresia
Glomerular filtration rate change in heart transplantation
Fragile X syndrome
Response to cognitive-behavioural therapy in anxiety and major depressive disorders
Facial morphology traits (63 three-dimensional facial segments)
Diabetic peripheral neuropathy in type 2 diabetes
Methioninesulfoxide levels
trans-Hydroxyproline levels
Propionylcarnitine levels
Hexanoylcarnitine levels
Pimelylcarnitine levels
Octanoylcarnitine levels
Acetylornithine levels
Symmetric dimethylarginine levels
Dodecenoylcarnitine levels
Tetradecanoylcarnitine levels
Aspartate levels
Sarcosine levels
Acetylcarnitine levels
Butyrylcarnitine levels
Valerylcarnitine levels
Methylglutarylcarnitine levels
Tryptophan levels
Nonaylcarnitine levels
Decanoylcarnitine levels
Decenoylcarnitine levels
Dodecanoylcarnitine levels
alpha-Aminoadipic acid levels
Tetradecenoylcarnitine levels
Tetradecadienylcarnitine levels
Hexadecanoylcarnitine levels
Hexadecenoylcarnitine levels
Octadecanoylcarnitine levels
Octadecenoylcarnitine levels
Octadecandienylcarnitine levels
lysoPhosphatidylcholine acyl C14:0 levels
lysoPhosphatidylcholine acyl C16:1 levels
lysoPhosphatidylcholine acyl C17:0 levels
lysoPhosphatidylcholine acyl C18:0 levels
lysoPhosphatidylcholine acyl C18:2 levels
lysoPhosphatidylcholine acyl C20:4 levels
lysoPhosphatidylcholine acyl C26:1 levels
lysoPhosphatidylcholine acyl C16:0 levels
lysoPhosphatidylcholine acyl C18:1 levels
lysoPhosphatidylcholine acyl C20:3 levels
lysoPhosphatidylcholine acyl C24:0 levels
lysoPhosphatidylcholine acyl C26:0 levels
lysoPhosphatidylcholine acyl C28:0 levels
lysoPhosphatidylcholine acyl C28:1 levels
Phosphatidylcholine diacyl C24:0 levels
Phosphatidylcholine diacyl C26:0 levels
Phosphatidylcholine diacyl C30:0 levels
Phosphatidylcholine diacyl C32:0 levels
Phosphatidylcholine diacyl C32:1 levels
Phosphatidylcholine diacyl C32:2 levels
Phosphatidylcholine diacyl C34:1 levels
Phosphatidylcholine diacyl C34:2 levels
Phosphatidylcholine diacyl C34:3 levels
Phosphatidylcholine diacyl C34:4 levels
Phosphatidylcholine diacyl C36:0 levels
Phosphatidylcholine diacyl C36:2 levels
Phosphatidylcholine diacyl C36:3 levels
Phosphatidylcholine diacyl C36:4 levels
Phosphatidylcholine diacyl C36:5 levels
Phosphatidylcholine diacyl C36:6 levels
Phosphatidylcholine diacyl C38:0 levels
Phosphatidylcholine diacyl C38:3 levels
Phosphatidylcholine diacyl C38:4 levels
Phosphatidylcholine diacyl C38:5 levels
Phosphatidylcholine diacyl C38:6 levels
Phosphatidylcholine diacyl C40:2 levels
Phosphatidylcholine diacyl C40:3 levels
Phosphatidylcholine diacyl C40:4 levels
Phosphatidylcholine diacyl C40:5 levels
Phosphatidylcholine diacyl C40:6 levels
Phosphatidylcholine diacyl C42:0 levels
Phosphatidylcholine diacyl C42:1 levels
Phosphatidylcholine diacyl C42:4 levels
Phosphatidylcholine diacyl C42:5 levels
Phosphatidylcholine diacyl C42:6 levels
Phosphatidylcholine acyl-alkyl C30:1 levels
Macular thickness
Estrone-3-glucuronide levels
Pregnanediol-3-glucuronide levels
Carotid plaque maximum area
Sum of carotid plaque area
Mean area of carotid plaque
Maximum stenosis
Mean degree of stenosis
Sum of stenosis
T-Cell Immunoglobulin and Mucin domain 1 levels
Coronary artery calcification
Central serous retinopathy
Cognitive performance in schizophrenia or bipolar disorder
Anxiety disorder (factor score)
Shigella-associated diarrhea
Childhood body fatness
Pancreatic ductal adenocarcinoma x smoking interaction
Cardiovascular event in colchicine-treated recent myocardial infarction (time to event)
Gastrointestinal event in colchicine-treated recent myocardial infarction (time to event)
Invasive breast cancer
"Breast cancer (estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor-receptor negative)"
Restless legs syndrome in migraine without aura
Restless legs syndrome in migraine with aura
Restless legs syndrome in migraine
Cerebrospinal fluid t-tau:AB1-42 ratio
Childhood ALL/LBL (acute lymphoblastic leukemia/lymphoblastic lymphoma) treatment-related venous thromboembolism
Mammographic density (dense area)
Mammographic density (non-dense area)
Percent mammographic density
Tafenoquine efficacy in P. vivax malaria (recurrence by 6 months)
Tafenoquine efficacy in P. vivax malaria (recurrence by 4 months)
Tafenoquine efficacy in P. vivax malaria (time to recurrence up to 6 months)
Leukoderma in response to rhododendrol
Dietary fat liking
Deep white matter hyperintensities
Periventricular white matter hyperintensities
Sensory peripheral neuropathy in microtubule targeting agent-treated breast cancer
Gestational insulin sensitivity
Autoimmune traits
Autoimmune disease (without mental disorder)
Mental disorder (without autoimmune disease)
Autoimmune disease and mental disorder
Self-harm ideation
Brugada syndrome
"Allergic disease (asthma, hay fever and/or eczema) (age of onset)"
"Allergic disease (asthma, hay fever and/or eczema) (multivariate analysis)"
Motor fluctuations in levodopa treated Parkinson's disease
Levodopa-induced dyskinesia in levodopa treated Parkinson's disease
spontaneous preterm birth x maternal stress interaction (1df)
Response to esketamine in treatment resistant depression
Response to esketamine (responder status) in treatment resistant depression
Response to esketamine (remission) in treatment resistant depression
Allergic march (atopic dermatitis to allergic rhinitis)
Allergic march (atopic dermatitis to asthma)
Cellular nuclear factor (erythroid-derived 2)-like 2 levels
Number of twin births
Geographic atrophy lesion growth rate in age-related macular degeneration
Alzheimer's disease with memory domain impairment
Alzheimer's disease with language domain impairment
Alzheimer's disease with visuospatial domain impairment
Alzheimer's disease with multiple cognitive domain impairments
Alzheimer's disease with no specific cognitive domain impairment
Carotid plaque
Health literacy
Sepsis (hospital admission)
Pneumonia (28-day mortality)
Pneumonia (90-day mortality)
Sepsis (28-day mortality)
Sepsis (90-day mortality)
Infectious disease (hospital admission)
Pneumonia (hospital admission)
Skin and soft tissue infections (hospital admission)
Urinary tract infection (hospital admission)
Brain shape (segment 1)
Brain shape (segment 27)
Brain shape (segment 28)
Brain shape (segment 29)
Brain shape (segment 7)
Brain shape (segment 31)
Brain shape (segment 10)
Brain shape (segment 11)
Brain shape (segment 12)
Brain shape (segment 34)
Brain shape (segment 15)
Brain shape (segment 16)
Brain shape (segment 17)
Brain shape (segment 18)
Brain shape (segment 19)
Brain shape (segment 20)
Brain shape (segment 21)
Brain shape (segment 40)
Brain shape (segment 24)
Brain shape (segment 42)
Brain shape (segment 43)
Brain shape (segment 44)
Brain shape (segment 45)
Brain shape (segment 46)
Brain shape (segment 47)
Brain shape (segment 48)
Brain shape (segment 49)
Brain shape (segment 50)
Brain shape (segment 101)
Brain shape (segment 102)
Brain shape (segment 103)
Brain shape (segment 104)
Brain shape (segment 105)
Brain shape (segment 106)
Brain shape (segment 107)
Brain shape (segment 108)
Brain shape (segment 109)
Brain shape (segment 110)
Brain shape (segment 111)
Brain shape (segment 112)
Brain shape (segment 113)
Brain shape (segment 114)
Brain shape (segment 115)
Brain shape (segment 116)
Brain shape (segment 117)
Brain shape (segment 118)
Brain shape (segment 119)
Brain shape (segment 120)
Brain shape (segment 121)
Brain shape (segment 122)
Brain shape (segment 123)
Brain shape (segment 124)
Brain shape (segment 125)
Brain shape (segment 176)
Brain shape (segment 177)
Brain shape (segment 178)
Brain shape (segment 179)
Brain shape (segment 180)
Brain shape (segment 181)
Brain shape (segment 182)
Brain shape (segment 183)
Brain shape (segment 184)
Brain shape (segment 185)
Brain shape (segment 186)
Brain shape (segment 187)
Brain shape (segment 188)
Brain shape (segment 189)
Brain shape (segment 190)
Brain shape (segment 191)
Brain shape (segment 192)
Brain shape (segment 193)
Brain shape (segment 194)
Brain shape (segment 195)
Brain shape (segment 196)
Brain shape (segment 197)
Brain shape (segment 198)
Brain shape (segment 199)
Brain shape (segment 200)
Brain shape (segment 126)
Brain shape (segment 127)
Brain shape (segment 128)
Brain shape (segment 129)
Brain shape (segment 130)
Brain shape (segment 131)
Brain shape (segment 132)
Brain shape (segment 133)
Brain shape (segment 134)
Brain shape (segment 135)
Brain shape (segment 136)
Brain shape (segment 137)
Brain shape (segment 138)
Brain shape (segment 139)
Brain shape (segment 140)
Brain shape (segment 141)
Brain shape (segment 142)
Brain shape (segment 143)
Brain shape (segment 144)
Brain shape (segment 145)
Brain shape (segment 146)
